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  ABSTRACT 
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ABSTRACT 
Wnt signalling is one the most important pathways involved in embryonic 
development. It controls a number of processes including cellular proliferation, stem cell 
maintenance, cell fate decisions and establishment of tissue polarity. It is also frequently 
deregulated in human cancers. Frizzled-7 (Fz7) is a member of the Frizzled family of 
receptors responsible for the signal transduction in Wnt signalling. Frizzled-7 has been 
reported to be upregulated in several types of cancer. Furthermore, recent reports suggest 
that endocytosis of Frizzled may play a critical role in enhancing role in Wnt signal 
transduction, thus facilitating cancer development. We demonstrate here that the C-terminal 
PDZ binding motif (PDZ-BM) of Frizzled-7 contributes to signalling triggered by the 
receptor. We also explore the interaction between Frizzled-7 and syntenin-1, a PDZ domain 
containing protein that controls endocytic trafficking of various transmembrane proteins. We 
demonstrate that syntenin-1 regulates Frizzled-7 cell distribution and also modulates 
canonical Wnt signalling in epithelial breast cancer cells. Further, we report that the C-
terminal PDZ-BM of Fz7 is indispensable for the receptor interaction with a number of PDZ 
proteins that control protein trafficking and cell polarity.  Among these PDZ proteins are 
LNX1 and LNX2, E3 ubiquitin ligases which are known to control trafficking of 
transmembrane proteins. In this study we characterize the interaction between Frizzled-7 
and LNX2. We demonstrate that LNX2 influences ubiquitylation of Frizzled-7 and has the 
ability to moderate signal transduction within the canonical Wnt pathway in breast cancer 
cells. 
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shRNA small hairpin RNA 
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siRNA Small interfering RNA 
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SMO Smoothened 
SNX27 Sorting nexin-27 
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TCF/LEF T-Cell Factor/Lymphoid Enhancer Factor 
TGFα transforming growth factor alpha 
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TMEN46 Transmembrane protein 46  
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TSHR thyroid stimulating hormone receptor 
Ulk1 Unc-51-like kinase 1 
USP8 ubiquitin specific protease 8 
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VEGF vascular endothelial growth factor 
VSDs ventricular septal defects  
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WIF Wnt inhibitory factors  
WRE Wnt response elements  
ZNRF3 zinc and ring finger 3 
ZO-1 Tight junction protein ZO-1 
ZO-2 Tight junction protein ZO-2 
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1. INTRODUCTION 
1.1. Wnt signalling overview 
Wnt signalling pathways evolved in multicellular organisms to mediate complex cell-
cell communication during development and in adult tissue homeostasis. Wnt signalling 
plays an important role in the regulation of many biological processes, such as development, 
proliferation, stem cell maintenance, cell movement and establishment of tissue polarity 
(Fuerer et al. 2008). Deregulation of Wnt signalling contributes significantly to the 
development of cancer and emerges as a central mechanism in cancer biology (Polakis 2012). 
Wnt signalling is extremely complex. It involves numerous components regulated in 
many steps and involves cross-talk with other pathways. There are three major pathways of 
Wnt signalling: the canonical pathway, also known as β-catenin-dependent pathway, and 
two noncanonical (β-catenin independent) pathways: the planar cell polarity (PCP) pathway 
and the Wnt/Ca2+ pathway. Activation of signal transduction in all of these pathways 
requires binding of a protein from the Wnt family to Frizzled receptors and co-receptors 
(Rao et al. 2010). A simplified overview of Wnt signalling pathways is presented in the 
Figure 1. 1.  
Wnt ligands are glycoproteins belonging to a large family of cysteine-rich secreted 
growth factors. In humans, there are 19 genes encoding evolutionarily conserved Wnt 
proteins (Miller 2002). They can bind to different receptors and activate various downstream 
pathways. Several Wnts preferentially activate either canonical (Wnt1, Wnt3a, Wnt8) or non-
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canonical pathways (Wnt5a and Wnt11). Nonetheless, Wnt activity depends on the cellular 
context and receptors on the cell surface, so Wnt proteins can not be strictly divided into 
subgroups based on the pathway they activate (Niehrs 2012).  
There are more than 15 Wnt receptors and co-receptors, and their various 
combinations with Wnt proteins determine the nature and extent of downstream pathway 
activation. Wnt receptors and co-receptors include 10 Frizzled receptors, low-density 
lipoprotein receptor-related protein 5/6 (LRP5/6), receptor Tyr kinase-like orphan receptor 
(ROR), protein Tyr kinase 7 (PTK7), receptor Tyr kinase (RYK), muscle skeletal receptor Tyr 
kinase (MuSK) and proteoglycan families. This allows for a number of ligand-receptor 
combinations (Kikuchi et al. 2007). Additionally, Frizzled can act as a receptor for both, 
canonical and non-canonical pathways. The outcome depends on the co-receptor expressed 
in the cells; for example, LRP5/6 allows engagement of the canonical pathway, whereas 
ROR1/2 the non-canonical pathway (Niehrs 2012;van Amerongen R. et al. 2009). Figure 1.2. 
summarizes reported Wnt/Frizzled interactions. 
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Figure 1. 1. Wnt signalling pathways. 
A simplified diagram showing the main pathways mediated by Wnt proteins, Frizzled 
receptors and Wnt co-receptors interactions. (A) Noncanonical planar cell polarity (PCP) 
signalling triggers activation RHO kinase (ROCK) and JUN-N-terminal kinase (JNK), 
leading to actin polymerization and microtubule stabilization. This pathway is involved 
in the cell polarity regulation, cell motility and morphogenetic movements. (B) Canonical 
Wnt signalling pathway. Upon stimulation with Wnt ligand, the β-catenin destruction 
complex (glycogen synthase kinase3β (GSK3β), casein kinase Iα (CKIα), Axin and 
adenomatosis polyposis coli (APC)) is recruited to the Wnt–Frizzled complex and 
inactivated. This leads to β-catenin accumulation and translocation to the nucleus, where 
it initiates the transcription of Wnt target genes under the control of T cell factor 
(TCF). (C) The Wnt/Ca2+ pathway activates Ca2+- and calmodulin-dependent kinase II 
(CAMKII), protein kinase C (PKC) and calcineurin. Calcineurin activates nuclear factor of 
activated T cells (NFAT), which regulates the transcription of genes involved in regulation 
of cell fate and cell migration. PCP and Ca2+ pathways antagonize β-catenin signalling at 
various levels. PLC, phospholipase C; DAAM, DVL-associated activator of morphogenesis 
1; DVL, Dishevelled; LRP, low-density lipoprotein receptor-related protein. Figure 
reproduced and modified from (Niehrs 2012).  
A. B. C.
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Figure 1. 2. Wnt/Frizzled interactions.  
An overview of reported human Wnt/Frizzled combinations and their possible 
interaction. Crosses (x) indicate evidence for direct binding based on 
immunoprecipitation, whereas circles (o) indicate colocalization, signalling outcomes such 
as TCF reporter activity, TOPFlash or internalization. Green indicates data already present 
in the IUPHAR Database. Figure is reproduced from (Dijksterhuis et al. 2014).  
 
1.1.1. Molecular mechanism of Wnt canonical pathway 
The best-characterized Wnt pathway described in the literature is the so-called 
canonical Wnt pathway. It is also known as the  β-catenin dependent pathway, as it involves 
a multifunctional protein β-catenin. β-catenin was discovered as a part of adherens junction 
complex, where it interacts with E-cadherin and α-catenin (McCrea et al. 1991). It has an 
important function in cadherin-based cell adhesion. It is also a central component of the 
canonical Wnt signalling pathway, and serves as a transcription co-factor through interacting 
with TCF/LEF (T-Cell Factor/Lymphoid Enhancer Factor) proteins in the nucleus (Behrens et 
al. 1996). It was proposed that dissociation of β-catenin from the cadherin complex (E-
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cadherin-β-catenin-α-catenin) causes loss of cell adhesion and promotes the migration of 
cancer cells (Xu et al. 2007).  
In the absence of Wnt ligand, the cellular levels of β-catenin are strictly controlled by 
a multi-protein destruction complex composed of axin, adenomatous polyposis coli (APC), 
glycogen synthase kinase 3β (GSK3β) and casein kinase 1α (CK1α). This complex 
phosphorylates β-catenin on the N-terminus, leading to its subsequent ubiquitylation and 
degradation by theproteosome. β-catenin can be phosphorylated on Ser33, Ser37, Thr41 and 
Ser45. Firstly, Ser45 is phosphorylated by CK1α (Amit et al. 2002). Other sites are 
phosphorylated later by GSK3β (Liu et al. 2002). All four residues have to be phosphorylated 
to allow ubiquitylation. Mutation in any of these sites leads to β-catenin stabilization in the 
cytoplasm. Axin serves as a scaffold protein to bring kinases and β-catenin together. 
Phosphorylated β-catenin is recognized by β-TrCP (β-transducin repeat-containing protein), 
an E3 ubiquitin ligase, that triggers the ubiquitylation process (Marikawa et al. 1998). Thus, 
the intracellular level of β-catenin remains low and TCF/LEF mediated expression of Wnt 
response genes is repressed by Grouchos (Rao et al. 2010).  
The canonical Wnt pathway is activated by binding of Wnt ligands to Frizzled 
receptors and LRP5/6 co-receptors, which leads to the phosporylation of LRP5/6 by CK1γ 
and GSK3β (Zeng et al. 2005). The phosphoprotein Dishevelled (Dvl) is recruited to the 
plasma membrane, where it interacts with Frizzled via its PDZ domain, self-polymerizes via 
DIX domain and serves as a mediator for recruitment of axin-GSK3β to the plasma 
membrane (Schwarz-Romond et al. 2007;Wong et al. 2003). Activation of LRP5/6 co-receptors 
leads to their redistribution in the plasma membrane to the caveolin-rich areas. This results 
in the formation of Wnt-Fz-LRP5/6-Dvl-Axin platform, called LRP5/6 signalosome (Bilic et al. 
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2007). Axin recruitment to the plasma membrane leads to disassembly of the destruction 
complex and stabilization of β-catenin, which accumulates in the cytoplasm and finally 
enters the nucleus. It is suggested that the main route of β-catenin nuclear transport is 
independent of the classical Ran-GTPase/importin import mechanism, as it does not possess 
a classical nuclear localization signal (NLS) or a nuclear export signal (NES) sequence.          
β-catenin is able to directly interact with the nuclear pore complex (nucleoporin Nup358 on 
cytoplasmic tail, Nup62 in central channel and Nup98 and Nup153 on the nuclear end).       
β-catenin can also self-regulate its own entry into the nucleus (Jamieson et al. 2014).  In the 
nucleus β-catenin associates with transcription factors from the TCF/LEF family and activates 
the transcription of Wnt response genes. Among them are genes that play role in cell 
differentiation (siamois and brachyury (protein T), cell signalling (VEGF (vascular 
endothelial growth factor), FGF4 (fibroblast growth factor 4) and FGF18), proliferation (cyclin 
D1, c-MYC), adhesion (E-cadherin) (Klaus et al. 2008). An overview of the Wnt/β-catenin 
pathway is presented in the Figure 1. 3. 
The canonical Wnt pathway is regulated by a number of proteins. Secreted Frizzled-
related proteins (SFRPs) and Wnt inhibitory factors (WIFs) can bind Wnt proteins, because 
they contain a domain that resembles the cysteine-rich domain (CRD) domain of Frizzled 
receptors. SOST and Wise proteins bind LRP5/6 and in consequence inhibit signalling. 
Dickkopf (Dkk) triggers LRP5/6 internalization and inactivation, as a result of enhancing 
LRP5/6 interaction with Kremen (Staal et al. 2008). Protein phosphatase 2 (PP2) is responsible 
for dephosporylation of β-catenin. Inhibitor of β-catenin and TCF (ICAT) and protein Chibby 
bind β-catenin inside the nucleus and prevent it from forming a complex with TCF (Klaus et 
al. 2008).  
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Figure 1. 3. The canonical Wnt pathway. 
In the default state (left panel), β-catenin is degraded by the cytoplasmic degradation 
complex, which comprises glycogen synthase kinase 3β (GSK3β), casein kinase Iα (CKIα), 
axin and adenomatosis polyposis coli (APC). Phosphorylation of β-catenin by this 
complex triggers SCF (SKP1, Cullin, F-box)/ β-TrCP-mediated polyubiquitylation and 
proteasomal degradation of  β-catenin. After Wnt ligand binding to the Frizzled receptor 
and LRP5/6 co-receptor, the degradation complex is recruited to the plasma membrane and 
inhibited by Dishevelled (Dvl). β-catenin translocates then to the nucleus, where it 
replaces TCF (T cell factor)-bound corepressors (such as groucho; middle panel) or co-
imports additional TCF to the Wnt response elements (WREs; right panel) and activates 
target gene expression. LGS, Legless; LRP, low-density lipoprotein receptor. Figure 
reproduced from (Mosimann et al. 2009).  
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1.1.2. Molecular mechanisms involved in non-canonical 
Wnt pathway signalling 
Non-canonical Wnt pathways are defined as routes independent of β-catenin 
transcriptional activity. There are many non-canonical pathways reported. However, due to 
a high level of cross-talk between receptors and secondary messengers from different 
signalling branches, it is difficult to separate individual pathways completely. For the sake of 
simplification, the following branches of the non-canonical Wnt pathways can be 
distinguished: PCP, Wnt/Ca2+, Wnt/RAP, Wnt/cAMP, Wnt/GSK3-microtubules, Wnt/aPKC, 
Wnt/mTOR, Wnt/ROR and Wnt/RYK (Schulte 2010;Semenov et al. 2007). Of these, the best 
described are the PCP and Wnt/Ca2+ pathways.  
Planar Cell Polarity (PCP) refers to cell polarization within two-dimensional 
epithelium. It occurs during hair orientation and gastrulation (Wu et al. 2009). PCP signalling 
is often activated by Wnt5a or Wnt11 through various Frizzled receptors (e.g. Fz6, Fz7 and 
Fz8 (Dijksterhuis et al. 2014)) and Dvl, but instead of LRP5/6, ROR and PTK7 are involved, 
and signals are transmitted without involving β-catenin. In Drosophila melanogaster, two 
complexes relocate to the opposite sites of the cell during the process. Frizzled-Dishevelled-
Diversin (Div) complex localizes distally and Strabismus (Stbm, Vangl in vertebrates)-Prickle 
(Pk) localizes proximally, which leads to planar cell polarization (Veeman et al. 2003a). Dvl 
together with DAAM (Dishevelled-Associated Activator of Morphogenesis) activates the 
small GTPase RhoA (RAS homologue-gene family member A)-ROCK (Rho-associated coiled-
coil containing protein kinase) and JUN-N-terminal kinase (JNK) routes, which results in 
actin cytoskeleton reorganization (Endo et al. 2005). PCP and Wnt canonical pathway are 
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known to antagonize each other and inhibiting one pathway will usually upregulate the 
other (Niehrs 2012). 
The Wnt/Ca2+ pathway is activated by interaction of Wnt5a with Frizzled-2 (Sheldahl 
et al. 2003). The Frizzled receptor activates phosphodiesterase (PDE) via heterotrimeric G 
protein. As a result, the cellular levels of cGMP (cyclic guanosine monophosphate) are 
decreased, which inactivates the cGMP-dependent kinase G (PKG) and increases the cellular 
concentration of calcium. Wnt/Fz also activates phospholipase C (PLC). It initiates a cascade 
of events that results in the generation of diacylglycerol (DAG) and inositol trisphosphate 
(IP3), followed by calcium fluxes. This leads to activation of the protein kinase C (PKC), 
which induces changes in actin cytoskeleton (Kuhl et al. 2000). Increased Ca2+ concentration 
also activates calcium-calmodulin-dependent kinase II (CamKII) and calcium-sensitive 
phosphatase calcineurin, which leads to activation of NFAT (nuclear factor of activated T 
cells) transcription factor. Wnt/Ca2+ signalling through CamKII inhibits Wnt/β-catenin 
pathway (Kohn et al. 2005;Semenov et al. 2007).     
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1.1.3. Wnt signalling in diseases 
Deregulation of Wnt signalling during development leads to developmental defects 
(van Amerongen R. et al. 2009). In adult organisms, Wnt signalling is often associated with 
loss of growth control and impaired cell differentiation. Mutations or altered expression of 
Wnt signalling pathway components are associated with development of different types of 
cancers, such as colon carcinoma. Somatic mutations of Wnt pathway components identified 
in cancer are summarized in the table 1.1. Wnt signalling proteins associated with distinct 
patient outcomes in a cancer-subtype-specific manner are presented in the table 1.2.  
Aberrant Wnt signalling has also been reported in breast cancer, lung cancer, kidney disease, 
inflammatory bowel disease, diabetes type II and sarcoidosis (Herr et al. 2012). Furthermore, 
Wnt signalling is also involved in maintaining bone mass and is important for bone healing; 
findings which may have implications in osteoporosis (Canalis 2013). 
Activation of the canonical Wnt pathway, evidenced by stabilization and nuclear 
accumulation of β-catenin, has been observed in colorectal, lung, breast, cervical, skin and 
liver tumours. β-catenin accumulation is linked with poor differentiation, high proliferative 
activity and poor prognosis (Endo et al. 2000). Stabilization of β-catenin may occur as a result 
of mutations in components of signalling pathway or due to epigenetic events. Mutations of 
APC lead to an inability to downregulate β-catenin (Polakis 2000). Mutations of APC rarely 
occur outside of the gastrointestinal tract, but have been found in the majority of sporadic 
colorectal cancers (SCC) (Polakis 2007). The acquisition of APC mutations is an initial step in 
colorectal carcinogenesis and facilitates and accelerates tumour development (Kinzler et al. 
1996). Gain-of-function mutations of the CTNNB1 gene, which encodes β-catenin, occur in 
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approximately 1% of SCC and more frequently in sporadic cancers outside of the intestines, 
for example in brain tumours, ovarian, prostate and hepatocellular cancers (Camilli et al. 
2010;Klaus et al. 2008).     
The Wnt pathway can be regulated by epigenetic mechanisms, such as 
hypermethylation. Silencing by hypermethylation was reported in different types of tumours 
for inhibitory Wnt ligands SFRPs (Caldwell et al. 2006;Jost et al. 2009;Nojima et al. 
2007;Suzuki et al. 2008) and DKK (Sato et al. 2007). Overexpression of several Wnt pathway 
components in cancer is also common. It was shown for Wnt proteins (Katoh et al. 2001), 
Frizzleds (Kirikoshi et al. 2001;Saitoh et al. 2002) and Dishevelled (Okino et al. 2003).  
Recent developments showed antagonistic crosstalk between Wnt and Notch 
signalling. It was reported that the expansion of intestinal progenitor cells by constitutively 
active Notch pathway was contingent to Wnt signalling in the intestine (Fre et al. 2009). The 
Notch receptor intracellular domain (ICD) was shown to bind unphosphorylated (active) β-
catenin, making it inaccessible for transcription activity. Notch1 depletion, upregulated Wnt 
signalling, whereas expression of non-cleavable Notch1 receptor or inhibition of γ-secretase 
led to downregulation of the Wnt pathway. The authors concluded that association of β-
catenin with the Notch receptor leads to its degradation in the lysosomes in a Numb-
dependent fashion (Kwon et al. 2011).  
The role of non-canonical pathways in cancer is less well studied, but there is 
evidence for their involvement in cancer development. Wnt5a is the main object in studies of 
β-catenin independent signalling in cancer. It was shown that, depending on the type of 
cancer; it can have either a suppressive or an oncogenic role. The suppressive function 
results from antagonizing the β-catenin dependent pathway. Wnt5a expression is 
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downregulated in colorectal cancer (Dejmek et al. 2005a;Ying et al. 2008), neuroblastoma 
(Blanc et al. 2004), ductal breast cancer (Dejmek et al. 2005b), esophageal squamous cell 
carcinoma (Li et al. 2010) and haematological malignancies (Ying et al. 2007). On the other 
hand, it is overexpressed in gastric (Kurayoshi et al. 2006), pancreatic (Ripka et al. 2007), 
prostate (Wang et al. 2007) and non-small cell lung cancer (Huang et al. 2005). It enhances 
cell motility and tumour invasion in breast cancer (Pukrop et al. 2006). It was reported that 
Wnt5a-induced migration of melanoma cells depends on signalling through Frizzled 5 and 
PKC (Weeraratna et al. 2002). Wnt5a and β-catenin in gastric cancer are expressed in 
mutually exclusive manner. Moreover, Wnt5a activates focal adhesion kinase and small 
GTP-binding protein Rac. Both play a role in the regulation of cell migration (Kurayoshi et al. 
2006).  
Recent data have revealed  roles for the Wnt/PCP pathway in cancer progression, 
invasion, metastasis and in cancer angiogenesis (Wang 2009). It was shown that Frizzled-7 
promotes migration of human hepatocellular carcinoma and invasion of colon cancer cells 
(Merle et al. 2004;Ueno et al. 2009;Vincan et al. 2007b). There is also evidence that Wnt 
signalling plays a significant role in angiogenesis (Masckauchan et al. 2006;Zhang et al. 2006) 
and it was reported that Wnt5a mediated signalling regulates endothelial cell growth and 
migration (Cheng et al. 2008;Cirone et al. 2008). The latter study by Cirone and colleagues 
showed that impaired non-canonical Wnt signalling leads to vascular defects in vertebrate 
model.  
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Table 1. 1. Somatic mutations of Wnt pathway components in cancer.  
Table is reproduced from (Anastas et al. 2013)  
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Table 1. 2. Wnt signalling proteins are associated with distinct patient outcomes in a 
cancer-subtype-specific manner. 
Table is reproduced from (Anastas et al. 2013)  
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1.2. Wnt/Frizzled signalling in breast cancer 
Breast cancer is the most invasive form of cancer in women and the second leading 
cause of death in women in industrialized nations. Evidence shows that Wnt signalling is 
essential in the development of normal mammary gland and also plays an important role in 
mammary oncogenesis. Mouse mammary carcinoma was the first known example of a Wnt-
related disease. An insertion of the MMTV (mouse mammary tumour virus) was found in 
Wnt1 locus, which resultantly was continuously driving Wnt1 expression (van 't Veer et al. 
1984). Later, Wnt3 and Wnt10b were also found to carry the insertion of MMTV in breast 
cancer (Tekmal et al. 1997). 
Numerous reports have shown the deregulation of Wnt signalling in breast cancer. 
Mutations in genes encoding components of Wnt signalling pathway, such as APC, β-catenin 
or Axin, are rare in breast cancer. Yet, upregulation of the pathway is evident, especially in 
basal-like and triple negative breast cancer (TNBC), where nuclear and cytosolic 
accumulation of β-catenin is associated with poor outcome (Geyer et al. 2011;Khramtsov et 
al. 2010;Lopez-Knowles et al. 2010). Cyclin D1 and c-Myc, well-known targets of canonical 
pathway, are also overexpressed in breast tumours (Lin et al. 2000). Recent report by Dey 
and colleagues provides additional evidence for preferential activation of Wnt signalling in 
TNBC and increased risk for brain and lung metastases (Dey et al. 2013). The mechanisms 
underlying activation of Wnt signalling pathways in breast cancer still remain unclear.  
However, it seems that it is mainly achieved through upregulation of potentially oncogenic 
receptors and co-receptors, such as Frizzled-7 and LRP5/6 (Liu et al. 2010;Yang et al. 2011). 
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Promoter hypermethylation of Wnt antagonist genes, like APC, WIF1 and SFRP1 was also 
reported (Klarmann et al. 2008;Suzuki et al. 2008). 
1.2.1. Frizzled-7 in TNBC 
Activation of Wnt signalling pathway is particularly associated with triple-negative 
(TNBC) basal-like breast cancer, which is one of the six major breast cancer subtypes. It 
represents approximately 10-20% of all breast cancers, and is more frequent in 
premenopausal women, especially of African-American and Hispanic descent (Carey et al. 
2010). TNBC is characterized by a very aggressive clinical behaviour, demonstrated by lack 
or limited expression of estrogen receptor (ER), progesterone receptor (PR) and human 
epidermal growth factor receptor 2 (HER2/ERBB2). That makes TNBC cells resistant to 
therapeutic protocols based on pharmaceutical targeting of mentioned receptors (Gusterson 
2009). TNBC was subdivided into six subtypes. Three of them (basal-like, mesenchymal-like, 
mesenchymal stem-like) were characterized by constitutive activation of Wnt signalling. 
Even though Herceptin (anti-HER2 antibodies), ER antagonists and aromatase inhibitors 
improved treatment of other breast cancer subtypes, the treatment of TNBC still remains 
a great challenge (Lehmann et al. 2011).  
Frizzled-7 (Fz7) emerges as the most important Frizzled receptor involved in breast 
cancer, where it activates the canonical Wnt pathway. Expression of Fz7 is characteristic for 
basal-like and triple-negative breast cancer. Fz7 is the only member of Frizzled family of 
receptors significantly overexpressed in triple-negative breast cancer (TNBC) and TNBC-
derived cell lines (Yang et al. 2011). Yang and colleagues demonstrated that Fz7 plays 
  1.INTRODUCTION 
17 
 
a crucial role in cell proliferation in TNBC. Its depletion reduces cell growth and expression 
of Wnt target genes (Cyclin D1 and c-Myc), inhibits tumourigenesis in vitro, and decreases 
the ability of the MDA-MB-231 cell line to form tumours in athymic nude mice. Additionally, 
in the same study it has been shown that tumour growth could be reduced by the use of 
FZD7shRNA in mice with xenografts of triple negative breast cancer cells (Yang et al. 2011). 
These findings indicate that Fz7 is a key factor involved in TNBC cell transformation, 
evidenced by changes in cell invasion, motility and clonogenicity. 
Recently, it has been shown that SIRT1, a class III histone deacetylase (HDAC) 
positively regulates Fz7 mRNA and protein levels in breast cancer cells (Simmons, Jr. et al. 
2014) 
1.2.2. Autocrine Wnt signalling 
Autocrine Wnt signalling has been reported in 25% of human breast and ovarian 
cancer cell lines (Bafico et al. 2004) and 50% of human non-small lung carcinoma cell lines 
(Akiri et al. 2009).  It was suggested that autocrine Wnt signalling contributes to the 
proliferation of breast cancer cells in a manner that depends on EGFR activity (Schlange et al. 
2007). Recently, Luga and colleagues showed that exosomes derived form human breast 
cancer associated fibroblasts (CAFs) are involved in mobilizing autocrine Wnt-PCP 
signalling in breast cancer cells and stimulate their invasive behaviour and metastasis in 
animal models in tetraspanin CD81 dependent manner (Luga et al. 2012). 
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1.2.3. Crosstalk with other pathways 
Several reports have shown evidences for crosstalk between Wnt signalling and other 
pathways in breast cancer. It was reported that TGFα and Wnt cooperatively induce 
mammary tumourigenesis, through the interaction between β-catenin and EGFR/ErbB2 
heterodimers (Schroeder et al. 2000;Schroeder et al. 2002). Wnt1 and Wnt5a binding to 
Frizzled transactivates ErbB1, which leads to MAPK activation and overexpression of Cyclin 
D1 (Civenni et al. 2003). Furthermore, Schlange and colleagues suggested that Wnt1 induces 
c-Src-dependent EGFR transactivation, which in turn stimulates ERK1/2 signalling and cell 
proliferation (Schlange et al. 2007). Recent report has also shown that Wnt3 expression in 
breast cancer cells leads to activation of canonical Wnt signalling, upregulation of EGFR and 
promotion of epithelial-to-mesenchymal-like transition. Consequently it results in reduction 
of the growth-inhibiting effects of Herceptin in HER2-overexpressing cells. This finding 
indicates a role for Wnt3 in the development of Herceptin resistance in patients with breast 
cancer tumours overexpressing HER2 receptor (Wu et al. 2012). Interestingly, upregulated 
Wnt signalling was also associated with breast cancer resistance to Tamoxifen (Loh et al. 
2013). Furthermore, it was reported that increased expression of Wnt1 in human mammary 
epithelial cells (HMEC) activates Notch signalling pathway, what leads to tumourigenic 
transformation of the HMEC cells (Ayyanan et al. 2006).  
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1.2.4. Epigenetic modifications 
Gene hypermethylation has been widely documented in several types of cancer 
including breast cancer. In relation to the Wnt canonical pathway, DNA methylation of the 
WIF1 (Wnt Inhibitory Factor 1) promoter was observed in 60% of breast carcinomas (Ai et al. 
2006;Wissmann et al. 2003). Expression of SFRP1, another protein that antagonizes Wnt 
signalling, was found to be silenced in breast cancer. 60% of samples from primary breast 
cancers displayed methylation of SFRP1 promoter and SFRP1 gene hypermethylation is 
associated with shorter survival of patients with invasive breast cancer (Shulewitz et al. 
2006;Veeck et al. 2006). It was shown that SFRP1 is methylated in 64%, SFRP2 in 100% and 
SFRP5 in 90% of breast cell lines (Suzuki et al. 2008). Furthermore, several studies revealed 
that APC gene promoter is hypermethylated in 35-50% of breast cancer tumours and cell 
lines (Jin et al. 2001). Downregulation of APC protein leads to activation of β-catenin. 
Accumulation of β-catenin can be also a result of E-cadherin downregulation caused by 
methylation of CDH1 gene. E-cadherin is a membrane receptor and a main part of adherens 
junction complex. It binds β-catenin and decreases its cytoplasmic concentration (Yang et al. 
2001).  
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1.3. Frizzled-7: member of Wnt receptor family  
1.3.1. Frizzled receptors 
Frizzled’s were originally identified as Wingless receptors in D. melanogaster (Bhanot 
et al. 1996). They are highly conservative in animal kingdom (Schioth et al. 2005). In 
mammals, 10 Frizzled isoforms have been identified. The amino acid sequence analysis 
revealed that Frizzled share 20 to 40% identity. The level of similarity is higher within 
particular clusters: Fz1, Fz2 and Fz7 share 75% amino acid identity, Fz5 and Fz8 share 80% 
identity, Fz4, Fz9 and Fz10 share 65% identity, and Fz3 and Fz6 share 50% identity with each 
other, as presented in the Figure 1. 4.A. (Fredriksson et al. 2003). The major characteristics of 
human Frizzled receptor are summarized in the table 1.3.  
 Receptors from Frizzled family are seven-transmembrane-spanning proteins. 
Although they are G protein-coupled receptors (GPCRs), they differ significantly from other 
GPCRs and represent a separate class surface receptors (Foord et al. 2005). Three regions can 
be distinguished within Frizzled structure: the extracellular N-terminal portion (224 amino 
acids), the transmembrane domains, and intracellular C-terminal cytoplasmic tail (25 amino 
acids) (Figure 1.4.B).  
The extracellular region consists of a signal sequence, which ensures correct protein 
insertion into the membrane, followed by the Cysteine-Rich Domain (CRD), responsible for 
binding of Wnt proteins. Ten cysteines present in CRD are highly conserved and form five 
disulfide bond (Xu et al. 1998). The three dimensional structure was solved for mFzd8-CRD 
(Dann et al. 2001). It revealed a new protein fold, which consists mainly of α-helical structure 
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(Figure 1.4.C). Moreover, the existence of CRD dimers was reported. A similar Cysteine-Rich 
Domain is also found in SMO (Smoothened), a protein closely related to Frizzled, which does 
not bind Wnts (Wu et al. 2002), SFRPs (Secreted Frizzled Related Proteins), collagen 
α1(XVIII), carboxypeptidase Z (CPZ), Ror family of receptor tyrosine family kinase and 
muscle-specific kinase (MuSK) family (Xu et al. 1998). CRD domain of Frizzled receptors 
contains also Asn residues that are predicted to be glycosylated (Schulte 2010). The structure 
of X.leavis Wnt8 in complex with mouse CRD of Frizzled8 has been recently resolved (Figure 
1.4.D). It revealed a new two-domain Wnt structure, not related to any known protein folds, 
with two finger-like domains (N-terminal “lipid thumb” and C-terminal “index finger”) 
grasping CRD of Fz8 at two distinct binding sites. The conservation of amino acids in both 
Wnt domains facilitates ligand-receptor cross-reactivity, which is important for 
understanding functionality of Wnt proteins (Janda et al. 2012).  
Transmembrane domain consists of seven membrane-spanning regions, three 
intracellular and three extracellular loops. In the extracellular loops 1 and 2 conserved 
cysteines are present. They are thought to stabilize an overall structure of the receptors 
(Lagerstrom et al. 2008). 
 The intracellular domain is involved in extensive protein-protein interactions. It also 
contains sites for posttranslational modifications, such as phosphorylation, ubiquitylation, 
nitrosylation and hydroxylation (Schulte 2010). Cytosolic tails of most Frizzled receptors 
have two Postsynaptic density-95, Disc large, ZO-1 (PDZ) binding motifs, PDZ-BM. They are 
4-6 amino acid motifs that interact with PDZ domains of partner proteins. Frizzled proximal 
PDZ-BM (K-T-xxx-W) interacts with the PDZ domain of the phoshoprotein Dishevelled 
(Dvl). This atypical, internal PDZ-BM is placed very close to the plasma membrane and is 
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conserved within all Frizzleds (Umbhauer et al. 2000;Wallingford et al. 2005). Dvl is a 
cytoplasmic scaffold of which three homologs exist in vertebrates (Dvl1, Dvl2, Dvl3). Their 
functional redundancy is evidenced by overlapping expression patterns and high degree of 
conserved structures (Gao et al. 2010b). The interaction between Frizzled and Dvl is essential 
for different Wnt-induced signalling pathways. Recently, Tauriello and colleagues presented 
a model of Frizzled-Dishevelled interaction involving a three-segmented discontinuous 
binding surface on the Frizzled receptor. They have shown that the DEP domain and C-
terminal region of Dvl binds cooperatively to the motifs I and II in the third intracellular loop 
and to the C-terminal motif III of mouse Frizzled-5 and Xenopus Frizzled-7 (Figure 1.4.D). 
That allows forming a stable Fz-Dvl complex at the plasma membrane and initiating 
canonical Wnt signalling. Whether Frizzled interaction with Dishevelled requires PDZ and 
DEP domains to act cooperatively or sequentially needs to be established (Tauriello et al. 
2012).   
The distal PDZ-BM (x-S/T-x-φ, where φ represents a hydrophobic residue) is a 
standard, terminal class I PDZ ligand (Jelen et al. 2003). It can bind a range of different PDZ 
proteins (GOPC, MAGI-3, Syntenin, Kermit, PSD-95) (Wawrzak et al. 2009). So far, the 
interactions involving the distal PDZ-BM have been shown for Fz1,-2,-3,-4,-5,-7,-8, but not for 
Fz6, -9 and -10 (Schulte 2010).   
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Table 1. 3.  Characteristics of Frizzled receptors 
(+) or (−) in the C-terminus column indicates experimental evidence for or against, 
respectively, the functionality of the class Frizzled receptor C terminus as PDZ ligand 
domain.  
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    aa kDa    
Frizzled-1 FZD1 NP_003496 7q21 647 71,158 1 1 ETTV (+) 
Frizzled-2 FZD2 NP_001457 17q21.1 565 63,554 1 1 ETTV (+) 
Frizzled-3 FZD3 NP_059108 8p21 666 76,263 1 8 GTSA (+) 
Frizzled-4 FZD4 NP_036325 11q14.2 537 59,881 1 2 ETVV (+) 
Frizzled-5 FZD5 NP_003459 2q33-q34 585 64,507 1 2 LSHV (+) 
Frizzled-6 FZD6 NP_003497 8q22.3-q23.1 706 79,292 1 7 HSDT (−) 
Frizzled-7 FZD7 NP_003498 2q33 574 63,620 1 1 ETAV (+) 
Frizzled-8 FZD8 NP_114072 10p11.22 694 73,300 1 1 LSQV (+) 
Frizzled-9 FZD9 NP_003499 7q11.23 591 64,466 1 1 PTHL (−) 
Frizzled-10 FZD10 NP_009128 12q24.33 581 65,336 1 1 PTCV (+) 
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Figure 1. 4. Structure of Frizzled receptors  
(A) Phylogeny comparing human Frizzled (FZD) receptors. Consensus sequences of C-
terminal tails are presented in the brackets. (B) Topology of a Frizzled receptor on the 
plasma membrane, with cysteine rich domain (CRD), seven transmembrane domains (1-7) 
and cytoplasmic domain (8) with C-terminal PDZ binding motif. Ten conserved cysteines 
„C” forming five disulfide bonds are highlighted in CRD. Ψ depicts potential N-
glycosylation sites. Dishevelled (DVL) is presented schematically with DIX, PDZ, and 
DEP domains. Two discontinuous regions of Frizzled-ICL3 (motif I „pink” and motif II 
ETxV
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„green”) bind to the C-terminus of Dvl. The cytoplasmic tail of Frizzled contains the 
KTxxxW motif („blue”), which interacts strongly with Dishevelled-PDZ domain. (C) 
Crystal structure of Fz8-CRD. Residues in red are suggested to be a Wnt-binding interface. 
Residues in green when altered did not affect Wnt activity (PDB:1IJY). (D) Wnt8–Fz8-CRD 
co-crystal structure, shown as a ribbon diagram superimposed on surface representation. 
Site 1 and site 2, mediate contacts between Wnt8 and Fz8-CRD. Palmitoleic acid adduct 
from the Wnt8 thumb at site 1 (red); N-glycans of Wnt8 and Fz8-CRD (yellow). N-term, 
amino terminal; C-term, carboxyl terminal; ICL, intracellular loop; ECL, extracellular loop. 
Figure reproduced and modified from (MacDonald et al. 2012). 
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1.3.2. Frizzled-7 
Human FZD7 gene is located on chromosome 2q.3317. Another form of Fz7, FzE3, 
was isolated from esophageal carcinoma tissue. FzE3 shares 98% homology with Fz7 and 
their sequences differ by 9 amino acids (Tanaka et al. 1998). Frizzled-7 is the only member of 
Frizzled family that regulates development of the gastric tract (King et al. 2012b). In recent 
years several reports have indicated that Fz7 is an important receptor governing Wnt 
signalling in cancer cells. 
1.3.2.1. Functions of Frizzled-7 
Frizzled-7 is a unique receptor that can activate canonical and noncanonical 
pathways. Human Wnt3a, Xenopus Wnt8b and mouse Wnt6 were reported to activate 
canonical Wnt signalling through interactions with Fz7 orthologs (Kim et al. 2008b;Linker et 
al. 2005;Medina et al. 2000). On the other hand, zebrafish and Xenopus Wnt11, as well as 
Xenopus Wnt5a are proposed to bind to Fzd7 to activate noncanonical Wnt pathways (Swain 
et al. 2001).  
Frizzled-7 activates the canonical signalling upon interaction with Wnt3a, which was 
shown in liver cancer cells (Kim et al. 2008b). Frizzled-7 was also found necessary for the 
mesenchymal-to-epithelial transition in the human colorectal cancer LIM1863-Mph cell line 
(Vincan et al. 2007a)   
PCP pathway activation by Frizzled-7 is responsible for regulation of cell movements 
via activation of JNK and Rho (Kinoshita et al. 2003;Tanegashima et al. 2008). Frizzled-7 was 
also reported to regulate bone morphogenesis through PCP signalling (Li et al. 2009). 
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Frizzled-7 interaction with Wnt11 activates PKC-Cdc42 and PKCδ-JNK signalling pathways 
that regulate convergent extension movements during gastrulation, as well as migration of 
neural crest cells in Xenopus and zebrafish (De Calisto et al. 2005;Djiane et al. 2000;Kinoshita 
et al. 2003;Knowlton et al. 2004;Penzo-Mendez et al. 2003). Xenopus Frizzled-7 signalling has 
been also shown to activate the PKC and Ca2+/calmodulin kinase signalling during cardiac 
development (Sheldahl et al. 2003). Furthermore, Frizzled-7 has been reported in the PCP 
pathway-dependent repair of mouse muscle. Receptor interaction with Wnt7a was shown to 
activate PCP pathway, in the mechanism involving Vangl2, which resulted in the expansion 
of satellite stem cells, and muscle repair (Le Grand et al. 2009). 
Recently Frizzled-7 has implicated in the maintenance of embryonic stem cell self-
renewal capacity (Takahashi-Yanaga et al. 2010). Dormeyer and colleagues have reported 
that FZD7 mRNA levels are 200-fold higher in human embryonic stem cells, when compared 
to differentiated cell types. They have also shown that Fz7 depletion by shRNA in human 
embryonic stem cells leads to dramatic changes in the morphology of embryonic stem cell 
colonies and loss of expression of the embryonic stem cell-specific transcription factor OCT4 
(Dormeyer et al. 2008). Furthermore, Frizzled-7 expression is upregulated in colonic crypt 
stem cells, but its expression level decreases when cells differentiate into mature epithelial 
cells (Gregorieff et al. 2005).  
Frizzled knockout mice (Fz7-/-) display tail truncation and kinking with 100% 
penetrance and ventricular septal defects (VSDs) with 15% penetrance. Furthermore, Fz2+/-; 
Fz7-/- mice display VSDs with 50% penetrance and Fz2-/-; Fz7-/- mice display convergent 
extension defects and mid-gestational lethality with 100% penetrance. It was suggested that 
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cross-talk events between different signalling pathways in development  are susceptible to 
disruptions in Frizzled signalling (Yu et al. 2012).  
Taken together, Frizzled-7 is involved in canonical and non-canonical Wnt signalling 
during embryogenesis, adult-tissue homeostasis and carcinogenesis.   
1.3.2.2. Ligands and binding partners of Frizzled-7  
Frizzled-7 has been reported to activate the canonical Wnt pathway upon interaction 
with Xenopus Wnt8b, mouse Wnt6, and human Wnt3 (Kim et al. 2008b;Linker et al. 
2005;Medina et al. 2000). As direct interaction between Wnt3a and Fz7-CRD has been shown 
in L-cells (Kemp et al. 2007). Frizzled-7 is also able to bind Xenopus Wnt11 and mouse Wnt7a. 
This, however leads to activation of noncanonical Wnt signalling (Bentzinger et al. 2014;Kim 
et al. 2008a).  
Frizzled-7 interacts with a number of PDZ (postsynaptic density protein (PSD)-95, 
Discs-large and ZO-1) domain-containing proteins. The PDZ domain of DVL family of 
proteins binds to the internal PDZ binding motif, KTxxxW,  in the C-terminal cytoplasmic 
region of Frizzled-7 (Umbhauer et al. 2000;Wong et al. 2003), while other PDZ proteins, such 
as discs large 1/synapse associated protein 97 (DLG1/SAP97), DLG2/PSD-93, 
DLG4/SAP90/PSD-95, MAGI3 and Syntenin-1 (syndecan binding protein, SDCBP) bind to 
the C-terminal PDZ binding motif, ETxV, of the receptor (Hering et al. 2002;Luyten et al. 
2008;Schulte et al. 2007;Yao et al. 2004). MAGI3-mediated assembly of Fz7 together with van 
Gogh-like 2 (Vangl2) has been shown to activate the Rac–JNK signalling cascade (Yao et al. 
2004),  while syntenin-dependent assembly of the Fz7–Dishevelled–Syndecan complex was 
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reported to activate the Cdc42 signalling pathway (Luyten et al. 2008). Syntenin-1 has been 
shown to facilitate interaction between Xenopus Frizzled-7 and Syndecan-2 or Syndecan-4 
(Luyten et al. 2008). The interaction between Frizzled-7 and Syndecan-4  leads to the 
recruitment of fibronectin in the extracellular matrix and cytoplasmic Dvl to the Fz7–
Syndecan-4 and activation of noncanonical Wnt signalling (Munoz et al. 2006). 
  There are also proteins involved in regulation of Fz7 trafficking. One of them is 
Transmembrane protein 46 (TMEM46; also called Shisa). Immature Fz7 after synthesis in the 
endoplasmic reticulum (ER) translocates to the trans-Golgi network (TGN) for further 
modification to generate mature Fz7, before being trafficked to the plasma membrane. 
TMEM46 is an ER protein with a Cysteine-rich region that associates with Fz7 and mediates 
its retention within the ER. It was shown that TMEM46 negatively regulates Fz7 post-
translational maturation and cell-surface delivery (Katoh et al. 2005;Yamamoto et al. 2005). 
1.3.2.3. Biosynthetic and endocytic trafficking of Frizzled-7 
Synthesized native Fz7 (about 50 kDa) is modified in the endoplasmic reticulum (ER) 
to immature Fz7 via Asn-linked glycosylation at two sites (Asn63 and Asn164) within the N-
terminal extracellular region (Katoh et al. 2007;Struewing et al. 2007). Immature Frizzled-7 
(about 54 kDa) is then further modified to mature Frizzled-7 (about 64 kDa) with complex 
oligosaccharides in the TGN, prior to trafficking to the cell surface. Glycosylation sites on the 
extracellular loops of Frizzled-7 could be involved in interactions with ligands. Glycosylation 
has also been shown to be important  for receptor maturation in the ER, regulated by the 
protein Shisa, which mediates Fz7 retention in ER (Yamamoto et al. 2005).  Mature Fz7 on the 
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plasma membrane is internalized in complex with Dishevelled via clathrin-mediated or 
caveolin-mediated endocytosis and can be found in endosomes (Blitzer et al. 2006;Gagliardi 
et al. 2008;Yu et al. 2007). Detailed information about endocytic trafficking of Frizzled 
receptors is presented in the section 1.4.1 and 1.4.2.2. 
1.3.2.4. Major sites of expression of Frizzled-7 
Human FZD7 is expressed in the blastocyst and in undifferentiated embryonic stem 
(ES) cells. Fz7 mRNA was also detected in ES-derived endodermal and neural progenitors, as 
well as in fetal cochlea and regenerating liver (Katoh et al. 2007). Frizzled-7 is relatively 
highly expressed in fetal kidney, lung, adult skeletal muscle and heart, and weakly 
expressed in adult brain, kidney and placenta (Sagara et al. 1998). It was also found in the 
gastrointestinal tract (the esophagus, stomach, duodenum, jejunum, ileum, cecum, colon and 
rectum) (Kirikoshi et al. 2001).  Boland and colleagues found that Frizzled-7 expression is 
downregulated in mesenchymal stem cells during osteogenesis (Boland et al. 2004).  
Frizzled-7 mRNA is upregulated in gastric cancer (Kirikoshi et al. 2001;Sagara et al. 
1998), esophageal cancer (Tanaka et al. 1998), colorectal cancer (Sagara et al. 1998;Vincan et 
al. 2007b) , hepatocellular cancer (Merle et al. 2004;Merle et al. 2005), nasopharyngeal cancer 
(Zeng et al. 2007),  and in triple negative breast cancer (Yang et al. 2011). 
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1.3.2.5. Frizzled-7 in cancer 
As already mentioned in the previous section, Frizzled-7 is upregulated in a number 
of cancer types, and becomes recognized as a potential therapeutic target for various cancers 
(King et al. 2012b). 
Frizzled-7 is abundantly expressed in colon cancer tissues and cell lines, also in those 
with mutations in genes encoding APC or β-catenin (Ueno et al. 2008). Fz7 is mainly 
expressed in well differentiated tumour cells in the centre of cancerous tissue where it is 
predominantly restricted to the proliferative regions (Vincan et al. 2007b;Vincan et al. 2010). 
Fz7 overexpression in colon cancer cell lines with APC and/or CTNNB1 mutations 
upregulates canonical Wnt signalling. Moreover, Fz7 depletion with siRNA downregulates 
β-catenin dependent pathway and decreases cell viability, migration and invasion. 
Furthermore, high expression of Frizzled-7 is correlated with a significantly shorter survival 
time in colon and gastric cancer (Ueno et al. 2009). It was also found that Fz7 is a 
downstream target of β-catenin in colorectal cancer cells that may explain its high expression 
level in colon cancer. This finding indicates the existence of a feed-forward mechanism that 
enhance canonical Wnt signalling in colorectal cancer and facilitate its progression and 
metastasis (Vincan et al. 2010). Recently, it was reported that interaction between Fz7 and 
Wnt11 might be also involved in progression of colorectal cancer. The authors suggested that 
Fz7 might be involved in Wnt11-induced migration  of  HCT-116 cells. They have also found 
a correlation between Wnt11 and Fz7 mRNAs expression in human colon cancer cell lines 
and primary tissues of colorectal cancer. The prognostic significance of Wnt11 and Fz7 
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expression in primary tissues has been suggested, as Fz7-high and Wnt11-high group had 
worse disease free survival than Fz7-low and Wnt11-low group (Nishioka et al. 2013).  
Canonical Wnt signalling plays role in normal liver development, and its aberrant 
regulation has been reported in hepatocellular carcinoma (HCC) (Fatima et al. 
2011;Whittaker et al. 2010). Frizzled-7 mRNA levels has been found elevated in hepatitis B 
and C, as well as in non-viral-induced HCC cell lines. Furthermore, Frizzled-7 and/or Wnt3a 
are upregulated in 60-90% of human HCCs and in 35-60% of the surrounding pre-neoplastic 
liver tissues. Increased expression of Frizzled-7 has been reported to correlate with increased 
level of cytosolic/nuclear β-catenin and cell migration (Bengochea et al. 2008;Merle et al. 
2004;Merle et al. 2005). A recent report showed that pharmacological inhibition of Fz7 with 
small interfering peptides, disrupting its interaction with Dishevelled, displayed anti-tumour 
properties against hepatocellular cancer (Nambotin et al. 2011) 
Frizzled-7 is also associated with gastric cancer and chronic lymphocytic leukaemia 
(CLL). Patients with Fz7-positive gastric cancers have poorer prognosis when compared with 
Fz7-negative cancers (Schmuck et al. 2011).  Increased Frizzled-7 expression is also associated 
with less favourable clinical prognosis in patients with CLL (Kaucka et al. 2013). Increased 
Frizzled-7 expression has been also observed in acute lymphoblastic leukaemia (ALL) (Khan 
et al. 2007). 
Frizzled-7 is the main Wnt receptor implicated in triple-negative breast cancer, where 
it plays a crucial role in regulation of cell proliferation (Yang et al. 2011).  
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1.4. Regulation of Frizzled signalling  
1.4.1. Endocytosis 
Endocytosis is a biological process in which cells uptake particles and 
macromolecules, such as proteins, into transport vesicles derived from plasma membrane. It 
is crucial in development, intercellular communication, signal transduction and cellular 
homeostasis. There are different mechanisms of endocytosis. The best studied is the clathrin-
dependent pathway. Beside that, there are several clathrin-independent pathways including 
the CLIC/GEEC (clathrin-independent carrier/GPI-AP-enriched early endosomal 
compartment) endocytic pathway, arf6-dependent endocytosis, flotillin-dependent 
endocytosis, macropinocytosis, circular doral ruffles, phagocytosis, trans-endocytosis and 
caveolin-mediated endocytosis (Doherty et al. 2009).   
Internalized by varied endocytic pathways, material is directed to different 
destinations within mammalian cells. There are two major sorting compartments: the early 
and late endosome. The early endosomes (marked by Rab5 GTPase) receive cargo from the 
plasma membrane and from the trans-Golgi. They direct the molecules back to the cell 
surface  by rapid recycling pathway controlled by Rab4 or through recycling endosomes in 
Rab11-dependent manner, to the trans-Golgi network by retrograde transport or to the late 
endosome/lysosome. The early endosomes also regulate cell signalling, through the 
downregulation of internalized receptors, which are packaged into intralumenal vesicles. 
These multivesicular regions mature to become the multivesicular body, which transports 
cargoes to late endosomes. The transition from early to late endosomes is driven by the 
  1.INTRODUCTION 
34 
 
replacement of Rab5 to Rab7. Rab factors are GTP-binding proteins that play a regulatory 
role in vesicle trafficking. The late endosome serves as a compartment gathering molecules 
from the endocytic, biosynthetic and autophagic pathways and directing them to the 
lysosomes, the Golgi complex or the plasma membrane (Scott et al. 2014). To direct cargoes 
to the lysosomes, the ESCRT (endosomal sorting complex required for transport) machinery 
assembles on the late endosome membrane. The ESCRT complex is composed of three 
subcomplexes, ESCRT I, II and III, recognizing in sequence ubiquitylated proteins and 
directing them into inner vesicles of multivesicular bodies and lysosomes. (Gagliardi et al. 
2008). Alternatively, some intraluminal vesicles can be released as exosomes into the 
extracellular space after fusion of secretory endo-lysosomes with the plasma membrane 
(Scott et al. 2014). Recently, some reports have shown that the relationship between 
endocytosis and signalling is more complex and it is possible for endocytosis to contribute 
positively to signalling.  
The inhibition of clathrin mediated endocytosis by different reagents leads to 
downregulation of Wnt3a induced canonical signalling in mouse fibroblast L cells  (Blitzer et 
al. 2006). It was also shown that Dishevelled-1 and Dishevelled-2 proteins bind β-arrestin, a 
clathrin adaptor, and these proteins activate synergistically Wnt-dependent transcriptional 
activity of TCF factor (Chen et al. 2001). Lack of β-arrestin affects the phosphorylation 
process of Dvl-2 and consequently β-catenin fails to be stabilized in response to Wnt (Bryja et 
al. 2007). 
In addition to these findings, it is proposed that caveolin-dependent route is also 
involved in the activation of β-catenin dependent pathway. Wnt3a induces phosphorylation 
of LRP6 and subsequently axin is recruited to the Wnt-receptor complex on the plasma 
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membrane, which is called LRP6-signalosome, and is highly dynamic. Signalosome is 
assembled by Dvl-2 mediated recruitment of axin, GSK3β and β-catenin to the activated 
receptors and partially disassembled by endocytosis (Bilic et al. 2007). It was shown that 
phosphorylated LRP6 forms intracellular aggregates, which do not co-localize with any 
endocytic markers except caveolin. In response to Wnt3a, LRP6 binds to caveolin and is 
internalized (Yamamoto et al. 2006). It is suggested that caveolin-mediated endocytosis plays 
an important role in inducing internalization of LRP6 and accumulation of β-catenin. The 
model of interactions was proposed where the binding of Wnt3a to LRP6 in the lipid rafts 
triggers a conformational change of LRP6. This leads to its phosphorylation and association 
with axin, Frizzled and Dishevelled. In the next step, the vesicles with phosphorylated LRP6, 
in complex with axin and caveolin, are severed from the plasma membrane by dynamin and 
transported to the early endosome by Rab5. When forming the vesicle, the complex between 
proteins and/or lipids on the vesicle can be altered, what may result in the inhibition of GSK3 
and dissociation of β-catenin from axin. This leads to the stabilization of β-catenin (Kikuchi et 
al. 2009). It was recently reported that after internalization the Wnt/Fz/LRP6 complex and the 
transducer complex (Dvl-2, axin, GSK3β and β-catenin) take separate routes. The first 
complex follows a Rab-positive path, whereas the latter forms intracellular aggregates 
(Hagemann et al. 2014). Zebrafish Rabconnectin-3a (Rbc3a), a protein associated with the 
vacuolar-ATPase (v-ATPase) proton pump control, was recently implied to control  
intracellular trafficking events required for Wnt signalling during neural crest migration. It 
was shown that loss of Rbc3a in zebrafish embryos disrupts the maturation of endocytic 
vesicles which leads to inhibition of Wnt signalling in neural crest cells before migration and 
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to increase of the Wnt signalling after the migration, as evidenced by accumulation of Fz7 in 
plasma membrane and increased level of β-catenin(Tuttle et al. 2014). 
There are several proteins implicated in the regulation of Wnt-induced endocytosis. It 
has been shown recently, that the tumour suppressor and endocytic adaptor protein, 
disabled-2 (Dab2) selectively recruits LRP6 to the clathrin-mediated endocytic pathway and 
sequesters it from the caveolin-dependent route. It was shown that LRP6 phosphorylation by 
casein kinase 2 (CK2), upon Wnt stimulation, promotes Dab2 binding and internalization 
with clathrin, which has inhibitory effect on canonical Wnt signalling. It is suggested that 
Dab2 expression levels influence canonical Wnt signalling by modulating LRP6 endocytic 
fate (Jiang et al. 2012). On the other hand, Rab GTPase RAB8B was identified as a positive 
regulator of the canonical pathway by promoting LRP6 internalization and rescuing caveolar 
inhibition of LRP6 endocytosis. RAB8B was also shown to be involved in regulation of Wnt 
signalling during vertebrate development and modulation of Wnt target genes (Demir et al. 
2013). Glypican-3 (GPC3) is a membrane bound proteoglycan, associated with hepatocellular 
carcinomas. It has been reported to promote canonical Wnt signalling by increasing the 
amount of Wnt at the cell surface, but also by direct interaction with Frizzled receptors 
through glycosaminoglycan chains. It is suggested that glypican stimulates the formation of 
complexes between Wnt and Frizzled. GPC3 was also found in complexes with Frizzled, 
Wnt and presumably LRP6, that were internalized after Wnt stimulation (Capurro et al. 
2014). 
The importance of endocytosis in the non-canonical Wnt pathway is well 
documented. As already mentioned, Dishevelled is a part of canonical and PCP pathways. 
Dishevelled enhances endocytosis of Frizzled through its interactions with β-arrestin, a 
  1.INTRODUCTION 
37 
 
protein known to recruit clathrin to activated GPCRs and thus to promote receptor 
internalization. Frizzled are not able to bind β-arrestin directly, but the interaction can occur 
through Dvl. It was shown that is Dvl-2, upon Wnt5a stimulation, recruits β-arrestin to 
Frizzled-4 and initiates clathrin-mediated endocytosis (Chen et al. 2003). The importance of 
β-arrestin-Dvl-Frizzled interaction was shown in Xenopus, where downregulation of β-
arrestin significantly affected PCP signalling (Kim et al. 2007).  
It was also reported that the region of Dishevelled-2 (Dvl-2), that corresponds to the 
DEP domain and is required for the PCP signalling, interacts with the μ2-adaptin subunit of 
AP-2. This interaction is essential for Frizzled-4 internalization. Moreover, authors suggest 
that it is crucial for the PCP signalling, but not for the canonical pathway. When Dvl-2 is 
mutated and unable to bind AP-2, there is no noticeable signalling via PCP pathway, but 
canonical pathway is not disturbed (Yu et al. 2007).   
Wnt5a and Wnt3a can induce the endocytosis of Frizzled-5, when the co-receptor 
LRP6 is not expressed ectopically. This process is clathrin dependent. Furthermore, Ryk, co-
receptor that plays role in activation of RhoA and JNK, also interacts with β-arrestin-2 and 
promotes internalization of Frizzled-7 and Dishevelled upon Wnt-11 treatment in Xenopus. 
Although there is no evidence that clathrin-dependent internalization of Frizzled-4 or 
Frizzled-5 is directly linked with activation of PCP or Ca2+ pathways, it is suggested that 
Frizzleds are endocytosed in response to Wnts and different endocytic pathways determine 
whether activated is canonical or noncanonical signalling (Kikuchi et al. 2009).     
Recently, it was reported that Frizzled-3 undergoes endocytosis via filipodia tips 
upon Wnt5a stimulation. It was also discovered that in filipodia with active PCP signalling 
pathway Dvl2 blocks Dvl1-induced Fz3 hyperphosphorylation and membrane accumulation. 
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Furthermore, Fz3 hyperphosphorylation is was found to correlate with loss of PCP signalling 
in vivo. It was also reported that small GTPase Arf6 is required for Fz3 endocytosis and 
crucial for Wnt-induced outgrowth, indicating the importance of Fz3 recycling in PCP 
signalling in growth cone guidance (Onishi et al. 2013) 
1.4.2. Ubiquitin 
1.4.2.1. Ubiquitin in Wnt signalling regulation 
Wnt signalling is regulated by several ubiquitin-mediated mechanisms. 
Ubiquitylation is one of the most important posttranslational modification, as it regulates 
many biological processes, including proteasome degradation, intracellular trafficking, DNA 
repair and signal transduction (Tauriello et al. 2010b). Diverse ubiquitin modifications link to 
distinct cellular mechanism. Ubiquitin can be recognized by specific ubiquitin-binding 
domains within proteins, thus it can serve as signalling device. Ubiquitylation occurs as a 
cascade of reactions catalyzed by three types of enzymes (E1, E2 and E3). The process leads 
to the covalent attachment of ubiquitin to the ε-amino group of a lysine residue in the target 
protein. Proteins can be mono- or multi-ubiquitylated, i.e. they can have single or multiple 
monomers of ubiquitin attached, respectively. Mono-ubiquitylation is associated with 
receptor endocytosis, lysosomal targeting, chromatin remodelling and DNA repair (Di Fiore 
et al. 2003;Haglund et al. 2003). In addition, very often, protein poliubiquitylation is 
observed. It occurs when ubiquitin moieties, added to a protein, form a chain. Ubiquitin has 
seven lysines (K6, K11, K27, K29, K33, K48, K63) and each of them can be used to form 
various poliubiquitin chains, generating different molecular signals (Acconcia et al. 
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2009;Komander et al. 2012). The fate of an ubiquitylated protein depends on the type of 
ubiquitin linkage. K48-linked ubiquitin chains target proteins for degradation by 
proteosomes, whereas other types of linkages also mediate non-proteolytic functions 
(Haglund et al. 2005;Ikeda et al. 2008). 
The core components of canonical Wnt pathway, APC, Axin and β-catenin, are 
regulated by ubiquitylation. As described in details in the section 1.1.1., phospho-β-catenin 
undergoes poliubiquitylation by β-TrCP E3 ligase and subsequent proteosomal degradation 
(Marikawa et al. 1998). Furthermore, β-catenin levels are controlled independent of Wnt 
signalling by Jade-1, a ubiquitin ligase found primarily in the nucleus, and Siah-1, a p53-
activated ubiquitin ligase, induced in response to DNA damage (Chitalia et al. 
2008;Dimitrova et al. 2010). Also, APC and Axin are subjected to ubiquitin-mediated 
proteolysis (Tauriello et al. 2010b). Regulation of Dishevelled involves ubiquitylation in at 
least two different manners. K48-linked ubiquitylation by the E3 ligases KLHL12 (Kelch-like 
12), NEDL1 and inversin targets Dishevelled for degradation and downregulates canonical 
Wnt pathway (Angers et al. 2006;Miyazaki et al. 2004;Simons et al. 2005). On the other hand, 
K63 poliubiquitylation of Dishevelled-DIX domain positively regulates Wnt signalling. 
Inhibition of Dishevelled K63-ubiquitylation by CYLD, tumour suppressor and DUB, was 
shown to negatively regulate Wnt signalling (Tauriello et al. 2010a).  Recently, Usp14 was 
identified as a major DUB of Dishevelled. It was shown that Usp14 regulates Dishevelled 
ubiquitylation and subsequent phosphorylation, essential for activation of Wnt pathway 
(Jung et al. 2013). 
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1.4.2.2. Ubiquitin and Frizzled 
Targeting transmembrane proteins to their destinations requires specific mechanisms. 
Studies have revealed that ubiquitylation acts as a signal for endocytosis and sorting of 
plasma membrane proteins. Addition of ubiquitin changes the properties of target proteins. 
It affects their stability, associations with other proteins, enzymatic activity and subcellular 
localization. 
Removal and recycling of ubiquitin moieties from ubiquitylated substrates is 
catalized by specific deubiquitylating enzymes (DUBs). They serve to balance the 
ubiquitination reactions within a cell and regulate different processes, such as endosomal 
sorting. In mammals deubiquitylation is carried out DUBs enzymes, such as USP8 (ubiquitin 
specific protease 8) also called UBPY. It is recruited to endosomes by interaction with ESCRT 
III complex and deubiquitylates cargo proteins (Clague et al. 2006). Ubiquitin plays a role in 
sorting of internalized receptors to multivesicular bodies and lysosomes. In early endosomes, 
proteins without attached ubiquitin are recycled to the plasma membrane or directed to 
other intracellular compartments.  In contrast, ubiquitylated proteins are directed into late 
endosomes and finally lysosomes  (Mukhopadhyay et al. 2007). 
It was discovered recently that the level of Frizzled receptors on the plasma 
membrane is controlled by a cycle of monoubiquitylation and deubiquitylation. The amount 
of Frizzled receptors on the cell surface seems to be an important factor that determines cell 
responsiveness to Wnt. The information comes from a study on Frizzled and UBPY/USP8 
both in mammalian cells and Drosophila. Mukai et al. found that the deubiquitinating enzyme 
UBPY/USP8 is a positive regulator of Wnt/β-catenin pathway. While inactivated, it 
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downregulates canonical Wnt pathway. Whereas a constitutive active variant of UBPY/USP8 
enhances the expression of β-catenin dependent genes. A model was proposed, whereby 
Frizzled (Fz8, but also Fz4, Fz5 and Fz6) in the plasma membrane is ubiquitylated by RING-
type ubiquitin ligase ZNRF3 or RNF43 and internalized (Hao et al. 2012;Koo et al. 2012). 
Afterwards, there are two possible scenarios. Frizzled receptor can be deubiquitylated by 
UBPY/USP8 and recycled to the cell surface via Rab11-positive recycling endosomes, or it 
can be trafficked to Rab7-positive multivesicular bodies, and subsequently degraded in a 
lysosome (Figure 1.5.). No evidence were found that the cycle of Frizzled 
monoubiquitylation – deubiquitylation is influenced by binding of Wnt. It is proposed that 
Frizzled recycling is crucial for setting the level of responsiveness of cells to the Wnt ligand 
(Cadigan 2010;Mukai et al. 2010).   
Recently, two studies have shown that two transmembrane RING finger ubiquitin 
ligases, ZNRF3 (zinc and ring finger 3) and RNF43 (ring finger 43), are involved in Wnt 
signalling modulation, through their interaction with Wnt receptors. ZNRF3 and RNF43 are 
highly homologous Wnt targets (they are both targets of β-catenin – dependent 
transcription), detected in LGR5 crypt stem cells and colon cancer (Hao et al. 2012;Koo et al. 
2012). Both reports demonstrated that ZNRF3 and RNF43 regulate the stability and cell-
surface levels of Frizzled receptors (Fz5 and Fz8) via multiubiquitylation of lysines in the 
cytoplasmic loops and subsequent internalization and lysosomal degradation. A similar 
mechanism was recently found for the C.elegans ortholog PLR-1 E3 ligase (Moffat et al. 2014). 
Due to the fact that ZNRF3 and RNF43 are Wnt target genes, it is suggested that these 
ubiquitin ligases function as a negative feedback regulators of Wnt signalling. However the 
structural basis for specific targeting of Frizzled receptors  by ZNRF3, RNF43 and PLR-1 
  1.INTRODUCTION 
42 
 
remains unknown (de Lau et al. 2014). Hao and colleagues also provide evidence that R-
spondins stabilize Frizzled receptors levels on the plasma membrane by tethering a complex 
of LGR family member (LGR4/5) and ZNRF3/RNF43 (Hao et al. 2012).  A model was 
proposed whereby formation of the R-spondin-LGR4/5-ZNRF3/RNF43 complex would lead 
to membrane clearance of the ubiquitin ligase, increased Frizzled level on the cell surface and 
enhanced Wnt signalling (Fearon et al. 2012). 
 
Figure 1. 5. A model for the regulation of the cell surface level of Frizzled. 
Frizzled in the plasma membrane is ubiquitylated by an E3 ubiquitin ligase and 
internalized. Afterwards, it can be deubiquitylated by UBPY/USP8 and recycled to the cell 
surface via Rab11-positive recycling endosomes, or it can be trafficked to Rab7-positive 
multivesicular bodies, and subsequently degraded in a lysosome. UBPY/USP, ubiquitin 
specific protease 8; MVB, multivesicular bodies; Ub, ubiquitin. Figure reproduced and 
modified from (Mukai et al. 2010).  
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1.4.3. PDZ domain containing proteins 
 PDZ (PSD95/Dlg/ZO-1) domains are common in multicellular organisms.  So far over 
250 PDZ domains have been identified in the human proteome (Finn et al. 2006). They 
facilitate protein-protein and protein-lipid interactions and play an important role in cell 
signalling, maintenance of cell polarity, stabilization of adhesion structures, organization of 
signalling complexes, trafficking and clustering of receptors (Wawrzak et al. 2009). PDZ 
domains consist of 80-100 residues forming a globular structure with six β-strands and two α-
helices (Figure 1.6.). Initially, they have been described as interacting with C-terminal tail of 
target proteins (Doyle et al. 1996;Jemth et al. 2007). Later, PDZ domains have been shown to 
bind other PDZ domains, internal binding sites and phosphoinositides (Gallardo et al. 
2010;Harris et al. 2001;Wong et al. 2003;Zimmermann 2006). 
 Traditionally, PDZ domains have been classified into four classes, depending on the 
consensus sequence of the binding motif: class 1 (x-S/T-x-φCOOH), class 2 (x-φ-x-φCOOH), class 3 
(x-D/E/K/R-x-φCOOH) and class 4 (x-x-ψ-φCOOH), where φ is a hydrophobic amino acid and ψ is 
an aromatic amino acid (Song et al. 2006).  More recent analysis showed that binding to a 
PDZ domain may involve more than four amino acids and the current classification 
distinguishes 16 subclasses (Tonikian et al. 2008).    
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Figure 1. 6. 3D structure of a bound PDZ domain. 
The PDZ domain is a globular structure built of six β-strands and two α-helices. Canonical 
interaction occurs through C-terminal tail of target proteins and the hydrophobic binding 
pocket formed between strand β2 and helix α2 of the PDZ domain. The core binding sites 
of PDZ domain are highlighted in blue, and the bound peptide is orange (RREQV). 
PDB:2OQS (NMR first model). Figure reproduced from (Hui et al. 2013). 
 
 
PDZ domains are often present in proteins containing other modular domains and 
most of the PDZ proteins function as scaffold proteins.  
Many PDZ domain-containing proteins are involved in signal transduction. It is 
particularly striking in the case of Wnt signalling, where the PDZ protein Dishevelled plays a 
central role in the signalling cascade, as it was already discussed in previous sections. 
Dishevelled binds to the internal, membrane proximal PDZ binding motif of Frizzled 
receptors. Other PDZ proteins interact with membrane distal PDZ-BM of Frizzled (with 
consensus sequence (x-S/T-x-φCOOH) and also play role in regulation of Wnt signalling (Figure 
1.7.) (Wawrzak et al. 2009).  
GOPC/PIST (Golgi associated PDZ and coiled-coil motif containing) is a Golgi protein 
containing one PDZ domain. GOPC was reported to bind the C-terminal PDZ-BM of 
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mammalian Fz5 and Fz8. It was shown that GOPC trafficked together with Frizzled through 
Golgi to the plasma membrane, which implies its role in vesicular transport of the receptors 
(Yao et al. 2001). GOPC/PIST was implicated in regulation of trafficking of several other 
transmembrane proteins. GOPC/PIST overexpression leads to different surface expression 
patterns of β1-adrenergic receptor, the somatostatin receptor subtype 5 (SSTR5) and 
Cadherin 23, by holding them back in the Golgi (He et al. 2004;Wente et al. 2005;Xu et al. 
2010). It also regulates membrane expression of cystic fibrosis transmembrane conductance 
regulator (CFTR), by facilitating its targeting to lysosomes (Cheng et al. 2005)  
Another PDZ protein involved in Frizzled trafficking is dGRIP (glutamate receptor-
interacting protein). It has been shown to co-localize with DFrizzled-2 in trafficking vesicles 
and to play role in transporting the receptor from neuromuscular junctions to the perinuclear 
area in Drosophila (Ataman et al. 2006).  
MAGI3 (Membrane-associated guanylate kinase, WW and PDZ domain-containing 
protein 3) is a protein with six PDZ domains, usually enriched in cell junctions. The second 
PDZ domain of the protein has been shown to bind Frizzled-4 and Frizzled-7. MAGI3 co-
localizes with Fz4 and Ltap protein, transmembrane protein supporting noncanonical Wnt 
signalling, at cell contact sites in MDCK cells. Complexing of Fz4 with Ltap by MAGI3 has 
been reported to enhance noncanonical Wnt/JNK pathway (Yao et al. 2004).  
Pals-1 associated tight junction protein (dPatj), also known as InaD-like protein 
(INADL),  is a protein with four PDZ domains, involved in the establishment of cell polarity. 
It forms a subapical complex together with Crumbs and Stardust/Pals-1 proteins. dPatj has 
been shown to interact with dFz1 (mediating PCP signalling), but not with DFz2 (mediating 
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canonical signalling), via Frizzled C-terminal PDZ-BM. It was proposed that dPatj facilitate 
the phosphorylation of dFz1 by atypical PKC (aPKC), what consequently inhibits PCP 
signalling, without compromising receptor localization or interaction with Dishevelled 
(Djiane et al. 2005).  
Kermit, the X. laevis ortholog of GIPC/Synectin, was shown to interact with C-
terminal PDZ-BM of XFz3 and XFz7, but not with XFz8. It has been reported that 
downregulation and high overexpression of Kermit blocks XFz3 mediated induction of 
neural crest, but discrete overexpression of Kermit enhances it. This led to a conclusion that 
Kermit is involved in regulation of canonical Wnt signalling in neural crest development, 
probably functioning as a scaffold for XFz3 and another unidentified component of the 
pathway (Tan et al. 2001).  
Proteins from the PSD-95 family (PSD-95/SAP90/Dlg4, PSD93/chapsyn-110/Dlg2 and 
SAP97/Dlg1) also have been shown to interact with Frizzled receptors. Proteins from this 
family contain three PDZ domains and function in synapses by organizing signalling 
complexes. PSD-95 has been shown to bind C-terminal PDZ-BM of Frizzled-1, -2, -4 and -7, 
whereas PSD-93 and SAP97 interact with Frizzled-1, -4 and -7. Based on the observation that 
PSD-95 form a complex with Fz2 and APC, it was suggested that it may serve as an adaptor 
protein recruiting components of the canonical Wnt pathway (Hering et al. 2002).  
FRIED (Frizzled interaction and ectoderm defects), an ortholog of mammalian PTP-
BL and a six PDZ domain containing tyrosine phosphatase, has been identified to interact 
with XFz8 in X. laevis. It was shown that FRIED can inhibit induction of secondary axis in 
frog embryos mediated by XWnt8, as well as modulate XWnt5a mediated reorganization of 
the actin cytoskeleton in a Dishevelled-independent manner (Itoh et al. 2005).  
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Finally, NHERF1(Na+/H+ exchange factor 1), adaptor protein highly expressed in 
normal mammary epithelium, was reported to regulate canonical Wnt signalling due to a 
direct interaction between its second PDZ domain and C-terminal PDZ-BM of Frizzled 
receptors (Fz4, Fz2 and Fz7). It was shown that Frizzled binding to NHERF1 modulates 
Dishevelled recruitment and Wnt-induced β-catenin activation. Furthermore, the loss of 
NHERF1 in breast cancer cell lines enhances Wnt signalling and cell proliferation, which 
imply that NHERF1 is involved in breast cancer pathogenesis (Wheeler et al. 2011).  
Syntenin-1 is another PDZ domain-containing adaptor protein implicated in the 
regulation of Frizzled signalling, and it will be discussed separately in the section 1.6.3.3. 
 
Figure 1. 7. Schematic domain structure of proteins directly interacting with Frizzled. 
Figure reproduced from (Schulte et al. 2007).   
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1.5. Syntenin-1 
Syntenin-1 is a protein containing two PDZ domains, originally identified as a 
syndecan binding protein (Grootjans et al. 1997) and as a melanoma differentiation gene 
(mda-9), expression of which was induced by interferon γ (IFNγ) (Lin et al. 1998). It is widely 
present in all adult tissues (Zimmermann et al. 2001) and especially robustly expressed in 
developing skin, spinal cord, heart and lung during development of mouse embryo (Jeon et 
al. 2013). Currently, many reports describe numerous interactions between syntenin-1 and 
different proteins. It is suggested that syntenin-1 can serve as a scaffold for a number of 
intracellular interactions. 
1.5.1. Subcellular localization of syntenin-1  
Analysis of the syntenin-1 distribution in epithelial cells revealed its localization at 
cell-cell contact sites. Syntenin-1 co-localizes with F-actin, syndecan-1, E-cadherin, β-catenin 
and α-catenin. In fibroblasts, it was shown that syntenin-1 localizes to focal adhesions and in 
stress fibres (Zimmermann et al. 2001). Syntenin-1 also localizes in the early secretory 
pathway, e.g. endoplasmic reticulum, intermediate compartment, cis-Golgi and apical 
endosomes (Sarkar et al. 2008). Thus, it is implicated that syntenin-1 facilitates trafficking of 
transmembrane proteins (Fernandez-Larrea et al. 1999). Furthermore, syntenin-1 interactions 
with phosphatidylinositol 4,5-bisphosphate (PIP2) and phospholipase Cδ facilitates its 
membrane anchorage (Zimmermann et al. 2002). 
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1.5.2. Molecular structure and binding partners of 
syntenin-1 
Syntenin-1 is a 32 kDa protein. It contains N-terminal domain (NTD), followed by 
two PDZ domains (PDZ1 and PDZ2) and C-terminal domain (CTD) (Figure 1.8).  
NTD contains 113 amino acids and does not display any structural motifs. However, 
it contains three conserved L-Y-P-x-L sequences, where X stands for any amino acid residue. 
The first one has a conserved serine residue at the “X” position, and was shown to be 
involved in ubiquitin binding to syntenin-1 (Rajesh et al. 2011). Recently, the L-Y-P-x-L 
motifs were implicated in syntenin-1 binding to ALIX protein during syndecan-lead cargo 
recruitment to exosomes and syntenin-1-syndecan-ALIX complex has been reported to 
regulate the biogenesis of exosomes (Baietti et al. 2012). The NTD domain recruits the 
transcription factor SOX4 and eukaryotic translation initiation factor 4A (EIF4A) into 
signalling complexes (Beekman et al. 2008). It is also important for homo-dimerization and 
hetero-dimerization with syntenin-2, protein homologous to syntenin-1 (Koroll et al. 2001). It 
was shown that endogenous syntenin-1 is phosphorylated within its NTD domain. Five 
conserved tyrosine’s were found (Y4, Y46, Y50, Y56 and Y91), which are potential 
phosphorylation sites. Tyrosine phosphorylation within NTD might be an important factor 
in the regulation of syntenin-1 functions (Beekman et al. 2008). Indeed, Wawrzyniak and 
colleagues showed that phosphorylation of Y56 of syntenin-1 decreases membrane 
localization of the protein (Wawrzyniak et al. 2012). It has been also shown that  Src-
dependent Tyr4 phosphorylation of syntenin-1 leads to binding of the protein to myosin 
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phosphatase Rho interacting protein (M-RIP). By that it regulates Rac GTPAse-dependent 
actin polymerization (Sala-Valdes et al. 2012).   
CTD is a short, 24 amino acid long domain. CTD domain is required, but not 
sufficient, for syntenin-1 interaction with CD63 (Latysheva et al. 2006). Negative charges of 
the K280 and R281 residues present in CTD increase syntenin-1 localization at the plasma 
membrane (Wawrzyniak et al. 2012). 
Syntenin-1 contains two PDZ domains (PDZ1 and PDZ2). They  do not bind a unique 
sequence, but different peptide motifs (PDZ-BM class 1, 2 and 3, but also to unconventional 
PDZ-BMs) with low-to-medium affinity (Grembecka et al. 2006). PDZ1 displays 26% of 
sequence similarity with PDZ2 domain. However both domains closely resemble each other 
structurally. They are linked by a conserved peptide built of five residues and extensive 
contact site between two PDZ domains have been observed in syntenin-1 crystals (Cierpicki 
et al. 2005). PDZ2 domain binds peptides in canonical orientation (Cierpicki et al. 2005). 
Whereas in case of  PDZ1, backbone of the interacting peptide is nearly in perpendicular 
orientation to the PDZ1 domain, when compared to the peptide-PDZ2 interaction 
(Grembecka et al. 2006). Recently, syntenin-1-PDZ2 has been found to bind internal PDZ-
BM. Two types of motifs were identified. The consensus sequence of the first one was φ-A-I-
x-(ALV)-(IV), which can be regarded as two tandem canonical class II PDZ-BM, i.e. φ-A-I 
and I-x-(ALV). The consensus of the second motif was identified as φ-R-φ-φ-φ, which 
includes two canonical class II PDZ-BM, i.e. φ-R-φ and φ-φ-φ (Mu et al. 2014). 
Most protein ligands show preference for PDZ2 (for example syndecans and 
ephrinB). PDZ1 binds with higher affinity to IL-5Rα (interleukin-5 receptor α), neurexin, 
merlin and CD63 (Beekman et al. 2008). It was also reported that PDZ1 can bind 
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phosphoinositol lipids in the plasma membrane (Zimmermann 2006). Even though PDZ 
domains of syntenin-1 can interact separately with their ligands, most of the interactions 
depend on cooperative ligand binding to the PDZ1-PDZ2 tandem (Grembecka et al. 
2006;Grootjans et al. 2000). Furthermore, it is suggested that PDZ1 plays a chaperone-like 
role in stabilizing of PDZ2 domain folding (Boukerche et al. 2010). 
 
 
Figure 1. 8. The domain structure of syntenin-1  
Syntenin-1 contains N-terminal domain (NTD), followed by two PDZ domains (PDZ1 and 
PDZ2) and C-terminal domain (CTD). Five tyrosine residues within the NTD are 
conserved, as indicated in the lower part of the figure. LY4PSL motif is implicated in the 
ubiquitin binding. Figure is reproduced and modified from (Beekman et al. 2008).   
 
 
 
 
 
 
 
 
 
PDZ1 PDZ2
NTD CTD
High-affinity binding
Moderate affinity for
protein/PtdIns(4,5)P2
Moderate affinity
for protein
LY4PSL
  1.INTRODUCTION 
52 
 
1.5.3. Functions  of syntenin-1 
1.5.3.1. Syntenin-1 and receptor trafficking 
Syntenin-1 plays an important role in receptor trafficking. Endocytosis of receptors 
leads to signal attenuation, as internalized receptors are targeted for degradation. However it 
can also positively influence signalling output, as receptors at endocytic compartments can 
interact with different downstream effectors, within the plasma membrane.  
The first reported functional interaction of syntenin-1 was with syndecans, membrane 
proteins with heparan sulphate (HS) side chains in the extracellular domain. HS chains allow 
syndecans to act as co-receptors. They bind and concentrate growth factors at the cell surface 
and facilitate their interactions with receptors. It was reported that syntenin-1 mutants, 
defective in phosphoinositol lipid PtdIns(4,5)P2 binding, trap syndecans in perinuclear 
recycling endosomes, characterized by the presence of Rab11 and Arf6, small GTPases 
involved in endosome recycling (Zimmermann et al. 2005). Thus, the interaction with 
syntenin-1 plays role in syndecans recycling to the plasma membrane. Furthermore, it has 
been shown that membrane receptors associated with syndecans, such as FGF receptor, can 
be recycled to the cell surface together with syndecans and syntenin-1 (Zimmermann et al. 
2005).  Recently, it has been demonstrated that ternary complex syndecan-syntenin-1-ALIX is 
able to recruit syndecan associated proteins to the intraluminal vesicles of multivesicular 
endosomes and exosomes (Baietti et al. 2012). 
Pro-TGFα is membrane bound and functions as a ligand for EGFR (epithelial growth 
factor receptor). It was reported that syntenin-1 binds to the C-terminus of the protein and 
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both PDZ domains of syntenin-1 are required for optimal interaction. It was shown that 
mutations of pro-TGFα, that disrupt its association with syntenin-1, result in retention of the 
protein in the endoplasmic reticulum (Fernandez-Larrea et al. 1999).    
It was suggested that syntenin-1 plays a role in maintaining Delta1 expression on the 
cell surface. Delta1 is a ligand for Notch receptor. Estrach et al. ( 2007) reported that Delta1 
interacts with syntenin-1 and its membrane expression is decreased by syntenin-1 depletion.  
Delta1 contains PDZ-BM on its C-terminus and a mutation of C-terminal valine leads to 
activation of Notch signalling (Estrach et al. 2007).  
Syntenin-1 was also reported to regulate endocytosis of tetraspanin CD63.  
Tetraspanins regulate maturation and processing of associated transmembrane proteins, 
their activity and internalization. CD63 directly binds syntenin-1 and it has been proposed 
that the interaction may have a negative effect on AP2-clathrin mediated endocytosis of 
CD63, by inhibiting CD63-AP2 association (Latysheva et al. 2006). 
1.5.3.2. Syntenin-1 and metastasis 
Syntenin-1 was reported to be involved in cancer metastasis. Ability to metastasize is 
the major characteristic of malignant tumours. Metastasis is a complex process that requires 
attachment of tumour cell to matrix proteins, degradation of extracellular matrix (ECM) by 
matrix metalloproteinases (MMP) and migration of cancer cells into surrounding stroma. 
Overexpression of syntenin-1 was observed in a number of metastatic breast and gastric cell 
lines. Breast cancer cell line MCF7 and gastric cancer cell line Az-521 showed increased 
invasion rate and migration properties after transfection with syntenin-1. Moreover, 
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syntenin-1 overexpression in MCF7 was associated with pseudopodia formation. Further 
analysis showed that PDZ2 domain of syntenin-1 is responsible for the stimulatory effect of 
the protein on cell migration (Koo et al. 2002). It was also observed that syntenin-1 
expression increases during melanoma progression from primary to metastatic melanoma 
(Helmke et al. 2004).  
Syntenin-1 displays preferential link with fibronectin signalling. In melanoma cells, 
after cell interaction with fibronectin, syntenin-1 facilitates phosphorylation of FAK (focal 
adhesion kinase) what leads to activation of p38, JNK (c-jun NH2-terminal kinase) and NF-κB 
(nuclear factor κB) activation. NF-κB was shown to induce expression of MMP-2 in 
melanoma cells (Boukerche et al. 2005;Boukerche et al. 2007). This pathway can be inhibited 
by RKIP (Raf kinase inhibitor protein), which prevents syntenin-1 binding to FAK and c-Src 
kinases (Das et al. 2012).  Nonetheless, syntenin-1-induced expression of MMP-2 or MMP-9 
was not observed in breast cancer cell lines (Koo et al. 2002). Recently, it was reported that 
syntenin-1 interaction with c-Src also positively regulates NF-κB activation (Boukerche et al. 
2010). Furthermore, activation of c-Src mediated by syntenin-1 induces activation of EGFR 
(epidermal growth factor receptor) in uroepithelial cells, and in consequence increases their 
proliferation and invasion properties (Dasgupta et al. 2013)    
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1.5.3.3. Syntenin-1 and Frizzled receptors 
Syntenin-1 was identified as an intracellular ligand for Frizzled receptors. It was 
shown that it interacts with the C-terminal PDZ-BM of human Frizzled-3,-7 and -8, but not 
with Frizzled-2, -5 and -6. Luyten et al. reported that association with Frizzled-7 requires 
PDZ1 domain of syntenin-1, whereas Frizzled-3 and Frizzled-8 prefer the second PDZ 
domain. However, the tandem of syntenin-1’s PDZ domains mediates higher affinity 
binding than the isolated domains. Syntenin-1 was reported to stimulate noncanonical 
Wnt/JNK pathway. Further investigation revealed that in Xenopus leavis Xsyntenin interacts 
with XFrizzled-7. Overexpression of Xsyntenin blocks convergent extension in animal cap 
assay, while its downregulation affects gastrulation movements and shortens body axis of 
embryos, process controlled by noncanonical Wnt signalling. It was also established that 
syntenin-1 stimulates Frizzled-7 dependent activation of the PKCα/CDC42 signalling (Luyten 
et al. 2008). Syndecans, syntenin-1 binding partners, are Wnt co-receptors and were shown to 
stimulate PKCα and CDC42 activities. Xsyndecan-4 functionally and physically interacts 
with XFrizzled-7 and XDvl, and a model was proposed where syntenin-1 acts as an 
intracellular scaffold protein between Frizzled and syndecans. This function of syntenin-1 
would support noncanonical Wnt signalling. In addition, as syntenin-1 was reported to 
interact with PIP2 and that this association stimulates syndecan and syndecan cargo 
recycling, it is possible that syntenin-1 plays role in joined recycling of Frizzled and 
syndecans (Wawrzak et al. 2009).  
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1.5.3.4. Other functions of syntenin-1  
Syntenin-1 plays several other important roles in cells. It interacts with IL-5Rα 
(interleukin-5 receptor α) and the transcription factor Sox4, thus mediates IL-5 dependent 
activation of Sox4. IL-5 and SOX4 are implicated in B-cell development and differentiation 
and syntenin-1 may also be involved in these processes (Geijsen et al. 2001). 
Syntenin-1 interacts with ephrinBs and ephrin receptors (Eph), thus may regulate 
ephrin-Eph signalling. It has been shown that syntenin-1 interaction with ephrinB ligands is 
important for the pre-synaptic machinery recruitment during development of presynaptic 
and postsynaptic compartments in neurons (McClelland et al. 2009). Syntenin also functions 
in regulation of axon outgrowth. It interacts with Unc51.1, which is a serine/threonine kinase 
important for neurite extension, and Rab5, a marker of early endosomes. This interaction 
creates a scaffold for Unc51.1 and endocytic machinery, what is important for the regulation 
of axon extension (Tomoda et al. 2004).  
Recently syntenin-1 was implicated in ubiquitin-dependent sorting of transmembrane 
proteins and facilitating recruitment of ubiquitylated proteins to transmembrane partners. 
Syntenin-1 was shown to bind ubiquitin via unconventional pocket in its N-terminal domain, 
in a process regulated by Ulk1, a serine/threonine kinase, known to control different 
trafficking pathways in cells (Rajesh et al. 2011). 
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1.6. LNX family of ubiquitin ligases 
1.6.1. RING-type E3 ligases 
E3 ubiquitin ligases catalyse the transfer of ubiquitin from an E2 enzyme to the target 
protein and also ensure the specificity of ubiquitin modification. E3 ubiquitin ligases 
function by one of the two mechanisms. HECT (Homologous to E6-AP Carboxy Terminus)-
type E3s serve as catalytic intermediates in ubiquitination. Ubiquitin is transferred from E2 
enzyme to the catalytic cysteine of HECT domain, and later to a lysine in the substrate. 
Alternatively, really interesting new gene (RING)-type E3s mediate the transfer of ubiquitin 
directly from E2~ubiquitin to the target protein. (Budhidarmo et al. 2012;Metzger et al. 2014).  
LNX proteins belong to the RING-type family of E3 ubiquitin ligases, defined by the 
presence of RING domain. RING type ubiquitin ligases are conserved from yeast to humans, 
and over 400 different ligases were identified in mammalian cells.  RING domain binds Zn2+ 
ion through a cross-braced arrangement of cysteine and histidine amino acids with a 
characteristic spacing. The consensus sequence of this domain is C-X2-C-X(9-39)-C-X(1-3)-H-X(2-3)-
C-X2-C-X(4-48)-C-X2-C (where X means any amino acid). Ligases use RING domain to recruit 
and activate an E2~ubiquitin enzyme, which in turn transfers ubiquitin to the substrate 
(Pickart 2001;Satija et al. 2013).   
RING-type E3s were described to function as both tumour suppressors and 
oncogenes. At the cellular level they play critical roles in endocytic trafficking, DNA repair 
and activation of NF-κB signalling (Metzger et al. 2014). The interaction between E3 ligase 
and substrate is often mediated via protein-binding domains on the E3, such as SH2 (Src 
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homology 2), SH3 (Src homology 3), FHA (forkhead associated domain), ankyrin repeats or 
PDZ domains. Indeed, bioinformatics analysis revealed that 75% of human RING-type E3 
ligases contain at least one other domain or binding motif (Deshaies et al. 2009) 
Mutations or impaired modulation of RING-type E3s activity are often linked with 
human disease. Mutations of BRCA1, an E3 ubiquitin ligase involved in DNA repair, are 
associated with familial breast and ovarian cancers (Welcsh et al. 2001). FANC ubiquitin 
ligase, which also plays role in DNA repair, is mutated in the multisystemic Fanconi anemia 
syndrome, cause of severe developmental defects (Moldovan et al. 2009). Another RING-
type E3, FBXO11 is often mutated or deleted in diffuse large B-cell lymphomas (Duan et al. 
2012). The malignant von Hippel–Lindau syndrome is associated with mutations in VHL 
protein, the component of the CRL2VHL E3 (Lipkowitz et al. 2011). Mutations in the RING–
IBR (in between RING)–RING (RBR) E3 ubiquitin ligase Parkin were reported in autosomal 
recessive juvenile Parkinsonism (AR-JP) (Kitada et al. 1998). Finally, increased expression of 
Mdm2 (double minute 2 protein) E3 ligase or loss of its negative modulator, leads to the 
upregulation of Mdm2 activity towards the tumour suppressor p53, and is associated with 
human cancers, especially those with wild type p53 (Lipkowitz et al. 2011;Metzger et al. 
2014).  
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1.6.2. Ligand of Numb Protein-X (LNX) family  
LNX (Ligand of Numb Protein-X) family of proteins, also known as PDZRN (PDZ 
and RING) family, consists of five members (LNX1 – LNX5) as presented in the Figure 1.9. 
Proteins belonging to this group are characterized by the presence of RING domain followed 
by one to four PDZ domains. Within the family, LNX1 and LNX2 share identical domain 
structure, consisting of one RING domain and four PDZ domains. There is a high degree of 
similarity between LNX3 and LNX4 (PDZRN3 and PDZRN4), and they are more distantly 
related to LNX1 and LNX2. They both contain one RING domain and two PDZ domains. 
LNX5 (PDZK4, PDZRN4L) lacks RING domain, but due to its high sequence homology to 
LNX3 and LNX4, it was also included in the family. The LNX proteins are unique in 
vertebrates as they are the only proteins characterized by the presence of both RING and 
PDZ domains. Combination of these two types of domains suggests that PDZ domains might 
be involved in substrate recognition and targeting the ubiquitin ligase activity of the proteins 
(Flynn et al. 2011). 
LNX1 was initially discovered as a protein interacting with Numb, a component of 
Notch signalling (Dho et al. 1998). Subsequently, LNX2 was also shown to interact with 
Numb and its paralog Numb-like (Rice et al. 2001). Apart from Numb, several other binding 
partners of LNX1 and LNX2 were discovered, and they will be further discussed in following 
sections.  
LNX3 was identified as a binding partner of Semaphorin (Sema4C) in yeast two-
hybrid screen (Wang et al. 1999). Its high expression was detected in heart and muscle. LNX3 
was shown to be involved in differentiation of C2C12 cells into myotubes (Ko et al. 2006) and 
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into osteoblasts (Honda et al. 2010). It served as a negative regulator of osteoblast 
differentiation through inhibition of canonical Wnt signalling. Furthermore, LNX3 was 
found to regulate formation of neuromuscular junction, as it interacts and ubiquitylates the 
muscle specific tyrosine kinase (MuSK), a key regulator of postsynaptic assembly. LNX3 
promotes MuSK endocytosis thus negatively regulates its cell surface expression (Lu et al. 
2007). 
LNX4 and LNX5 were identified in silico based on homology to LNX3, and they 
remain virtually uncharacterized. LNX4 was found to be down regulated in the 
hypothalamus of Sim1 (single-minded homolog 1) knockout mice. Whereas LNX5 was 
identified as up-regulated in synovial sarcomas. Their physiological functions remain 
unknown (Flynn et al. 2011). 
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Figure 1. 9. Domain structures of mammalian LNX family members. 
LNX1 and LNX2 share a similar domain structure, as do LNX3 and LNX4. The number of 
amino acids the murine LNX protein is indicated. Alternative splicing variants of LNX1, 
LNX3 and LNX4 are not presented. RF, RING finger domain; Y, NPxY motif; F, NPxF 
motif; PDZ, post synaptic density protein (PSD95), Drosophila disc large tumour 
suppressor (Dlg1), and zonula occludens-1 protein (ZO-1) domain; LNX3H, homology 
domain with a significant sequence similarity between LNX family members. Figure 
reproduced from (Flynn et al. 2011).  
 
 
 
 
 
 
 
 
 
  1.INTRODUCTION 
62 
 
1.6.3. Molecular structure of LNX1 and LNX2 
LNX1 and LNX2 display similar domain organisation, one RING domain followed by 
NPXY motif and four PDZ domains. RING finger-domains function as a catalytic component 
of E3 ubiquitin ligases, whereas NPXY motif (NPAY in LNX1, or NPAF in LNX2) serves a 
binding place for Numb protein. Amino acid sequences of LNX1 and LNX2 are identical in 
50%. Orthologs of both proteins were found in all vertebrates with available genome 
sequences. Additionally, fish, marsupial, amphibian and bird genomes contains a LNX-2-
related protein, called LNX-like or LNX2b (Flynn et al. 2011). 
BLAST analysis of the NCBI GenPept protein sequence database showed that 
corresponding PDZ domains of LNX1 and LNX2 display sequence identity in range of 56% 
to 63%. Sequence identity of 17 amino acids identified as PDZ domain binding site sequence 
was also examined. PDZ2 and PDZ4 of LNX1 were found to share over 70% identity with 
PDZ2 and PDZ4 of LNX2, respectively (Wolting et al. 2011). 
Furthermore, LNX1, but not LNX2, exists in two splice variants. Two cDNAs were 
isolated, 2.8 kb and 2.6 kb, encoding 80 and 70 kDa proteins. The 80 kDa protein (LNX1 p80) 
encodes the RING domain and four PDZ domains, whereas the 70 kDa protein (LNX1 p70) 
lacks the RING domain but contains all four PDZ domains (Figure 1.10.) (Dho et al. 1998).  
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Figure 1. 10. Ligand of Numb Protein X 1 and 2. 
LNX1 and LNX2 share a similar domain organisation: one RING domain followed by 
NPXY motif and four PDZ domains. RING finger-domains function as a catalytic 
component of E3 ubiquitin ligases, whereas NPXY motif (NPAY in LNX1, or NPAF in 
LNX2) serves a binding place for Numb protein. LNX1 exists in two splice variants, p80 
and p70. Figure based on (Wolting et al. 2011). 
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1.6.4. Binding partners of LNX1 and LNX2 
LNX1 interacts with a number of proteins, predominantly those with a PDZ binding 
motif. Predicted functional partners of human LNX1, retrieved from the STRING database 
(www.string-db.org), are presented in the Figure 1.11. A total of 166 binding partners of 
LNX1 have been discovered in different yeast two-hybrids and proteomics studies (Guo et 
al. 2012;Rice et al. 2001;Rual et al. 2005;Wolting et al. 2011). LNX1 was initially identified to 
interact with the cell fate determinant NUMB in a yeast two-hybrid screen (Dho et al. 1998), 
and subsequently it was shown to interact with all four isoforms of human NUMB as the 
NUMB PTB domain binds the NPAY motif in LNX1 (Dho et al. 1999). In addition, the first 
PDZ domain of LNX1 binds to the PTB domain of NUMB (Nie et al. 2004). 
LNX1 interacts with RhoC, a small GTPase playing role in reorganization of the actin 
cytoskeleton. Efficient binding of RhoC to LNX1 requires the first PDZ domain of LNX1 
(Zheng et al. 2010). KCNA4, a shaker-type voltage-gated K+ channel and PLEKHG5 
(pleckstrin homology domain-containing family G member 5) are also recognized by the 
PDZ1 of LNX1 via their carboxy terminal tails (Wolting et al. 2011). PLEKH5 can also bind to 
PDZ3 of LNX1. Similarly to PLEKH5, LNX1-PDZ1 and PDZ3 can both recognize the carboxy 
termini of the proto-oncogene c-Src, a cytoplasmic protein kinase (Weiss et al. 2007). PDZ-
binding kinase (PBK) also binds to LNX1-PDZ1 (Guo et al. 2012). 
LNX1-PDZ2 is involved in binding to the pre-synaptic active zone protein CAST 
(Higa et al. 2007), junctional adhesion molecule 4 (JAM4) (Kansaku et al. 2006) and to 
Coxsackie and adenovirus receptor (CAR) (Sollerbrant et al. 2003) via their C-terminus. 
However efficient binding to the latter requires not only C-terminal PDZ binding motif of the 
  1.INTRODUCTION 
65 
 
receptor, but also upstream sequences. Protein kinases Tyk2, PAK6 and PKC-α1 also interact 
with the second PDZ domain of LNX1. Additionally PAK6 and PKC-α1 also bind to LNX1-
PDZ4. Tyk2 is a member of Janus kinase (JAK) family of cytoplasmic protein tyrosine 
kinases, whereas PAK6 and PKC-α1 are serine/threonine kinases involved in signal 
transduction, cell proliferation and apoptosis (Wolting et al. 2011). LNX1-PDZ4 was also 
shown to bind numerous PIPs (phosphatidylinositol phosphates). PDZ4  is the only PDZ 
domain of LNX1 found to interact with membrane phospholipids and it may regulate LNX1 
subcellular localization (Wolting et al. 2011).   
Several other ligands have been identified for LNX1, including: CD8α, the T-cell co-
receptor (D'Agostino et al. 2011); Claudin-1, a tight junction protein (Takahashi et al. 2009); 
ErbB2, a member of the epidermal growth factor receptor family (Young et al. 2005); SKIP, 
the transcription and splicing factor Ski-interacting protein (Chen et al. 2005) and the human 
endogenous retrovirus protein NP9  (Armbruester et al. 2004). Additionally, MAGE-B18, a 
melanoma antigen family member has been shown to bind to a basic region between the 
RING and first PDZ domain of LNX1 via the MAGE homology domain (MHD) (Doyle et al. 
2010).  
LNX2 has been shown so far to interact only with Numb protein (Nie et al. 2002), 
CAR receptor (Sollerbrant et al. 2003) and with CD8α (D'Agostino et al. 2011).  
LNX1 and LNX2 contain consensus type I PDZ domain-binding motifs (T-x-L in 
LNX1 and S-x-V in LNX2) at their C-termini that can also bind PDZ domains. Indeed, in 
yeast two-hybrid assays, LNX1 has been shown to homo-oligomerize and hetero-oligomerize 
with LNX2, indicating the possibility that LNX proteins may be able to form large oligomeric 
networks in the cell (Rice et al. 2001). In the latest proteomics study Guo and colleagues 
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discovered that PDZ domains of LNX can interact with each other and form dimers (Guo et 
al. 2012). They have found three pairs of PDZ-PDZ interactions: LNX1-PDZ1 and LNX1-
PDZ4, LNX1-PDZ1 and LNX2-PDZ4, and LNX2-PDZ1 ad LNX2-PDZ4. Using LNX1-PDZ1 
and LNX2-PDZ1 as baits in Y2H, they have also discovered that neither of these domains 
interact with their own C-termini. However, the interaction of LNX1-PDZ1 with C-terminus 
binding motif of LNX2 was detected. Recent study by Mu and colleagues revealed that the 
first PDZ domain of LNX2 (LNX2-PDZ1) is able to bind internal PDZ-BM. 17 unique internal 
binding motifs were identified, with consensus sequence φ-Tx-φ-Tx- φ, which can be 
regarded as two canonical class II C-terminal PDZ-BM in tandem  (Mu et al. 2014).      
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Figure 1. 11. Functional partners of LNX1. 
Network of binding partners of LNX1 based on experimental evidence, retrieved from the 
STRING database (www.string-db.org). LNX1, ligand of numb protein X1; LNX2, ligand 
of numb protein X2; NUMB, numb homolog; MAGEB18, melanoma antigen family B 18; 
IGSF5, immunoglobulin super family member 5; SRC, c-Src sarcoma viral oncogene 
homolog; RHOC, Ras homolog gene family member C; CXADR, coxsackie virus and 
adenovirus receptor; CD8A, CD8α molecule; INPP5K, inositol polyphospate-5-
phosphatase K. 
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1.6.5. Functions of LNX1 and LNX2  
The functional significance of many interactions presented in the previous section 
remains unclear. Nevertheless LNX1 and LNX2 have been shown to function as both E3 
ubiquitin ligases and molecular scaffolds in regulation of the activity, stability, or subcellular 
localization of their interacting partners. LNX proteins are involved in several different 
biological process, such as Notch signalling, tight junction reorganization and Wnt 
signalling.  
1.6.5.1. Notch signalling 
The E3 ligase activity of LNX1 p80 and LNX2 is possible due to the RING domain, 
which has been shown to have the ubiquitin ligase activity in vitro and in vivo. The first 
protein identified as a target of LNX1 ubiquitylation was Numb protein, a component of 
Notch signalling pathway. Numb is an endocytic adapter, shown to control cell fate during 
development by suppressing Notch receptor. LNX1 can ubiquitilate two isoforms of Numb 
(p66 and p72), containing the eleven amino acid insert in the PTB domain, and target them 
for proteasomal degradation. LNX1 functions as a positive regulator of Notch signalling by 
promoting Numb degradation and reducing its ability to antagonize Notch (Nie et al. 
2002;Nie et al. 2004). Homologous LNX2 was also shown to interact with Numb and is also 
likely to ubiquitilate the protein and thereby modulate Notch signalling (Nie et al. 2002;Rice 
et al. 2001). Finally, LNX2 siRNA-mediated silencing leads to downregulation of NOTCH1 
expression. Also, following LOF (loss-of-function mutation) of LNX2, the protein level of 
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Numb and expression of JAGGED1, a ligand for the receptor Notch1, were significantly 
reduced in colorectal cell line SW480 (Camps et al. 2013).  
1.6.5.2. Tight junction reorganization 
Both LNX1 and LNX2 play a crucial role in tight junction (TJ) reorganization, as they 
have been shown to interact with multiple TJ components, namely CAR, JAM4 and claudins. 
LNX1 and LNX2 bind to the Coxsackie and adenovirus receptor (CAR) and might function 
together at intercellular junctions (Sollerbrant et al. 2003). LNX1 was also reported to interact 
with junctional adhesion molecule 4 (JAM4), an immunoglobulin superfamily member 
present at TJs. LNX1 is involved in JAM4 endocytosis and redistribution after transforming 
growth factor (TGF) β induction. Numb protein was found to be involved in this process and 
to form a tripartite complex with JAM4 and LNX1, important for the LNX1-mediated 
endocytosis of JAM4. This suggests that LNX1 provides an endocytic scaffold for JAM4 
(Kansaku et al. 2006). Finally, claudin-1, claudin-2 and claudin-4 had been reported to be 
polyubiquitylated by LNX1, followed by their internalization and degradation in lysosomes. 
Overexpression of LNX1 in MDCK (Madin-Darby canine kidney) cells led to downregulation 
of claudins from TJs and reduced the number of tight junctions (Takahashi et al. 2009). 
Recently, LNX1 has been shown to interact also with claudin-17 (Guo et al. 2012). 
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1.6.5.3. Wnt  signalling 
Recently, several reports have implicated the role of LNX family members in Wnt 
signalling. Wnt signalling regulators Naked2 (Nkd2) and Dishevelled-3 (Dvl3) have been 
identified to interact with LNX1 PDZ domains (Wolting et al. 2011). Additionally, LNX3 was 
found in a high-throughput siRNA screen designed to identify novel Wnt regulators, as 
required for Wnt signal transduction (Major et al. 2008). LNX3 has been shown to be an 
antagonist of Wnt signalling transmission in osteoblast precursor cells (Honda et al. 2010) 
and also to ubiquitylated Dishevelled-3 to promote PCP signalling in endothelial cells 
(Sewduth et al. 2014). Furthermore, LNX2b (an LNX zebrafish ortholog) has been implicated 
in canonical Wnt signalling in the developing zebrafish embryo. LNX2b was shown to bind 
and ubiquitylate the Wnt inhibitor Bozozok, followed by its degradation. Also, altered 
dorso-ventral patterning in the LNX2b knockdown embryos coincided with increased 
stabilization of Bozozok. As a consequence LNX2b-mediated degradation of Bozozok, the β-
catenin Wnt signalling was upregulated (Ro et al. 2009). Finally, it was reported that siRNA-
mediated silencing of LNX2 downregulated the transcription factor TCF7L2  and its targets, 
and reduced Wnt signalling in colorectal cancer cells. TCF7L2 is an important effector of the 
Wnt pathway and is responsible for transcriptional regulation of genes involved in Wnt 
signalling (Camps et al. 2013). 
 
 
 
  1.INTRODUCTION 
71 
 
1.6.5.4. Other functions 
LNX1 p80 and LNX2 are also involved in ubiquitylation, internalization and 
degradation in lysosomes of CD8α, a T-cell co-receptor (D'Agostino et al. 2011). Authors also 
suggested that LNX2 might be involved in the regulation of CD8α transport to, through, or 
from Golgi complex.   
LNX1 also ubiquitilates the non-receptor tyrosine kinase c-Src. In addition to acting as 
a substrate for LNX1 ubiquitylation, c-Src was shown to phosphorylate LNX1. That suggests 
that c-Src may have a role in regulation of LNX1 activity (Weiss et al. 2007). 
Guo and colleagues reported that LNX1 mediates ubiquitylation and degradation of 
PBK, what leads to inhibition of cell proliferation and enhances cell sensitivity to 
doxorubicin-induced apoptosis. It indicates the role of LNX1 in regulation of cell growth and 
apoptosis, thus it may act as a tumour suppressor (Guo et al. 2012). Furthermore, a separate 
genomic study demonstrated that LNX1 knockdown leads to cell cycle arrest in the G0/G1 
phase (Zheng et al. 2011). 
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1.6.6. Major sites of expressions of LNX1 and LNX2 
Murine LNX1 mRNA is widely expressed. It was found in brain, lung, heart, kidney 
and skeletal muscle. LNX1 p80 was specifically reported in heart, skeletal muscle and lunges, 
whereas LNX1 p70 expression was restricted to brain and heart (Dho et al. 1998). Human 
LNX1 mRNA is similarly expressed in brain, heart, kidney, skeletal muscle and lunges as 
well as placenta and pancreas (Xie et al. 2001). Murine LNX2 mRNA was detected in liver, 
spleen, lung, heart, kidney, thymus, skeletal muscle and brain. Interestingly, expression 
of LNX1 and LNX2 overlaps in some brain regions and differs in others (Rice et al. 2001). 
1.6.7. Subcellular localization of LNX1 and LNX2  
Several studies have examined the subcellular localization of LNX1 and LNX2 in 
different cell lines by fluorescence microscopy and reported its diffuse distribution 
throughout the cytoplasm and nucleus. In HEK293 cells LNX1 colocalizes with CAR at cell-
cell contacts (Sollerbrant et al. 2003). In HeLa cells, LNX1 was shown to localize in the 
plasma membrane proximity, as well as diffuse in the cytoplasm and nucleus. It also 
localizes to the microtubule-like structures (Weiss et al. 2007). Sometimes LNX1 distribution 
is altered by co-expression with its interacting partners. Interaction with NP9 leads to LNX1 
recruitment to punctuate nuclear structures (Armbruester et al. 2004). Additionally, LNX1 
and LNX2 were recruited from the cytoplasm to the plasma membrane by the human 
glycoprotein CD8α (D'Agostino et al. 2011). On the other hand, RhoC was redistributed from 
the cytoplasm to the nucleus by LNX1 (Zheng et al. 2010). In MDCK cells, endogenous LNX1 
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co-localizes with JAM4 to TJs along with JAM4 (Kansaku et al. 2006).  However 
overexpressed LNX1 localizes to the cytoplasm and to the apical junctional complex, where it 
colocalizes with ZO-1 at TJs. Furthermore, LNX1 was reported to colocalize with claudin-2 in 
late endosomes and lysosomes of MDCK cells (Takahashi et al. 2009)  
1.6.8. LNX1 and LNX2 in diseases 
LNX1 has been implicated in brain tumourigenesis. LNX1 mutations were found in a 
number of human gliomas (Blom et al. 2008) and the protein was reported to be 
downregulated in all gliomas (Chen et al. 2005). Susceptibility to Kawasaki disease, an 
infectious inflammatory vasculitis has also been linked to alterations in LNX1 expression 
(Burgner et al. 2009). Additionally, interactions of LNX1 with proto-oncogene NP9 and c-Src 
indicate its role in tumourigenesis (Armbruester et al. 2004;Weiss et al. 2007). High levels of 
LNX1 and LNX2 mRNAs were found in endocarditis, the principal manifestation of chronic 
Q fever, but not in acute Q fever (Mehraj et al. 2012). Finally, LNX2 overexpression was 
linked with chromosome 13 amplification and activation of the Wnt and Notch signalling 
pathways in colorectal cancer (Camps et al. 2013).  
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1.7. Research objectives 
Frizzled-7, a member of Frizzled family of Wnt receptors, emerges as a key 
component involved in activation of Wnt signalling in breast cancer cells. It is a 
transmembrane receptor containing two PDZ binding motifs (PDZ-BM) in its cytoplasmic 
tail. The membrane proximal PDZ-BM is a binding  site for Dishevelled, a crucial component 
of Wnt signalling pathways. Whereas the contribution of the C-terminal PDZ-BM of Frizzled 
receptors to Wnt signalling remains poorly studied. PDZ domains are very common in 
multicellular organisms and present in structures of many scaffolding proteins. They 
facilitate protein interactions and are implicated in regulation of cell signalling, maintenance 
of cell polarity, as well as in modulation of trafficking and clustering of membrane receptors. 
We hypothesized that PDZ proteins interacting with the C-terminal PDZ-BM of Frizzled 
receptors are involved in these processes. In this study we focused on Frizzled-7 and the role 
of the C-terminal PDZ-BM in the receptor functionality. Specific aims of this study were as 
follow: 
 To determine the importance of Frizzled-7 interactions via the C-terminal PDZ-
BM for transduction of canonical Wnt signalling  
 To determine the role of syntenin-1, an established Frizzled-7 PDZ partner in 
canonical Wnt signalling 
 To identify novel Frizzled-7 partners interacting with the C-terminal PDZ-BM of 
the receptor and examining their role in canonical Wnt signalling 
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Antibodies  
Table 2. 1. Primary antibodies used in this study. 
Abbreviations: mAb, monoclonal antibody; pAb, polyclonal antibody; WB, western 
blotting; IF, immunofluorescence; FC, flow cytometry; 
Primary 
Antibody 
Species Target antigen Supplier 
Catalogue 
number 
Dilution 
anti-beta actin 
mAb 
mouse 
human beta-
actin 
Sigma Aldrich A5316 
WB:  
1:40 000 
anti-beta-
catenin mAb 
mouse 
human beta-
catenin 
BD Laboratories 610153 WB: 1:2000 
anti-FLAG M2 
mAb 
mouse 
FLAG tag 
sequence 
Sigma Aldrich F1804 
IF: 1:1000;  
FC: 1:300 
anti-FLAG 
pAb 
rabbit 
FLAG tag 
sequence 
Sigma Aldrich F7425 
WB: 1:3000;  
IF: 1:1000 
anti-GFP pAb rabbit GFP Invitrogen A6455 WB: 1:1000 
anti-HA  pAb rabbit 
HA tag 
sequence 
Santa Cruz 
Biotechnology 
sc-805 WB: 1:500 
anti-HA  mAb mouse 
HA tag 
sequence 
Santa Cruz 
Biotechnology 
sc-7392 IF:1:25 
anti-LNX2 
pAb 
rabbit human LNX2 ProteinTech 13719-1-AP WB 1:500 
anti-Myc mAb 
(9E10) 
mouse 
Myc tag 
sequence 
Santa Cruz 
Biotechnology 
sc-40 
WB: 1:500;  
IF: 
anti-Myc pAb 
(A-14) 
rabbit 
Myc tag 
sequence 
Santa Cruz 
Biotechnology 
sc-789 
WB: 1:200;  
IF:1:100 
anti-Syntenin 
1 mAb 
rabbit 
human 
syntenin-1 
Abcam ab133267 WB: 1:1000 
anti-V5 pAb rabbit 
V5 tag 
sequence 
Sigma Aldrich V8137 WB: 1:2000 
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Table 2. 2. Secondary antibodies used in this study. 
Abbreviations: HRP, horseradish peroxidise; FITC, fluorescein-5-isothiocyanate; 
Antibody 
against 
Conjugation 
Host 
species 
Supplier 
Catalogue 
number 
mouse IgG HRP goat Dako P0447 
rabbit IgG HRP goat Dako P0448 
mouse IgG IRDye 680RD goat Licor 926-68078 
rabbit IgG IRDye 800CW goat Licor 926-32211 
mouse IgG FITC goat Sigma-Aldrich F2012 
mouse IgG (H+L) Alexa Fluor® 488 goat Life Technologies A-11017 
mouse IgG (H+L) Alexa Fluor® 546 goat Life Technologies A-11003 
rabbit IgG (H+L) Alexa Fluor® 488 goat Life Technologies A-11008 
rabbit IgG (H+L) Alexa Fluor® 594 goat Life Technologies A-11012 
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2.1.2. DNA oligonucleotides 
Table 2. 3. DNA oligonucleotides used for cloning, sequencing or mutagenesis. 
All DNA oligonucleotides were purchased from Sigma-Aldrich and were designed to 
amplify human genes. Abbreviations: Fw, forward primer; Rv, reverse primer;  
Primer Sequence (5'-3') Application 
P1 
GTCATTGAATTCGCCACCATGCGGGAC
CCCGGCGC 
Fw Fz7, cloning 
P2 
GATCTCGGATCCGTCATACCGCAGTCT
CC 
Rv Fz7, cloning 
P3 
GATTATAAAGATGATGATGATAAAGGT
AGTTACCACGGAGAGAAGG 
Fw Fz7, cloning, FLAG insert 
P4 
TTTATCATCATCATCTTTATAATCACTA
CCCGGCTGCGCCCCGGCG 
Rv Fz7, cloning, FLAG insert 
P5 
TACCGGTCGTTATTATGAAGTCCGGAG
GTAGTTACCACGGAGAGAAGG 
Fw Fz7, cloning, linker 
sequence insert 
P6 
TCCGGACTTCATAATAACGACCGGTAG
ACTACCCGGCTGCGCCCCGGCG 
Rv Fz7, cloning, linker 
sequence insert 
P7 
GATCTCGGATCCGTCA TCC CGC AGT 
CTC CCC CTT G 
Rv Fz7, cloning, V574G 
P8 
GATCTCGGATCCGTCA TTC CGC AGT 
CTC CCC CTT G 
Rv Fz7, cloning, V574E 
P9 AGAACACGTCGGACGGC Fw Fz7, sequencing 
P10 CCATGGCCAGGATAGTG Rv Fz7, sequencing 
T7 TAATACGACTCACTATAGGG sequencing 
As TAGAAGGCACAGTCGAGG Rv pcDNA3, sequencing 
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2.1.3. DNA plasmids 
DNA constructs were generated according to cloning procedures, as described in 
2.3.2. These are listed in Table 2.4. The DNA constructs provided by other scientists and used 
for transfections or as templates for cloning are listed in Table 2.5. 
Table 2. 4. Cloned DNA constructs. 
Construct Cloning details 
pcDNA™3.1-FLAG-Fz7 FLAG epitope was introduced at position 34 of human 
Fz7; cloned into pcDNA3.1 plasmid using EcoRI and 
BamHI sites 
pcDNA™3.1-Myc-Fz7 Myc epitope was introduced at the position 34 of 
human Fz7; cloned into pcDNA3.1 plasmid using 
EcoRI and BamHI sites 
pcDNA™3.1-GFP-Fz7 GFP was introduced at the position 34 of human Fz7; 
cloned into pcDNA3.1 plasmid using EcoRI and 
BamHI sites 
pcDNA™3.1-FLAG-Fz7 V574G Mutagenised Flag-tagged human Fz7 cloned into 
pcDNA3.1 plasmid using EcoRI and BamHI sites 
pcDNA™3.1-FLAG-Fz7 V574E Mutagenised Flag-tagged human Fz7 cloned into 
pcDNA3.1 plasmid using EcoRI and BamHI sites 
pcDNA™3.1-Myc-Fz7 V574G Mutagenised Myc-tagged human Fz7 cloned into 
pcDNA3.1 plasmid using EcoRI and BamHI sites 
pcDNA™3.1-GFP-Fz7 V574G Mutagenised GFP-tagged human Fz7 cloned into 
pcDNA3.1 plasmid using EcoRI and BamHI sites 
pcDNA™3.1-GFP-Fz7 V574E Mutagenised GFP-tagged human Fz7 cloned into 
pcDNA3.1 plasmid using EcoRI and BamHI sites 
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Table 2. 5. Other plasmids. 
The plasmids listed in the table contain sequences of human genes, unless otherwise 
stated. 
Plasmid encoding: Kindly provided by: 
FLAG-GIPC1 Dr Fedor Berditchevski 
FLAG-MAGI1 Dr Lawrence Banks 
FLAG-MPP5 Dr Fedor Berditchevski 
FLAG-MPP7 Dr Scott Vande Pol 
FLAG-NHERF Dr Maria-Magdalena Georgescu 
FLAG-Syntenin 1 Dr Fedor Berditchevski  
GFP-GOPC Dr Fedor Berditchevski 
GFP-LNX1 p70 Dr Yutaka Hata 
GFP-LNX1 p80 Dr Massimo D'Agostino  
GFP-LNX2 Dr Massimo D'Agostino  
HA-Dlg1 Dr Lawrence Banks 
HA-LNX2 Dr Massimo D'Agostino  
HA-LNX2 PDZ1-2 Dr Massimo D'Agostino  
HA-LNX2 PDZ1-4 Dr Massimo D'Agostino  
HA-LNX2 PDZ3-4 Dr Massimo D'Agostino  
HA-Scribble Dr Lawrence Banks 
HA-Syntenin 1 Dr Fedor Berditchevski  
HA-Syntenin 1-PDZ1* (G126D) Dr Fedor Berditchevski  
HA-Syntenin 1-PDZ1*-PDZ2* (G126D, G210E) Dr Fedor Berditchevski  
HA-Syntenin 1-PDZ2* (G210E) Dr Fedor Berditchevski  
M50 Super 8x TOPFlash Addgene, plasmid 12456 
M51 Super 8x FOPFlash (TOPFlash mutant) Addgene, plasmid 12457 
Myc-Fz7-V5-His; Fz7-V5-His Dr Catherine Mao 
Myc-INADL Dr Fedor Berditchevski 
Myc-LNX2 Addgene, plasmid 37010 
Myc-PSD95 Dr Karen Sommer  
Myc-Syntenin-1 Dr Fedor Berditchevski 
pcDNA™3.1 (puromycin resistant) Dr Fedor Berditchevski 
pcDNA™3.1-GFP Dr Fedor Berditchevski 
pEGFP-C1 Dr Fedor Berditchevski 
pRenilla Dr Chris Dawson 
V5-MAGI3 Dr Lawrence Banks 
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2.1.4. siRNA duplexes 
The siRNAs used included siLNX2 (ON-TARGETplus Human LNX2 siRNA – 
SMART pool) purchased from ThermoScientific Dharmacon, siSyntenin-1 purchased from 
Eurofins MWG Operon, and siNEG (negative control siRNA) purchased from Qiagen. 
Table 2. 6. siRNA duplexes. 
 Sequence (5’-3’) 
ON-TARGETplus SMARTpool Human 
LNX2 siRNA 
CCAAGUGGCUCUUCAUAAA 
GGACAUACAUUCUGCUACA 
CUUCAUAGCUGCCACGAUA 
CAACGAAACACCUUUGAUU 
Syntenin-1 siRNA GGAUGGAGCUCUGAUAAAGTT 
Negative siRNA UUCUCCGAACGUGUCACGUdTdT 
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2.2. Cell culture methods 
2.2.1. Mammalian cell lines 
Origin and characteristics of cell lines used in the study are listed in the Table. 
HEK293T, SKBr3, MDA-MB-231, T47D and MCF7 were obtained from Cancer Research UK, 
L cells and L-Wnt3a from ATCC. 
Table 2. 7. Mammalian cell lines used in this study. 
Cell line Tissue Cell type Tumour 
HEK293T 
Human Embryonic 
Kidney 
Epithelial NA 
MCF7 Human Breast Epithelial Adenocarcinoma 
MDA-MB-231 Human Breast Epithelial Adenocarcinoma 
SKBr3 Human Breast Epithelial Adenocarcinoma 
T47D Human Breast Epithelial Ductal Carcinoma 
L cells 
Mouse Subcutaneous 
Connective Tissue 
Fibroblast NA 
L Wnt3a 
Mouse Subcutaneous 
Connective Tissue 
Fibroblast NA 
 
2.2.2. Maintenance of mammalian cell lines 
All mammalian cells were cultured in sterile tissue culture dishes or flasks (Corning). 
HEK293T, SKBr3, MDA-MB-231, MCF7 and L cells were grown in high glucose (4500 mg/l) 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco), supplemented with 10% (v/v) Fetal 
Calf Serum (FCS) (Gibco) and 50 U/ml Penicillin / 50 μg/ml Streptomycin (Gibco). L Wnt3a 
cells were grown in medium as mentioned above, supplemented with 0.4 mg/ml G418 
(Sigma-Aldrich). Stably transfected SKBr3 cells were maintained in the presence of 2 μg/ml 
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puromycin (Sigma-Aldrich). All cell lines were cultivated at 37°C, in humidified incubator 
(Galaxy R CO2 Incubators, RS Biotech) in 5% CO2 atmosphere. When passaging, cells were 
split in the ratio 1:5 (SKBr3, MDA-MB-231, MCF7) or 1:10 (HEK293T, L cells, L Wnt3a) twice 
a week. Growth medium was removed, and a confluent monolayer of cells was washed with 
sterile phosphate buffer saline (PBS) to remove all traces of serum that contains trypsin 
inhibitors. To detach cells from a plastic surface, they were incubated with 0.05% Trypsin-
EDTA (Gibco) for 5 min at 37°C to facilitate dispersal. Subsequently, cells were collected 
from plate in a fresh growth medium and pelleted by centrifuging at 900 RPM for 3 min. 
After resuspension in complete growth medium, cells were plated at required density. Cell 
growth and condition were monitored using Nikon TMS microscope. 
2.2.3. Cryopreservation and recovery of cell lines 
Detached cells, as described in section 2.2.2, were resuspended in freezing solution 
(10% (v/v) dimethyl sulfoxide (DMSO) (Sigma-Aldrich) and 90% (v/v) Fetal Calf Serum 
(FCS)). The suspension was subsequently frozen in 1 ml CryoTube™ vials (Nunc) at -80°C 
for at least 24h before transferring to liquid nitrogen for long term storage. 
Cells were recovered by thawing in a water bath for 2 min at 37°C. Thawed cell 
suspension was transferred to a tube with 9 ml of pre-warmed, complete growth medium 
and pelleted by centrifugation at 900 RPM for 3 min. Pellet was resuspended in fresh 
medium and cells were seeded in T25 tissue culture flask. Cells were incubated at 37°C, in 
humidified 5% CO2 atmosphere for at least 48h before further manipulation.  
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2.2.4. Counting cells 
When a specified number of cells was required for an experiment, cells were 
trypsinized (Section 2.2.2), resuspended in fresh complete medium and counted. 10 μl of cell 
suspension was used to count cell in Neubauer haemocytometer counting chamber 
(Marienfeld) according to the manufacturer’s instructions.  
2.2.5. Mycoplasma testing 
Cultured cell lines were routinely tested to ensure they were mycoplasma free. 
Mycoalert® Mycoplasma Detection Kit (Lonza) was used, according to the manufacturer’s 
instructions. 
2.2.6. Cell transfection 
2.2.6.1. Polyethyleimine (PEI) 
HEK293T cells were transfected with DNA plasmids using polyethyleimine (PEI) 
(Sigma-Aldrich). PEI working solution (1 mg/ml) was prepared by warming up stock 
solution at 55°C and dissolving appropriate amount in dH20. After cooling down to room 
temperature, PEI was neutralized with HCl to pH 7.0 and filter sterilized (0.22 μm syringe 
filters (Appleton Woods)). Aliquots were stored at -20°C.  
To transfect cells, DNA and PEI were mixed in Opti-MEM® I reduced-serum 
medium (Gibco) (without FCS), in the amounts indicated in the Table 2.8. Prepared mix was 
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vortexed, briefly centrifuged and incubated at room temperature for 45-60 min. Cell growth 
medium was removed from culture dishes, and changed for DMEM (without FCS). 
Transfection mix was gently added to the dishes with cells and incubated for 3h at 37°C. 
After that time, cell medium was changed for complete growth medium (DMEM 
supplemented with 10% FCS and pen/strep). Experiments were performed 24h after 
transfection, unless stated otherwise.  
Table 2. 8. Transfection guidelines for PEI transfection reagent.  
Container Opti-MEM® [μl] DNA [μg] PEI [μl] Number of cells 
6 well (1 well) 100 2.5 3.75 0.5*106 
6 cm 200 7.3 11 1.5*106 
10 cm 600 20.0 30.0 4*106 
 
2.2.6.2. FuGENE®6 Transfection Reagent 
MCF7 and SKBr3 cells were transfected using FuGENE®6 Transfection Reagent 
(Promega), according to the manufacturer’s protocol. 24h prior transfection, cells were 
trypsinized and plated on a required dish in numbers adequate to obtain 50-70% cell 
confluency on the day of transfection. FuGENE®6 Transfection Reagent and plasmid DNA 
ratio of 3:1 (3μl of transfection reagent for 1 μg of plasmid DNA) was maintained throughout 
all experiments. FuGENE®6 was brought to room temperature, added drop wise to Opti-
MEM® I reduced-serum medium and incubated for 5 minutes at room temperature. 
Subsequently, plasmid DNA was added to FuGENE®6-OptiMEM, mixed immediately and 
incubated for further 20 minutes at room temperature to allow formation of lipo-complexes 
with DNA. Volumes and amounts of required reagents are summarized in the Table 2.9. 
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Transfection mix was added directly to cells cultured in full growth medium and gently 
mixed to obtain even distribution of complexes. Cells were returned to the incubator (37°C, 
5% CO2) for 24-48h before performing further assays. 
Table 2. 9. Transfection guidelines for FuGENE®6 transfection reagent. 
Container Opti-MEM® [μl] FuGENE®6 [μl] DNA [μg] Number of cells 
48-well (1 well) 10 0.3 0.1 0.25*105 
24-well (1 well) 20 0.6 0.2 0.5*105 
12-well (1 well) 50 1.5 0.5 1*105 
6-well (1 well) 100 3.0 1.0 1.5*105 
35 mm 100 3.0 1.0 1.5*105 
60 mm 200 6.0 2.0 7.5*105 
10 cm 600 18.0 6.0 1.8*106 
  
2.2.6.3. Lipofectamine™ RNAiMAX Reagent 
SKBr3 and HEK293T were transfected with siRNA duplexes using Lipofectamine™ 
RNAiMAX Reagent (Invitrogen), according to the manufacturer’s protocol. Reverse 
transfection procedure was employed, where the complexes are prepared inside the wells of 
culture dishes, after which cells and medium are added. To prepare siRNA-Lipofectamine™ 
RNAiMAX complexes, siRNA was diluted in Opti-MEM® I Medium without serum. Then 
Lipofectamine™ RNAiMAX was added, mixed gently and incubated for 10-20 minutes at 
room temperature. Trypsinized cells were resuspended in complete growth medium without 
antibiotics and added to each well containing siRNA-Lipofectamine™ RNAiMAX 
complexes. Cell density should be 50% confluent on the next day after plating. The final 
volume of Opti-MEM® I Medium transfection mix together with the volume of cell 
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suspension was calculated to obtain a final RNA concentration of 10 nM. All amounts and 
volumes are summarized in the Table 2.10.  
Table 2. 10. Transfection guidelines for Lipofectamine™ RNAiMAX Reagent. 
Culture 
vessel 
Volume 
of 
plating 
medium 
[μl] 
Number of 
cells plated 
per well 
Dilution 
medium 
(Opti-
MEM®) [μl] 
siRNA 
[pmol] 
Final siRNA 
conc. [nM] 
Lipofectami-
ne™ 
RNAiMAX 
[μl] 
48-well 
(1 well) 
200 0.25*105 40 2.4 10 0.4 
24-well 
(1 well) 
500 0.5*105 100 6 10 1 
12-well 
(1 well) 
1000 1*105 200 12 10 2 
6-well (1 
well) 
2500 1.5*105 500 30 10 5 
60 mm 5000 7.5*105 1000 60 10 10 
 
 
2.2.7. Generation of SKBr3 cell lines with stable 
expression of Frizzled 7 
As described in Section 2.2.6.2., parental SKBr3 cell were transfected plasmids 
pcDNA™3.1-FLAG-Fz7, pcDNA™3.1-FLAG-Fz7 V574G or pcDNA™3.1(-) using FuGENE®6 
Transfection Reagent. The first plasmid encodes the wild type human Frizzled-7 cDNA with 
N-terminal FLAG-tag. Second encodes FLAG-tagged  human Frizzled-7 cDNA with the 
mutation of the last Valine to Glycine (V574G). Both constructs were cloned into 
 pcDNA™3.1 (-) mammalian expression vector encoding puromycin resistance gene 
(procedure described in details in the section 2.3.2.2.). pcDNA™3.1(-) plasmid was used to 
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generate SKBr3-control cell line. 48h after transfection with DNA plasmids, cells medium 
was changed for the regular growth medium containing puromycin (Sigma-Aldrich) 
(2μg/ml) to select for stable transfectants. Puromycin containing medium was replaced every 
3-4 days, until isolated colonies started to appear. After selection (2-3 weeks) cells were 
sorted two times using anti-Flag mouse mAb and fluorescent activated cell sorting (FACS) 
(Section 2.6.1.) to obtain SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G stable cell lines. 
2.2.8. Production of Wnt3a conditioned medium 
Mouse fibroblast, L cells, were transfected for stable expression of Wnt3a (Willert et 
al. 2003). L Wnt3a cells are cultivated in DMEM complete growth medium supplemented 
with 0.4 mg/ml G418. To prepare Wnt3a conditioned medium (Wnt3a CM) cells were split 
and replated into 15 cm culture dish, without G418 if conditioned was to be used with a cell 
line sensitive to G418. For 15 cm dish, 4*106 cells were seeded. Cells were grown until almost 
confluent, for approximately 48h. Each plate was washed with PBS and 25 ml of complete 
growth medium was added. Cells were then incubated for 4 days (37°C, 5% CO2). 
Conditioned media were collected into 50 ml tubes and centrifuged at 1000 RPM for 5 
minutes. Supernatants were filter sterilized and stored at 4°C. In all experiment conditioned 
medium was used in dilution 1:2. Since the conditioned medium contains also other factors 
than Wnt3a, it was important to control all experiments with control conditioned medium 
from the parental cell line (L cell), prepared in similar way as Wnt3a conditioned medium. 
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2.2.9. Bacteria strains, media and antibiotics 
The chemically competent Escherichia Coli (E.Coli) DH5α (NEB) were used for 
transformation with various DNA plasmids.  Bacteria were cultured in Luria Bertani (LB) 
broth or LB agar (Invitrogen) with appropriate antibiotics. Final concentrations of used 
antibiotics were as follow: ampicillin (Sigma-Aldrich) 100 μg/ml and kanamycin (Sigma-
Aldrich) 30 μg/ml.  Bacteria were grown on LB agar plates at 37°C in incubator (Heraeus) or 
in liquid LB media at 37°C in the orbital shaking incubator (Gallenkamp). 
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2.3. Manipulation of DNA material.  
2.3.1.  Molecular cloning 
The DNA cloning was performed as summarised in the figure. 2.1.  All the steps are 
described in detailed in the next sections. Tagged Fz7 constructs were generated using Myc-
Fz7-V5-His or Fz7-V5-His plasmids as the templates (Struewing et al. 2007). Amino acid 
sequences corresponding FLAG and Myc epitopes, and GFP were introduced at the position 
34, after the signal peptide, on the N-terminus of the receptor.  Tagged Fz7 WT, Fz7 V574G 
and Fz7 V574E were generated using a standard PCR technique and cloned into pcDNA™3.1 
plasmid using EcoRI and BamHI sites. Sequences of all DNA oligonucleotides (primers) used 
in this study are listed in the Table 2.3. 
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Figure 2. 1. Cloning process.  
The DNA sequence of interest (insert) was generated by PCR with forward and reverse 
primers which contained specific restriction sites. The insert and plasmid were then 
digested with restriction enzymes, resolved by agarose gel electrophoresis, purified and 
ligated together. The ligation mixtures were subsequently introduced into competent 
bacteria by transformation. Bacteria from the antibiotic-resistant colonies were further 
cultivated for small scale DNA preparation (DNA mini-prep). Purified DNA plasmids 
were screened by diagnostic digest to identify positive clones and subsequently 
sequenced. Plasmids with correctly introduced inserts were produced on large scale (DNA 
maxi-prep). 
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2.3.2. Amplification of DNA insert by Polymerase Chain 
Reaction (PCR) 
2.3.2.1. Myc-Frizzled-7 
Myc-Frizzled-7 cDNA was amplified in a PCR reaction on the template of Myc-Fz7-
V5-His. For the reaction forward primer P1 containing restriction site for enzyme EcoRI and 
reverse primer P2 containing restriction site for enzyme BamHI were used. PCR reactions 
were conducted using Expand High Fidelity PCR System (Roche) following manufacturer’s 
guidelines. 50 μl reaction mixes were prepared by adding 40.25 μl of water, 5 μl of 10x 
concentrated Expand High Fidelity buffer with MgCl2, 1 μl of 10 mM deoxyribonucleotide 
triphosphate (dNTP) mix (New England Biolabs), 1 μl of each 100 μM primer (Sigma-
Aldrich), 0,75 μl of Expand High Fidelity Enzyme Mix and 1 μl of DNA template (10 ng). The 
PCR reaction involved initial denaturation (94°C, 2 min), then 40 cycles of denaturation 
(94°C, 30 sec), annealing (56°C, 1 min) and elongation (72°C, 2 min). A final DNA elongation 
step of 72°C for 7 minutes was added when all cycles were completed. Amplified PCR 
products were separated and purified using agarose gel electrophoresis. 
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2.3.2.2. FLAG-Frizzled-7 
In order to generate FLAG-Frizzled-7 construct a two-step PCR protocol was  utilised 
(Figure 2.2. schematically summarises this experiment). In the 1st round of PCR, two 
fragments of Frizzled 7 cDNA were amplified using the Fz7-V5-His:pcDNA3 construct as a 
template of. Fragment A was amplified with primers: forward P1 with restriction site for 
EcoRI and reverse P4 with FLAG-tag sequence (GATTATAAAGATGATGATGATAAA, 
encoding DYKDDDDK). Fragment B was amplified with primers: P3 with FLAG tag 
sequence (as above) and P2 with restriction site for BamHI. After the first round of PCR two 
products were generated: PCR product A (‘leader’) contained EcoRI site, Fz7 leader sequence 
(1-102bp) and FLAG-tag; PCR product B (‘sequence’) contained FLAG-tag, Fz7 sequence 
(103-1725bp) and BamHI site. PCR reactions were conducted using Expand High Fidelity 
PCR System (Roche) following manufacturer’s guidelines. 50 μl reaction mixes were 
prepared by adding 40.25 μl of water, 5 μl of 10x concentrated Expand High Fidelity buffer 
with MgCl2, 1 μl of 10 mM deoxyribonucleotide triphosphate (dNTP) mix, 1 μl of each 100 
μM primer, 0,75 μl of Expand High Fidelity Enzyme Mix and 1 μl of DNA template (10 ng). 
The PCR reaction involved initial denaturation (94°C, 2 min), then 40 cycles of denaturation 
(94°C, 30 sec), annealing (56°C, 2 min) and elongation (72°C, 2 min). A final DNA elongation 
step of 72°C for 7 minutes was added when all cycles were completed. Amplified PCR 
products were separated and purified using agarose gel electrophoresis (Section 2.3.4).  
The PCR products A (‘leader’) and B (‘sequence’) were subsequently used as 
templates for 2nd round of PCR. Sequence encoding FLAG-tag present on the 5’ end of 
‘leader’ and 3’ end of ‘sequence’ was used as a linker to join two fragments into one DNA 
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template during the PCR reaction. To achieve this, Expand High Fidelity PCR System was 
used.  50 μl reaction mix was prepared by adding 42 μl of water, 5 μl of 10x concentrated 
Expand High Fidelity buffer with MgCl2, 1 μl of 10 mM dNTP mix, 0.75 μl of Expand High 
Fidelity Enzyme Mix, 10 ng of template A ‘leader’ (0.5 μl) and 100 ng of template B 
‘sequence’ (1 μl). First step of PCR reaction involved initial denaturation (94°C, 2 min), then 
15 cycles of denaturation (94°C, 30 sec), annealing (56°C, 1 min) and elongation (72°C, 2 min), 
and a final elongation step (72°C, 7 min). Primers were not included in this step to create the 
ssDNA. Obtained ssDNA was used as a template for the final amplification with forward 
primer P1 and reverse P2. 50 μl reaction mixes were prepared by adding 31.25 μl of water, 5 
μl of 10x concentrated Expand High Fidelity buffer with MgCl2, 1 μl of 10 mM dNTP mix, 1 
μl of each 100 μM primer (Sigma-Aldrich), 0.75 μl of Expand High Fidelity Enzyme Mix and 
10 μl of ssDNA template. The PCR reaction involved initial denaturation (94°C, 2 min), then 
35 cycles of denaturation (94°C, 30 sec), annealing (56°C, 1 min) and elongation (72°C, 2 min). 
A final DNA elongation step of 72°C for 7 minutes was added when all cycles were 
completed. Final PCR product contained EcoRI and BamHI restriction sites, and FLAG-tag 
introduced at the position 34, after signal peptide (‘leader’).  
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Figure 2. 2.  A two-step PCR protocol utilised to generate FLAG-Frizzled-7. 
Details of the protocol are presented in the section 2.3.2.2. „A”, Fz7 leader sequence (1-
102bp); „B”, Fz7 sequence (103-1725bp); P1; forward primer with restriction site for EcoRI; 
P4, reverse primer with FLAG-tag sequence; P3, forward primer with FLAG-tag sequence; 
P2, reverse primer with restriction site for BamHI;  ssDNA, single-stranded DNA; 
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2.3.2.3. GFP-Frizzled 7 
In order to generate GFP- tagged Fz7 construct a similar two-step PCR protocol was 
used with slight modifications (summarised in Figure 2.3.). Initially, a linker with two 
restriction sites for AgeI and BspEI enzymes was introduced into Fz7 sequence at the 
position 34. The experimental PCR conditions were similar to those described in Section 
2.3.2.2. As a result Frizzled-7 construct was obtained with the introduced linker sequence, 
containing two restrictions, after the leader peptide. These two sites were used for insertion 
of GFP into Fz7. GFP sequence was cut out from plasmid pEGFP-C1, using restriction 
enzymes AgeI and BspEI. This process is described in details in the section 2.3.3. Digested 
Fz7 and GFP fragments were gel purified (Section 2.3.5) and ligated together (Section 2.3.7).  
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Figure 2. 3. A two-step PCR protocol utilised to generate GFP-Frizzled-7. 
Details of the protocol are presented in the section 2.3.2.3. When Fz7-linker:pcDNA3.1 
construct was prepared, GFP was ligated into the linker using AgeI and BspEI restriction 
sites. „A”, Fz7 leader sequence (1-102bp); „B”, Fz7 sequence (103-1725bp); P1; forward 
primer with restriction site for EcoRI; P6, reverse primer with linker sequence; P5, forward 
primer with linker sequence; P2, reverse primer with restriction site for BamHI;   
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2.3.2.4. Frizzled 7 V574G and V574E 
In order to generate constructs of Frizzled-7 with mutation of the last amino acid, 
V574G or V574E, PCR reactions were set up with forward primer P1 and reverse P7 or P8, 
respectively. As templates Myc-Fz7, FLAG-Fz7 and GFP-Fz7 constructs were used. 
Amplified PCR products were Fz7 V574G or Fz7 V574 with restrictions sites for EcoRI and 
BamHI. Conditions for PCR reaction were the same as in Section 2.3.2.1.  
2.3.3. DNA digestion with endonuclease (restriction) 
enzymes 
Frizzled-7 PCR products and vector pcDNA3.1 were digested with restriction 
enzymes EcoRI and BamHI (Roche) according to manufacturer’s guidelines. The digestion 
was performed as follows. Purified PCR product (from 50 μl reaction) or vector DNA (3 μg) 
were incubated in 50 μl of digestion solution containing dH2O, 1x buffer A (Roche) and 10 
units of each enzyme. Digestion was carried out overnight at 37°C.  
To generate GFP-Fz7, Fz7-linker construct (Section 2.3.2.3) in pcDNA3.1 and pEGFP-
C1 were sequentially digested with AgeI and BspEI endonucleases. In the first step both 
constructs were incubated in 50 μl digestion mixes containing dH2O, 1x buffer 1 (NEB) and 
10 units of AgeI enzyme, overnight at 37°C. Subsequently, AgeI digested constructs were 
purified and  incubated in second 50 μl digestion mix containing dH2O, 1x buffer 3 (NEB) 
and 10 units of BspEI endonuclease (NEB), overnight at 37°C. 
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Restriction digest reactions for diagnostic purposes were scaled down appropriately 
to the volume of 10 μl, and carried out for 1h at 37°C. 
2.3.4. Agarose gel electrophoresis 
PCR products or DNA restriction digest were mixed with 6xDNA Loading buffer 
(Qiagen) and subjected to horizontal electrophoresis (Geneflow). Gels were prepared by 
boiling agarose, 1% (w/v) (Invitrogen), in H2O and subsequently supplementing the solution 
with the appropriate volume of 10xTAE buffer and SYBR Safe (Invitrogen). The samples 
were resolved by electrophoresis at 100V, and subsequently gels were visualized and 
recorded by UV gel documentation system (InGenius® Syngene).  
2.3.5. DNA extraction from agarose gel (DNA gel 
purification) 
DNA bands were cut from the agarose gels and DNA was extracted using the Qiagen 
Gel Extraction Kit, following manufacturer’s guidelines. Efficiency of purification was 
assessed by loading 1/10 of obtained DNA on 1% agarose gel and visualised as described 
above. 
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2.3.6. DNA ligation 
Ligation reactions were performed using T4 DNA ligase (NEB) as follows. 1 μl of T4 
DNA ligase (400 000 U/ml) and 2 μl of T4 DNA ligase buffer (NEB) were added to the 17 μl of 
insert:vector mixture, prepared in ratio 3:1. Before adding T4 ligase, DNA mixture was 
preincubated for 2 minutes at 60°C. Ligation was performed for 2h at room temperature. 
Reactions were stopped by incubating samples for 10 minutes at 65°C. 
2.3.7. Heat-shock transformation of competent bacteria 
Chemically competent 5-α Iq E.coli cells (18 μl; NEB) were mixed with 10 μl of ligation 
mix or 500 pg of DNA plasmid and incubated for 30 minutes on ice. Afterwards bacteria 
were heat-shocked at 42°C for 30 seconds and incubated on ice for further 2 minutes. 
Transformation mixed was diluted with 250 μl of antibiotic-free LB medium and bacteria 
were allowed to recover for 1h at 37°C in an orbital shaker incubator. Subsequently bacteria 
were plated on LB-agar plates with appropriate antibiotic for overnight incubation. 
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2.3.8. Preparation of plasmid DNA from transformed 
bacteria  
Large scale production of DNA plasmid was performed using Qiagen Plasmid Maxi 
Kit (Qiagen) according to the manufacturer’s protocol. For small scale DNA purification 
Mini-Prep DNA Purification Kit (Qiagen) was used. Final DNA concentration was measured 
with the Nanodrop ND-1000 Spectrophotometer (Labtech).  
2.3.9. DNA sequencing 
All the constructed plasmids were verified by sequencing at the Functional Genomics 
and Proteomics Laboratory (School of Biosciences, University of Birmingham). Briefly, 150 
ng of plasmid DNA, 3.2 pmol of an appropriate primer and dH2O were mixed up to the final 
volume of 10 μl. Samples were then sent for sequencing analysis.  
 
2.3.10. Preparation of glycerol stocks 
All constructs were stored in glycerol stock in -80 °C. Bacterial cultures were mixed 
with glycerol (Fisher Scientific) to obtain its final concentration of 30% (v/v).  
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2.4.  Protein analysis 
2.4.1. Preparation of mammalian cell lysates 
Unless specified otherwise, procedure described in this section was used to obtain 
mammalian cellular lysates. Proteins were extracted from cells growing in 60 mm dishes, 24h 
(HEK293T) or 48h (SKBr3; MCF7) after transfection. Cells were lysed using 500 μl of 1% v/v 
Triton X-100 (150 mM NaCl, 50 mM Tris pH 7.4), 0.5% v/v Brij98- 0.5% v/v Triton X-100 (150 
mM NaCl, 50 mM Tris pH 7.4) or 0.8% v/v Brij98- 0.2% v/v Triton X-100 (150 mM NaCl, 50 
mM Tris pH 7.4), supplemented with 2 mM phenylmethylsulfonyl fluoride (PMSF), 10 μg/ml 
aprotinin, 10 μg/ml leupeptin, 2 mM NaVO3 (sodium orthovanadate) and 10 mM NaF 
(sodium fluoride). Cells were scraped quickly with a cell scraper and cell lysates were 
transferred into a 1,5 ml eppendorf tube. The tubes were subsequently placed on a rotary 
wheel for 30 minutes at 4°C. The insoluble material was pelleted at 13,000 rpm for 10 min. 
Supernatants were used directly for different assays or stored in -80°C. If needed for SDS-
PAGE (Section 2.4.3.) cell lysates were mixed in ratio 3:1 (v/v) with 4x concentrated Laemmli 
loading buffer (0.5M Tris pH 6.8 2.1 ml, 4.4 ml glycerol, 2.2 ml 20% SDS, 1 ml dH2O and 
0,05 g bromophenol blue). 
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2.4.2. Protein concentration determination 
Protein concentration was determined using Bio-Rad DC Protein Assay Kit according 
to the manufacturer’s protocol. In 96-well plate (BD-Falcon) 5 μl of cell lysate was mixed with 
25 μl of Bio-Rad mixture (20 μl of reagent S in 1 ml of reagent A) and with 200 μl reagent B. 
Samples were incubated at room temperature for 15 minutes and absorbance was measured 
at 630 nm wavelength using microplate reader (Bio-Rad). To obtain standard curve, bovine 
serum albumin (BSA, Sigma-Aldrich) was serially diluted in an appropriate lysis buffer in a 
range of 0.4 – 3.2 mg/ml. Based on the absorbance values for the known concentrations of 
BSA standards the protein standard curve was created in MS Excel Software and the protein 
concentration in lysate samples was determined. The protein samples and BSA samples were 
measured in triplicate to obtain more accurate values.       
2.4.3. SDS-PAGE and Western Blot analysis 
Lysate samples, with equal amount of proteins, along with prestained protein ladder, 
were resolved in  SDS-PAGE (sodium dodecyl sulphate-poliacrylamide gel electrophoresis). 
If required samples were reduces by adding β-mercaptoethanol in dilution 1:20. Samples 
were loaded on 10% polyacrylamide gel (unless stated otherwise) and resolved at 120V using 
Bio-Rad electrophoretic equipment and 1x SDS/Tris/Glycine running buffer (GeneFlow). 
Table 2.11. shows recipes for preparation 5% stacking and 10% resolving SDS-PAGE: . 
The proteins resolved  by SDS-PAGE were stained with InstantBlue (Expedeon) or 
transferred to a nitrocellulose membrane, using Trans-Blot® Turbo™ Transfer System (Bio-
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Rad) and Trans-Blot® Turbo™ Transfer System RTA Transfer Kit (Bio-Rad) according to the 
manufacturer’s protocol. To block non-specific binding of antibodies, membranes were 
incubated with 5% dry skimmed milk (Marvel) (dissolved in TBST) for 1h at room 
temperature. Subsequently, membranes were incubated overnight with specific primary 
antibodies (diluted in solution containing 5% (w/v) skimmed milk, 3 mM NaN2 and TBST). 
After washing with TBST (3x10 min), membranes were incubated with secondary antibody 
conjugated with fluorescent dye, goat anti-mouse Ab IRDye 680LT, or goat anti-rabbit Ab 
IRDye 800CW (LI-COR), for 1 hour at room temperature. After another washing with TBST 
(3x10 min), proteins were visualized and quantified using Odyssey®CLx Infrared Imaging 
System (LI-COR). If blots were developed  using a Chemiluminescence-based protocol, 
membranes were incubated with a secondary antibody conjugated with HRP (horseradish 
peroxidase), goat anti-mouse or goat anti-rabbit (Dako). Afterwards proteins were detected 
using Enhanced Chemiluminescence Plus reagents (ECL Plus) (Biological Industries). Protein 
bands were visualized onto Amersham Hyperfilm™ X-ray film using Kodak X-OMAT 1000 
developer. All primary and secondary antibody used in this study are summarized in Tables 
2.1. and 2.2, respectively. 
Table 2. 11. Components of a single mini SDS-PAGE running gel. 
 5% stacking gel 10% resolving gel 
30% w/v Acrylamide:Bis 1.3 ml 6.7 ml 
1.5 M Tris-HCl pH 8.8 - 5.0 ml 
1 M Tris-HCl pH 6.8 1.0 ml - 
dH2O 5.5 ml 7.9 ml 
10% w/v SDS 80 μl 200 μl 
10% w/v Ammonium 
Persulphate 
80 μl 200 μl 
Temed 8 μl 12 μl 
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2.4.4. Quantitative analysis of Western blot images 
Densytometric analysis was carried out on images obtain by Odyssey CLx infrared 
imaging system (LI-COR) using Image Studio Lite Software (LI-COR). Rectangular shapes of 
equal size were drawn separately around bands of interest and the fluorescent absorbance 
within the shapes was calculated. The background absorbance of the blot was subtracted 
from the shapes using the software to obtain consistent data. The Median Method was 
chosen to subtract the median value of the pixels in the background segment of each shape. 
Absorbance values representing the densitometric values were used to quantify protein 
expression level in this study. 
2.4.5. Immunoprecipitation 
For immunoprecipitation experiments, lysates prepared as described in section 2.4.1., 
were incubated for 1h or overnight on a rotary wheel at 4°C with 18 μl of agarose or 
magnetic beads conjugated with mouse anti-FLAG M2 mAb (Sigma-Aldrich) or magnetic 
GFP-Trap® beads (Chromotek). Subsequently, beads were washed 3 times with 700 μl of ice-
cold TBS –Tween and retained proteins were eluted by adding 15 μl of 2x concentrated 
Laemmli sample buffer and boiling for 10 minutes at 60°C.  If necessary, beads were pre-
incubated with 0.5% BSA/PBS before adding lysates, to prevent unspecific binding of 
proteins to the beads.  
 
 
  2. MATERIALS AND METHODS 
105 
 
2.4.6. Pull-down with peptides 
For pulldown experiments lysates, prepared as described in section 2.4.1.,  were 
incubated with NeutrAvidin™-conjugated agarose resins (Pierce) with immobilized custom 
synthesised biotinylated peptides corresponding to the C-terminal cytoplasmic tails of Fz7, 
Fz3 and Fz8 (Alta Bioscience, sequences of peptides are summarized in the Table 2.12.). In 
several experiments the Fz7-V574G peptide (Table Table 2.12.) was used alongside of the Fz7 
wild-type peptide. NeutrAvidin™ beads (50% slurry solution) were transferred into 1.5 ml 
tubes (30 μl/sample for analytical (A) or 50 μl/ sample for preparative (P) purposes) and 
washed twice with 500 μl (A) or 1000 μl (P) of ice cold PBS. Beads were incubated with 6 μg 
(A) or 20 μg (P) of peptides  in ice cold PBS at 4°C on a rotary wheel for at least an hour. 
Subsequently, NeutrAvidin™ beads with immobilized peptides were washed twice with ice 
cold PBS. 
Lysates of mammalian cells were prepared as described in section 2.4.1. (500 μl/6 cm 
dish (A), or 3 ml/15 cm dish (P)).  An aliquot from each lysate was kept for WB to serve as a  
positive control. Lysates were then incubated with NeutrAvidin™ beads for pre-clearance 
for 1h at 4°C on a rotary wheel. Subsequently, pre-cleared cell lysates were incubated with 
peptide-conjugated NeutrAvidin™ resins over night at 4°C on a rotary wheel. 
Beads were washed 3 times with ice-cold TBS–Tween 0.1%  and retained proteins 
were eluted by adding 15 μl (A) or 25 μl (P) of 2x concentrated Laemmli sample buffer and 
boiling for 5 minutes at 95°C.   
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Table 2. 12. Biotinylated peptides used in this study. 
Peptide Sequence 
Fz7 WT Biotin-SGKTLQSWRRFYHRLSHSSKGETAV 
Fz7 V574G Biotin-SGKTLQSWRRFYHRLSHSSKGETAG 
Fz3 Biotin-SNNPMTHITHGTSMNRVIEEDGTSA 
Fz8 Biotin-STGLTWRSGTASSVSYPKQMPLSQV 
 
2.4.7. Preparation of samples for Mass-Spectrometry  
Proteins were resolved by SDS-PAGE using gradient 4-20% Mini-PROTEAN® TGX™ 
Precast Gel (Bio-Rad), which subsequently was stained with InstantBlue (Expedeon) 
according to the manufacturer’s instruction. Briefly, gel was incubated with InstantBlue for 
1h and then washed several times with de-ionized Millipore H2O.  Bands of interest were cut 
and placed in 1.5 ml sterile tube and destained by incubation in 500 μl of 50% (v/v) 
acetonitrile (Sigma-Aldrich) in 50 mM ammonium bi-carbonate (Sigma-Aldrich) an a shaker 
for 30 minutes at room temperature. Afterwards gel slices were reduced by incubation in 500 
μl of 50 mM DTT (ditiotreitol; USB Corporation) in 50 mM ammonium bi-carbonate for 1 h at 
56°C, and alkalyted  with 300 μl of 100 mM iodoacetamide (Sigma-Aldrich) for 30 minutes at 
room temperature, in the dark. Finally they were dehydrated in 100% acetonitrile for 10 min. 
Solution was removed and gel slices were dried at room temperature. Proteins were in-gel 
digested with 25 μl of trypsin (1.25 mg/ml) (Promega) in 10% acetonitrile in 50 mM 
ammonium bi-carbonate overnight at 37°C. Next day, peptides were extracted from the gel 
slices by incubating twice in 50 μl of 1% (w/v) formic acid for 1 h at room temperature on a 
shaker. Supernatants were transferred to new 1.5 tubes and placed in Speedivac for 30-60 
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min at 45°C in order to diminish sample volumes to 40-50 μl. Retained peptides were 
analyzed by mass spectrometry.  
2.4.8. Mass spectrometry 
Proteomic analysis was performed at Proteomics Facility (University of Birmingham) 
by Dr Doug Ward. Samples prepared in Section 2.4.7. were used in liquid chromatography 
and mass spectrometry analysis, performed on Bruker micrOTOF II (LC-MS). To identify 
proteins encompassing detected peptide sequences, data base  SwissProtDecoy was used 
(Species: Human). During peptide analysis following parameters were applied: Missed 
Cleavage: 1; Accurance search: 50 ppm; Fragment searching: 0.1 Da; Peptide score Mascot : 
25. 
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2.5. Assays on live cells (functional studies) 
2.5.1. Luciferase TOP-Flash assay 
TOPFlash luciferase reporter assay was designed to demonstrate activation of 
canonical Wnt pathway. It is a read-out for β-catenin transcription activation, the end-point 
of canonical Wnt pathway (Korinek et al. 1997).   
Cells were plated at the density 2.5×104 per well in 48-well plate. If protein knock-
down was required during the assay, cells were transfected, in triplicates, with 2.4 pmol of 
siRNA per well, using Lipofectamine RNAiMAX using reverse protocol during plating cells 
(section 2.2.6.3). 24 hours later cells were transfected with DNA plasmids using FuGENE6 
(section 2.2.6.2), indicated as a total amount per well in a 48-well plate: SKBr3 with 50 ng 
luciferase plasmid (M50 Super 8x TOPFlash or M51 Super 8x FOPFlash; Addgene), 25 ng 
pRenilla and 50 ng pcDNA™3.1 plasmids encoding the respective cDNA inserts; HEK293T 
with 22.5 ng luciferase plasmid, 2.5 ng pRenilla, 5 ng of pcDNA™3.1 plasmids encoding the 
respective cDNA inserts and supplemented with 95 ng pcDNA™3.1. M50 Super 8x 
TOPFlash is a β-catenin reporter plasmid, containing TCF/LEF sites upstream of a luciferase 
reporter. M51 Super 8x FOPFlash is a control for β-catenin reporter plasmid, containing 
mutated TCF/LEF sites upstream of a luciferase reporter. Both constructs were generated at 
Randall Moon’s laboratory (Veeman et al. 2003b), based on original TOPFlash constructed at 
laboratory of Hans Clevers (Korinek et al. 1997). 
At 48h following plating, cells were treated for 24 hours with 50% Wnt3a-conditioned 
medium or 50% control medium produced by L-cells (Section 2.2.9). Subsequently, cells were 
  2. MATERIALS AND METHODS 
109 
 
washed with PBS and lysed by incubating with Passive Lysis Buffer (Promega) overnight at -
20°C, 50 μl/well. 20 μl of lysate from each well was transferred to 96-well plate. Firefly 
(Photinus pyralis) and Renilla (Renilla reniformis) luminescence signals were measured 
sequentially from the same sample, using the Dual-Glo luciferase assay system (Promega). 
Briefly, the luminescence signal of the firefly luciferase expressed from TOPFlash or 
FOPFlash plasmid was quantitatively measured first by the addition of Luciferase Assay 
Reagent II (LARII). Afterwards, the firefly signal was quenched by addition of Stop & Glo® 
reagent to the same sample, and Renilla luciferase signal was measured and quantified. 
Luminesence signal was measured using Orion L Microplate Luminometer (Berthold 
Detection Systems).  
Firefly luminescence signal values were normalized according to their corresponding 
Renilla signal values. TOP-flash signal was standardized to the background signal (FOP-
flash). Histograms were constructed to show the relative fold change in the levels of 
promoter reporter activity. Statistical significance was determined using MS Excel software 
using the relevant Student’s t-test after determining whether the sample variance is equal or 
unequal by performing an F-test.  
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2.5.2. In vivo ubiquitylation assay 
HEK293T cells, plated on 6 cm dish, were co-transfected with HA-Ubiquitin, FLAG-
Fz7 and GFP-LNX2 (GFP-LNX1 p70; GFP-LNX1 p80) or GFP. 48h after transfection cells 
were lysed using 100 μl of SDS lysis buffer (containing 0.5% SDS, 50 mM NaF, 1 mM EDTA 
in PBS), supplemented with 2 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin and 20 mM 
iodoacetemide. Samples were incubated at 60°C for 15 minutes, and diluted with 900 μl of  
1% v/v Triton X-100 (150 mM NaCl, 50 mM Tris pH 7.4) supplemented with 2 mM PMSF, 10 
μg/ml aprotinin, 10 μg/ml leupeptin and 20 mM iodoacetemide. Subsequently samples were 
sonicated and the insoluble material was pelleted at 13,000 rpm for 10 min. Supernatants 
were incubated for 1h with magnetic beads conjugated with anti-FLAG M2 mAb (Sigma-
Aldrich). Later, beads were washed three times with TBS-Tween. Proteins retained by the 
magnetic resins were eluted by incubating with 15 μl of 2x Laemmli buffer for 10 minutes at 
60°C. Eluates were analysed by the SDS-PAGE and Western Blotting as described in Section 
2.4.3. Frizzled-7 ubiquitylation level was assessed by incubating membranes with rabbit 
antibodies against HA-tag, to detect HA-ubiquitin. 
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2.6. Staining and imaging methods 
2.6.1. Flow cytometry 
Cells growing in monolayer were detached using enzyme-free dissociation buffer 
(Gibco) and counted. 3-5 x 105 cells was centrifuged at 1000 RPM for 3 minutes and 
resuspended in 50 μl of ice cold 1% HI-BSA/PBS. All the following steps were performed on 
ice. To block non-specific binding of antibodies, 1% HI-BSA/PBS was aliquoted into U-
shaped 96-well plate (50 μl/well) and placed on ice for 20 minutes. Then, the blocking 
solution was removed and replaced with 150 μl of specific primary antibody diluted in 1% 
HI-BSA/PBS or hybridoma supernatant. Subsequently, 50 μl of cell suspension was added to 
each well and incubated on ice for 1h. The cells were pelleted by centrifugation at 1000 RPM 
for 5 minutes at 4°C and washed twice with 200 μl of ice cold PBS. The last wash was 
followed by incubation of cells with secondary FITC- or PE-conjugated antibody (Sigma), 
diluted in 1% HI-BSA/PBS for 1h. The incubation with fluorescently labelled secondary 
antibodies was carried out under the aluminium foil to prevent sample exposure to light. 
Cells were washed again twice with ice cold PBS, as described above. Finally cells were 
resuspended in 250 μl of ice cold PBS and transferred into FACS tubes containing 250 μl of 
4% paraformaldehyde (PFA). Stained cells were analyzed using Accuri C6 Flow Cytometer 
(BD Biosciences) and FlowJo v7.6 software. All antibodies used in this study are listed in 
Tables 2.1. and 2.2. 
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2.6.2. Fluorescent Activated Cell Sorting (FACS) 
Homogenous population of cells stably expressing Flag-tagged Frizzled proteins 
(SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G, section 2.2.7) was established using 
Fluorescent Activated Cell Sorting (FACS). The day before cell sorting, cells were trypsinized 
and replated at ~50-60% confluency. The sample preparation and all subsequent procedures 
were conducted under sterile conditions. On the day of sorting, cells were detached using 
enzyme-free dissociation buffer (Gibco) and pelleted by centrifugation at 1200 RPM for 3 min 
at 4°C. Subsequently cells were resuspended in 1.5 ml of ice-cold complete growth medium 
containing primary antibody, the anti-FLAG M2 mAb (Sigma-Aldrich) was diluted at 1:300 
and sterilised by filtration. After incubation for 1 hour, cells were pelleted by centrifugation 
at 1200 RPM for 3 min at 4°C, and washed twice with 2 ml of ice-cold complete growth 
medium. Then cells were resuspended in 1.5 ml of ice cold complete growth medium 
containing secondary, fluorescent labelled antibody (FITC (fluorescein isothiocyanate)-
conjugated goat anti-mouse pAb, (Sigma-Aldrich) in dilution 1:300) and incubated on ice for 
one hour in dark. Cells were pelleted, and washed twice with ice-cold complete growth 
medium. Finally they were resuspended in 2 ml of ice cold complete growth medium and 
passed through Cell Trics filters (Partec) to remove cellular aggregates. Cell suspension was 
transfered to sterile FACS tubes (BD Falcon). Cells were sorted using a Beckman Coulter 
MoFlo Legacy FACS machine and positive and negative cell populations were separated. 
After sorting cells were resuspended in complete growth medium containing double amount 
of penicillin/streptomycin to prevent sample contamination. 48h later medium was changed 
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for a regular complete growth medium and cells were cultivated in humidified incubator 
(37°C, 5% CO2) until they were ready to use.  
2.6.3. Immunofluorescence 
Cells grown on glass coverslips or Nunc™ Lab-Tek™ II Chamber Slide™ System 
(Thermo Scientific) were transfected with appropriate DNA plasmids using FuGENE6 
(Roche). Staining was performed 48h after transfection. Cells were fixed with 4% 
paraformaldehyde/PBS for 15 min at room temperature and permeabilized  with  0.1% v/v 
Triton X-100 for 2 minutes. Coverslips or chambered slides were incubated with blocking 
buffer (20% heat inactivated goat serum/PBS) for 1h, followed by 1 h incubation with a 
primary antibody, diluted in blocking solution. Cells were washed three times with PBS for 
10 minutes, with agitation. Subsequently coverslips or Lab-Tek™ chambered slides were 
incubated with appropriate secondary antibodies conjugated with fluorochrome (diluted in 
blocking solution), for 1h in darkness. After removing secondary antibody, cells were 
incubated with Hoechst33342 (1μg/ml in PBS) for 10 min at room temperature to stain cell 
nuclei. Finally cells were washed again with PBS, as described earlier. Coverslips were air 
dried and mounted on glass slides, whereas chambers from Lab-Tek™ slides were removed 
and slides were mounted with appropriate size coverslips, using anti-fade fluorescence 
mounting medium (SlowFade® Gold Antifade Mountant with DAPI, Molecular Probes®). 
Coverslips were sealed on the edges using nail polish and stored at -20°C in darkness. The 
images were captured using Zeiss LSM510 META confocal system with 63X oil immersion 
objective. All antibodies used in this study are summarized in Tables 2.1. and 2.2. 
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3. RESULTS AND DISCUSSION 
3.1. Establishing a model system to study Fz7 biology 
Frizzled-7 (Fz7) is a transmembrane receptor that transduces signals from secreted 
glycoproteins known as Wnts. Activation of Wnt signalling pathway frequently occurs in 
colorectal cancer, but also in breast cancer. Activation of canonical Wnt signalling is well 
studied in colorectal cancer cells, and it is predominantly associated with mutations in APC 
or β-catenin proteins (Polakis 2012). However, the mechanism of Wnt pathway activation in 
breast cancer remains unclear. Recent reports suggested that Fz7 is involved in breast cancer 
malignancy (King et al. 2012a;Simmons, Jr. et al. 2014;Yang et al. 2011) 
However, the contribution of the C-terminal PDZ-BM in signalling triggered by Fz7 
remains unknown. The work described in this chapter covers characterization of Fz7 
expression vectors and identification of a suitable breast cancer cell line to use as a model in 
further the study. 
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3.1.1. Characterization of Fz7 expression vectors 
There is no suitable antibody available to detect endogenous Fz7. Therefore, to be 
able to monitor Fz7 expression throughout the functional experiments, a molecular tag had 
to be introduced into the Fz7 sequence. The procedure is described in details in the section 
2.3. of Materials and Methods. In the vast majority of the following experiments FLAG-Fz7 
was used, but Myc- and GFP-Fz7 constructs were also generated. 
Fz7 contains a PDZ binding motif on the C-terminal end that enables interactions of 
the receptor with PDZ domain containing proteins. Given that the main objective of this 
study was to investigate the role of Fz7 interactions with PDZ proteins, the molecular tag 
was introduced at the N-terminal extracellular portion of the protein. Employing molecular 
biology techniques, FLAG-, Myc- or GFP-sequences were introduced at the position 34, after 
the leader peptide, to ensure correct topology of the protein on the plasma membrane. 
A schematic representation of Fz7 structure with introduced tag is shown in Figure 3.1.A.  
In order to assess FLAG-Fz7 expression in transfected cells, SDS-PAGE and western 
blot analysis was used. Samples for the analysis were prepared by mixing cellular lysates 
with 4xLaemmli loading buffer containing β-mercaptoethanol, and subsequently boiled at 
100°C for 5 minutes. Anti-FLAG pAb were used to detect FLAG-Fz7. While analysing 
samples by western blot, it was observed that Fz7 forms aggregates of a high molecular mass 
and monomers of the receptor were not detected. Aggregate formation might be a 
consequence of Fz7 being a transmembrane receptor with seven hydrophobic regions. 
Therefore the procedure of sample preparation for SDS-PAGE-western blot analysis was 
modified. In order to do find an alternative protocol several conditions were examined. Cell 
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lysates, obtained from HEK293Ts transfected with FLAG-Fz7, were mixed with 4xLaemmli 
loading buffer, with or without a reducing agent (β-mercaptoethanol), and incubated at 
100°C for 5 minutes or at 60°C for 10 minutes. Results of these experiments are shown in the 
Figure 3.1.B. When samples were boiled (100°C), Fz7 formed aggregates and receptor 
monomers were impossible to detect (reduced conditions; lane 1) or they were barely 
detectable (non-reduced conditions; lane 3). Decreasing the denaturation temperature to 
60°C prevented formation of protein aggregates. Separated Fz7 forms included two 
monomeric forms with apparent sizes 50 kDa and 60 kDa, (in reduced, lane 5, and non-
reduced conditions, lane 7). These forms are likely to represent a different degree of N-
glycosylation of Fz7 and were observed in both HEK293T and SKBr3 cells (see below). Under 
non-reduced conditions (lanes 3 and 7), Fz7 dimers (around 130 kDa) and higher oligomers 
with sized exceeding 200 kDa, were also observed.    
In order to determine cell localization of Fz7, immunofluorescence analysis was 
performed on MCF7s transiently transfected with FLAG-Fz7 expression vector.  Cells were 
fixed and stained using anti-FLAG antibody. DAPI was used to visualize nuclei. Analysis by 
confocal microscopy showed that Fz7 immunoreactivity is mostly detected on the plasma 
membrane (Figure 3.1.C). Similar, plasma membrane localization of Fz7 was observed in 
SKBr3 cells (see below).  
As mentioned at the beginning of this section, in addition to FLAG-Fz7 expression 
vector, Myc-Fz7 and GFP-Fz7 expression vectors were generated. Both of them were 
subjected to a similar analysis as FLAG-Fz7 construct. Both Myc- and GFP-Fz7 were found to 
be expressed in transfected cells and localize on the plasma membrane. Western blot analysis 
showed that Myc-Fz7 and GFP-Fz7 are also expressed as two monomers with a different 
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degree of N-glycosylation (50 kDa and 60 kDa for Myc-Fz7; 80 kDa and 90 kDa for GFP-Fz7), 
but also form dimers and aggregates of higher molecular weight, as seen for FLAG-Fz7. 
Summary of this work is presented in the Supplementary Figure S.1.         
Taken together, western blot and immunofluorescence experiments showed that 
generated construct allows for FLAG-Fz7, Myc-Fz7 and GFP-Fz7 expression on the surface of 
transfected cells.  
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Figure 3. 1. Characterization of the FLAG-Fz7 expression construct. 
(A) Schematic representation of Fz7 structure with PDZ-binding motif at the C-terminus 
and molecular tag introduced at the position 34, after the leader peptide. PDZ-BM, PDZ 
domain binding motif. (B) Western blot analysis of whole cell lysates of HEK293T cells 
transiently transfected with FLAG-Fz7 expression vector. Cells were lysed in 1% Triton X-
100 and equal amounts of protein were resolved by SDS-PAGE under indicated 
conditions, followed by detection with rabbit anti-FLAG antibodies. β-actin served as a 
loading control. (C) MCF7 cells transiently transfected with FLAG-Fz7 expression vector 
display membrane immunoreactivity. 48h after transfection cells were fixed and stained 
with mouse anti-FLAG (M2) mAb and Alexa Fluor 488-conjugated goat-anti mouse Ab 
(green). DAPI was used to visualize nuclei.  
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3.1.2. Assessing functionality of FLAG-Fz7 
Fz7 is a membrane receptor which contains a ligand binding site within the N-
terminal extracellular domain. It was important to confirm that insertion of the molecular tag 
(FLAG sequence) in the N-terminus did not alter receptor functionality and its ability to bind 
Wnt ligands. In order to assess functionality of constructed tagged-Fz7 a luciferase-based 
reporter assay, called TOP-Flash, was used. It is a widely used method that allows the 
measurement of canonical Wnt signalling activity. HEK293T cells were transfected with two 
reporter plasmids: (pRenilla and TOPFlash (or FOPFlash)) and stimulated with Wnt3a 
conditioned medium. “TOP” is a read-out for β-catenin transcription activation, the end-
point of the canonical Wnt pathway, whereas “FOP” is a read-out for a background signal. 
The TOP-Flash assay procedure is described in details in the section 2.5.1. of Materials and 
Methods. 
The ability of FLAG-Fz7 to transduce signals after binding to the Wnt3a ligand, and 
to activate canonical Wnt signalling pathway was examined. HEK293T cells were transfected 
with reporter plasmids and with FLAG-Fz7 or pcDNA™3.1 plasmids. Cells were incubated 
with Wnt3a conditioned medium, or with control conditioned medium for 24h, and TOP-
Flash activity measured 48h post-transfection. Control HEK293T cells, transfected only with 
reporter plasmids, but not with Fz7 plasmid, were used as a reference sample. Reporter 
activity was compared in control cells and cells expressing FLAG-Fz7 upon stimulation with 
Wnt3a, as presented in the Figure 3.2. Due to the fact that the parental HEK293T cells express 
endogenous Frizzled receptors, they are able to transduce signals after incubation with 
Wnt3a. As expected, control HEK293T cells showed activation of Wnt signalling pathway 
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upon stimulation with Wnt3a ligand, as evidenced by a 20 fold increased signal of the 
TOPFlash reporter when compared with FOPFlash reporter. Canonical Wnt pathway 
activation was significantly stronger in HEK293T cells expressing Fz7 than in control cells, as 
evidenced by four times increased signal of the TOPFlash reporter. Hence, the generated 
FLAG-Fz7 is functional.   
 
 
 
Figure 3. 2. Verification of FLAG-Fz7 functionality. 
Wnt3a-induced signalling was analysed using TOP-Flash luciferase assay. HEK293T cells 
were transfected with reporter plasmids and with plasmid encoding FLAG-Fz7 or mock 
transfected. Cells were stimulated for 24h with Wnt3a conditioned medium and TOP/FOP 
activity was analysed 48h after the transfection. Test was done in triplicates and three 
independent experiments were performed. Statistical significance was determined by 
two-tailed, unpaired Student’s t-test (*** p<0.001) 
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Functionalities of other generated Fz7 constructs (Myc-Fz7 and GFP-Fz7) were also 
assessed in HEK293T cells in similar experiments. The activation level of Wnt canonical 
pathway was two fold higher in cells expressing Myc-Fz7 and almost three fold higher in 
cells expressing GFP-Fz7, when compared with control samples, as presented in the 
Supplementary Figure S.2. Therefore both Myc-Fz7 and GFP-Fz7 appear to be functional. 
Wnt pathway activation was also assessed in HEK293T cells expressing Fz7-V5-His. 
V5- and His-tag were introduced at the C-terminal end of Fz7 receptor, leaving the N-
terminus intact. Transfection of HEK293T cells with different amounts of DNA encoding 
Fz7-V5-His (80 ng, 40 ng, 20 ng, 10ng, 5 ng or 2,5 ng as per one well of 48-well plate) showed 
that signal transduction depends on expression level of Fz7. High level of the receptor 
expression prevents activation of canonical Wnt signalling pathway by endogenous Frizzled 
receptors in HEK293Ts, as was observed in cells transfected with 80 ng to 10 ng of Fz7-V5-
His. The highest activation of Wnt signalling was found in HEK293Ts transfected with 5 ng 
of Fz7-V5-His plasmid. Yet, even in the sample with the highest activation of the pathway, it 
wasn’t significantly higher then in the control cells, thus demonstrating that insertion of the 
molecular tag at the C-terminus of Fz7 receptor attenuates its capability to transduce signals 
(Figures 3.2. and 3.3). Furthermore, our results seems to indicate that the Fz7-V5-His 
construct have a dominant negative properties.   
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Figure 3. 3. Activation of canonical Wnt signalling in Fz7-V5-His expressing cells. 
(A) HEK293T cells were transfected with TOPFlash or FOPFlash luciferase plasmid, 
pRenilla plasmid and different amount of plasmid DNA encoding Fz7-V5-His, and 
stimulated with Wnt3a conditioned medium for 24h. TOP and FOP activity was analysed 
48h after transfection with reporter plasmids. (B) Lysates obtained in the assay were 
analysed by western blotting. Anti-V5 pAb were used to detect Fz7-V5-His and anti-β-
catenin to detect endogenous β-catenin. β-actin served as a loading control.  
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Taken together, insertion of molecular tags within the N-terminus of Fz7 (at the 
position 34) does not affect the receptor functionality. However, inserting a tag at the C-
terminus, behind the PDZ binding motif, leads to loss of receptor ability to transduce the 
canonical Wnt signalling. This indicates the importance of Fz7 interactions with PDZ 
proteins, via the C-terminal binding motif, in the activation of the canonical Wnt signalling. 
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3.1.3. Identifying a suitable epithelial breast cancer model 
Having generated a functional epitope-tagged Fz7 construct, we proceeded to 
identify a suitable breast cancer cell line to use as a model for signalling studies. To 
investigate activation of canonical Wnt signalling pathway by Fz7, we have decided to find a 
model system in which we could establish a stable expression of the Fz7. For that purpose 
several well-characterized epithelial breast cancer cell lines were initially screened using 
TOP-Flash reporter assay. The aim of these experiments was to find cells with low 
responsiveness to Wnt3a, indicating low expression of endogenous receptors. At the same 
time, we were looking for cells in which all the components of the canonical Wnt signalling 
pathway downstream of the receptor were intact  (i.e. be able to transduce signals upon 
activation). 
In order to identify a suitable cell line, activation of the canonical Wnt signalling 
pathway was analysed in cells stimulated with Wnt3a or when treated with SB216763, an 
inhibitor of GSK3,. Wnt3a activates Wnt signalling through the interaction with Frizzled 
receptor. TOP-Flash activity, after Wnt3a stimulation, would reflect on expression of the 
receptors and an overall functionality of the pathway. SB216763  is a small molecule that 
inhibits GSK3 by competing with ATP. Inhibition of GSK3 kinase activates β-catenin 
dependent Wnt pathway downstream of Wnt receptor and allows testing functionality of the 
pathway in cells deficient in the expression of the receptors. Four epithelial breast cancer cell 
lines were tested in these experiments: MDA-MB-231, T47D, MCF7 and SKBr3. HEK293T cell 
were used as a control cell line. Cells were transfected with reporter plasmids and incubated 
for 24h with Wnt3a conditioned medium or with control conditioned medium (Figure 3.4.A). 
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In parallel experiments, cells were treated for 24h with 10 μM SB216763 or vehicle (DMSO) 
(Figure 3.4.B). 48h after the transfection activity of TOP-Flash reporter was analysed and 
activation of the Wnt pathway was evaluated in samples treated with Wnt3a and GSK3 
inhibitor. In order to compare results in different cell lines, obtained TOPFlash reporter 
values were standardized to the corresponding FOPFlash reporter values for each of the 
tested cell lines. We found that in MDA-MB-231 cells, the canonical Wnt pathway could be 
activated by both Wnt3a (two fold increase), and GSK3i (four fold increase), compared to 
control samples. These results indicate that canonical Wnt pathway is functional in MDA-
MB-231, but also that these cells express endogenous Frizzled receptors. On the contrary, 
T47D and MCF7 cell lines did not display pathway activation upon stimulation with Wnt3a 
or GSK3i thus suggesting that the β-catenin-dependent pathway is not functional in these 
cells. This may be due to mutations in pathway components downstream of Frizzled, or 
interference of other proteins involved in regulation of the pathway (Wheeler et al. 2011). 
Finally, analysis of the Wnt signalling pathway in SKBr3 cell line showed that it was not 
activated by Wnt3a, but could be induced by GSK3i (more than seven fold stronger when 
compared with the control). Whilst these results indicate that SKBr3 cells express no (or low 
levels) of endogenous Wnt3a receptors, the β-catenin-dependent pathway remains 
functional. That makes the SKBr3 cell line a suitable model to establish stable cell lines and to 
study Fz7-dependent signalling.  
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Figure 3. 4. Analysis of  canonical Wnt signalling pathway activation in epithelial breast 
cell lines. 
(A) Wnt3a-induced signalling or (B) SB216763 (10 μM) (GSK3 inhibitor)-induced 
signalling was analysed using TOP-Flash luciferase reporter assay. Cell were stimulated 
for 24h  with Wnt3 CM or control CM (A), SB216367 or vehicle (B) and TOP/FOP activity 
was analysed 48h after the transfection with reporter plasmids. HEK293T cell line was 
used as a control. Tests were done in triplicates. Statistical significance was determined by 
two-tailed, unpaired Student’s t-test (**p<0.01; ***p<0.001); CM – conditioned medium.  
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3.1.4. Fz7 activates canonical Wnt signalling pathway in 
SKBr3 cells 
In the previous section, SKBr3 epithelial breast cancer cell line was identified as a 
suitable model to establish stable cell lines for signalling studies. To verify whether Fz7 is 
able to induce activation of canonical Wnt signalling in SKBr3 cells, when stimulated with 
Wnt3a, activity of TOPFlash reporter was assessed in cells transiently expressing FLAG-Fz7. 
SKBr3 cells were transfected with TOP-Flash reporter plasmids, and with vector expressing 
FLAG-Fz7 or mock transfected (pcDNA™3.1). Subsequently cells were incubated with 
Wnt3a conditioned medium or with control conditioned medium. Activation of Wnt 
signalling upon stimulation with Wnt3a was examined using the TOP-Flash luciferase assay. 
Cellular lysates obtained in the assay were also analysed by western blotting. The canonical 
Wnt pathway was significantly stronger activated in SKBr3 cells expressing Fz7 cells, as 
evidence by more than a six fold increase in signal (Figure 3.5.A). Accordingly, stabilization 
of β-catenin was observed in western blot experiments (Figure 3.5.B). Here, control SKBr3 
cells (not expressing FLAG-Fz7) exhibit low pathway activation (four fold increase of 
TOPFlash activity over the base level). It can be explained by the fact that in this experiment 
more sensitive TOPFlash reporter construct was used. Specifically, the reporter construct 
contained eight binding sites for TCF/β-catenin, as compared to three sites in the construct 
used for the results shown in Figure 3.4. The 8xTOPFlash reporter plasmid was used in all 
following experiments.. Taken together, these experiments demonstrated the functionality of 
the ectopically expressed Flag-Fz7 construct in SKBr3 cell line. 
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Figure 3. 5. Fz7 activates the canonical Wnt pathway in SKBr3 cells. 
(A) Wnt-induced signalling was analysed using TOP-Flash luciferase assay. SKBr3 cells 
were transiently transfected with plasmid encoding FLAG-Fz7 or mock transfected. Cells 
were stimulated for 24h with Wnt3a conditioned medium and TOP/FOP activity was 
analysed 48h after transfection with reporter plasmids. Tests were done in triplicates and 
three independent experiments were performed. Statistical significance was determined 
by two-tailed, unpaired Student’s t-test (* p<0.05). (B) Western blot analysis of Frizzzled-7 
expression level in transiently transfected SKBr3 cells. β-actin served as a loading control. 
Image shown is a representative of three independent experiments.  
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3.1.5. Generation and characterization of SKBr3 cell lines 
stably expressing wild type and mutant of Fz7.      
The SKBr3 cell line expresses endogenous Frizzled receptors at relatively low levels 
and canonical Wnt signalling  in these cells can only be weakly induced by Wnt ligands. 
Nonetheless, introduction of Fz7 into SKBr3 cells leads to strong activation of the pathway in 
response to Wnt3a stimulation (sections 3.1.3. and 3.1.4.). These properties made SKBr3 cell 
line a suitable model to study Fz7-mediated signalling. SKBr3 cells were stably transfected 
with FLAG-Fz7 expression vector as described in section 2.2.7 of Materials and Methods. 
Fluorescence-activated Cell Sorting (FACS) using an anti-FLAG mAb was subsequently 
performed in order to select and separate FLAG-Fz7 expressing cells from non-expressing 
cells, as described in section 2.6.1 of Materials and Methods. FACS-based enrichment was 
performed twice to obtain a homogenous population of SKBr3 cells expressing Fz7 on the 
cell surface. This cell line will be hereafter referred to as SKBr3-FLAG-Fz7. 
A similar approach was used to generate SKBr3 cell line expressing FLAG-Fz7 V574G 
mutant of Fz7. In this mutant, the hydrophobic valine at position 574 (Val574, V) was 
replaced with neutral amino acid glycine (Gly, G) (Figure 3.5.A). We predicted that such 
mutation would prevent binding of PDZ domain containing proteins to Fz7. This cell line 
will be referred to as SKBr3-FLAG-Fz7 V574G in the study.  
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3.1.5.1. Assessing cell surface expression, overall expression and 
cell localization of Fz7 in SKBr3 cells. 
After generating the SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cell lines, 
expression of the wild type and V574G mutant Fz7 receptor was verified by WB, flow 
cytometry and immunofluorescence staining. 
Figure 3.6.B. shows the results western blot experiments: comparable expression 
levels were observed for both Fz7 WT (lane 2) and Fz7 V574G (lane 3). However, we have 
observed differences in the appearance of antibody-reactive bands in cells expressing Fz7 
WT and Fz7 V574G. Specifically, the relative abundance of the 60 kDa protein species was 
higher in cells expressing Fz7 V574G mutant, when compared with Fz7 WT. Flow cytometry 
analysis also revealed comparable cell surface levels of Fz7 in both cell lines (Figure 3.6.C). In 
order to determine localization of Fz7 in SKBr3 cells, an immunofluorescence staining 
analysis was carried out. Figure 3.6.D. shows that both, Fz7 WT and Fz7 V574G, were mainly 
detected on the plasma membrane. Interestingly, Fz7 V574G expressing cells formed small 
Fz7 positive membrane protrusions, which have not been observed in cells expressing wild 
type Fz7.  
Taken together, WB analysis, flow cytometry, and immunofluorescence staining 
demonstrated that Fz7 is expressed in SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cells 
and that it is mainly localized on the cell surface.   
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Figure 3. 6. Characterization of SKBr3 cells stably expressing Fz7 proteins (WT and V574G 
mutant). 
(A) Schematic representation of Fz7 structure with PDZ binding motif (PDZ-BM) at the C-
terminus. Mutation V574G was introduced in the PDZ-BM. (B) Equal amounts of protein 
lysates were resolved by SDS-PAGE, followed by western blotting and detection with 
rabbit anti-FLAG antibodies. β-actin served as a loading control. (C) Cells were incubated 
with either mouse anti-FLAG (M2) mAb or 4C5G, an isotype control mAb. Cell surface 
staining of FLAG-Fz7 (WT or V574G) were detected by flow cytometry following 
incubation with anti-mouse FITC-conjugated secondary antibodies. Data analysis was 
carried out using FlowJo analysis software. (D) Fz7 WT and V574G cell distribution was 
analysed by confocal imaging. Cells were fixed and stained with mouse anti-FLAG (M2) 
mAb and Alexa Fluor 488-conjugated goat-anti mouse ab (green). DAPI was used to 
visualize nuclei. 
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3.1.5.2. Mutation in the C-terminal PDZ binding motif of Fz7 
attenuates canonical Wnt signalling in SKBr3 cells 
Having established and characterized SKBr3 cell lines stably expressing FLAG-Fz7 
wild type and FLAG-Fz7 V574G, activation of canonical Wnt signalling was compared in 
these two cell lines. SKBr3 parental, SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cells 
were transfected with reporter plasmids and incubated with Wnt3a conditioned medium for 
24h. 48h after  transfection, the activation of β-catenin-dependent signalling in the cell lines 
was assessed by TOP-Flash luciferase reporter assay. Lysates obtained in the assay were 
further analysed by WB to confirm Fz7 expression between cell lines and to monitor β-
catenin stabilization within cells after Wnt3a stimulation. As demonstrated in the Figure 3.7. 
both, Fz7 WT and Fz7 V574G, activate Wnt signalling pathway over the background level of 
parental SKBr3 cell line. This was evident by  the increase of TOPFlash reporter signal 
(Figure 3.7.A) and β-catenin stabilization detected in western blot analysis (Figure 3.7.B). The 
comparison of canonical Wnt pathway activation in cell lines expressing Fz7 WT or Fz7 
V574G reveals that Fz7 wild type is more potent signalling receptor when compared with the 
Fz7 V574G mutant. In cells expressing Fz7 WT the signal TOPFlash reporter was five times 
stronger, when compared to the parental cell line. By comparison, cells expressing Fz7 
V574G exhibited only a three fold signal increase. A histogram in the Figure 3.7.A represents 
one of three independent experiments. The compilation of the results obtain in three 
independent experiments is presented in the Supplementary Figure S.3. In some of the 
experiments we also noticed that the level of 60 kDa monomer in the Fz7 WT sample 
decreased after stimulation with Wnt3a ligand. However, these changes were not observed 
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in all the experiments and, therefore, require further investigation. Our results clearly 
demonstrate that the introduction of mutation V574G in the C-terminal PDZ-BM attenuates 
activation of the Wnt pathway. These findings provide an evidence for the importance of Fz7 
binding to PDZ domain containing proteins in the regulation of the canonical Wnt signalling.  
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Figure 3. 7. Mutation in the C-terminal PDZ-binding motif of Fz7 attenuates the canonical 
Wnt signalling in SKBr3 cells.  
(A) Wnt-induced signalling was analysed using TOP-FLASH luciferase assay. SKBr3 cells 
were stimulated for 24h with Wnt3a conditioned medium and TOP/FOP activities were 
analysed 48 hours after the transfection with reporter plasmids. Tests were done in 
triplicates. Statistical significance was determined by two-tailed, unpaired Student’s t-test 
(**p<0.01). (B) Western blot analysis of Fz7 expression in SKBr3 cells using anti-FLAG 
pAb. β-catenin expression level was monitored using anti-β-catenin mAb. Densitometry 
values for β-catenin were standardized to the β-actin values of the same sample. β-actin 
served a loading control. Image shown is a representative of three independent 
experiments.  
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3.1.6. Discussion 
The ability to monitor the expression level of Fz7 receptor throughout the 
experiments was essential. Due to lack of reagents detecting the endogenous receptor in 
cells, it was necessary to generate constructs to express tagged forms of the Fz7 receptor. 
Protein expression, subcellular localization and the luciferase-based TOP-Flash assays 
demonstrated that the insertion of the tag sequences did not affect the functionality of Fz7. 
Interestingly, we detected different forms of Fz7 in cells, including two monomers (50 kDa 
and 60 kDa) characterized by different degree of N-glycosylation, dimers (around 130 kDa) 
and higher oligomers with sized exceeding 200 kDa. Similar forms of Fz7 have been reported 
by Struewing and colleagues, who analysed expression of the protein in bovine aortic 
endothelial cells (BAEC) (Struewing et al. 2007). They showed that both monomers of Fz7 (54 
kDa and 64 kDa) were sensitive to tunicamycin treatment, an inhibitor of N-glycosylation. 
Furthermore, the lower molecular weight species were also sensitive to endoglycosidase H 
treatment that specifically removes N-linked oligomannose, but not complex 
oligosaccharides. Oligomannose chains are adjoined to the receptor during the initial steps of 
glycosylation in the ER, whereas more complex oligosaccharides are added in the Golgi. 
Hence it was concluded that the 64 kDa monomer is a fully mature receptor, while the 54 
kDa monomer is an immature receptor retained in the ER (Struewing et al. 2007). Protein 
glycosylation has been shown in the past to be crucial in Wnt signalling. Specifically, 
porcupine (Por)/Mom-1 has been shown to be involved in N-glycosylation of Wnt ligands in 
the ER (Kadowaki et al. 1996;Tanaka et al. 2002), whereas Boca/Mesd has been implicated to 
act as a chaperone for LRP5/6 (Culi et al. 2003). However glycosylation of Frizzled receptors 
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haven’t been extensively studied. Yamamoto and colleagues found that Frizzled 
glycosylation is regulated by the protein Shisa, which mediates Fz7 retention in the ER 
during maturation (Yamamoto et al. 2005). In another study glycosylation was suggested to 
facilitate binding of Wnt ligands to mature receptors (Schulte et al. 2007).  
We have observed that in HEK293T cells FLAG-tagged Fz7 formed dimers and high 
order oligomers. Similarly, the ability of Frizzled receptors to form dimers and oligomers has 
been reported previously (Kaykas et al. 2004). These authors have shown that different 
Frizzled receptors (Fz1, 2, 4, 7 and 9) form specific homo- and hetero-oligomers. The 
heptahelical transmembrane domain of receptors is sufficient for the oligomerization, which 
occurs independently of the CRD domain C-terminal tail and associated scaffolding proteins, 
and is not influenced by Wnt ligands. Frizzled oligomerization has been also shown to occur 
in the ER during or after translation. It was suggested that the process may modulate Wnt 
signalling, as different combinations hetero-oligomers may signal in a distinct fashion than 
homo-oligomers (Kaykas et al. 2004). 
To assess the functionality of the generated tagged-Fz7 constructs we relied on the 
luciferase-based reporter assay (called TOP-Flash). It is a widely used test, enabling to 
quantify activation level of canonical Wnt pathway in cells, first described in (Korinek et al. 
1997). We found that all generated constructs are functional, thus demonstrating the tag 
insertion on the N-terminal site did not influence ability of the receptor to transduce signals. 
On the other hand, C-terminally tagged Fz7-V5-His was not able to efficiently activate the 
canonical Wnt pathway (Figure 3.3.), indicating the importance of the C-terminus in signal 
transduction. Importantly, the critical role of the C-terminal PDZ-BM was further confirmed 
in experiments involving the Fz7 V574G mutant: ligand-induced activation of the canonical 
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Wnt pathway in cells expressing the mutant receptor was ~30% lower when compared to 
that observed in the Fz7 wild type expressing cells.  To our knowledge this is the first 
demonstration of the involvement of the C-terminal PDZ-BM of a Frizzled receptor in the 
canonical Wnt pathway. Several studies also shown that the PDZ-BM of a protein is 
important for regulation of its signalling. For example, Delta1, a ligand for the Notch 
receptor, contains a PDZ-BM within its C-terminus. Mutation of its C-terminal valine leads to 
activation of Notch signalling (Estrach et al. 2007). PDZ proteins also affect GPCR signalling. 
For example, GABAB receptors interaction with PDZ protein MUPP1 (multi PDZ protein 1) 
enhances receptor signalling by affecting G-protein coupling or association of the receptor 
with other proteins (Balasubramanian et al. 2007).   
Fz7 is the only member of Frizzled family reported to be overexpressed in breast 
cancer, especially in basal-like, triple-negative breast cancer (Yang et al. 2011). While 
searching for a suitable model breast cancer cell line to study the involvement of the Fz7 C-
terminal PDZ-BM in the canonical Wnt pathway, we confirmed its functionality in MDA-
MB-231 cells, a model triple negative breast cancer cell line (Yang et al. 2011). On the other 
hand, we found that the β-catenin-dependent pathway is not functional in T47D and MCF7 
cells In this regard, it has been shown that high expression level of NHERF1, protein which 
interacts with Fz2, Fz4 and Fz7, attenuates canonical Wnt pathway in MCF7 cells by 
preventing Dishevelled recruitment to the receptor. Accordingly, NHERF1 depletion enabled 
activation of Wnt signalling in MCF7 cells (Wheeler et al. 2011). In a more recent study 
Simmons and colleagues have shown that T47D cell line expresses a set of different Frizzled 
receptors, including Fz7, and that activation of Wnt/β-catenin pathway in these cells can be 
stimulated by Wnt1 (Simmons, Jr. et al. 2014). One possible explanation for the observed 
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discrepancies is differences in ligands (i.e. Wnt1 vs. Wnt3a) and their concentrations. Also, 
the outcome of used test depends greatly on the transfection efficiency wherein low 
transfection efficiency might explain lack of signal increase after stimulation with Wnt ligand 
or GSK3 inhibitor.  
Although, mutation of the C-terminal PDZ-BM did not seem to have an apparent 
effect on cellular distribution of Fz7, we observed differences in the relative abundance of 
two Fz7 molecular species: high- (60kDa) and low-glycosylated (50kDa). The 
immunoreactivity for the low-glycosylated form of Fz7 V574G in the western blot was 
weaker when compared with corresponding band of the Fz7 WT. These results suggest that 
the mutation in the PDZ-BM influences the Fz7 maturation process. Although we have not 
explored it further, previous reports have identified a role for  PDZ domain proteins in 
biosynthetic trafficking of the associated transmembrane receptors. It was shown for 
example for cystic fibrosis transmembrane conductance regulator, CTFR, reviewed in 
(Pranke et al. 2014).  
Immunofluorescence analysis of SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cell 
lines revealed that both Fz7 and Fz7 V574G, localize mainly to the plasma membrane. 
Nonetheless, Fz7 V574G expressing cells formed small Fz7 positive membrane protrusions, 
which have not been observed in cells expressing wild type Fz7 (Figure 3.6). This indicates 
that one or more of PDZ proteins interacting with Fz7 may be involved in regulation of the 
trafficking of the receptor. Indeed, many PDZ domain containing proteins have been 
implicated in the regulation of receptor trafficking. As an example may serve PDZ proteins 
interacting with G protein coupled receptors (GPCRs), another group of heptahelical 
membrane receptors structurally similar to Frizzled proteins, e.g. NHERF/EBP50 interacting 
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with β2AR, NHERF1 with type I parathyroid hormone receptor (PTHR1R) or Golgi 
associated CAL (cystic fibrosis transmembrane conductance regulator-associated ligand) 
interacting with somatostatin receptor subtype 5 (SSTR5), all reviewed in (Magalhaes et al. 
2012). On the other hand, observed differences may occur due to aberrant signalling on the 
actin cytoskeleton, and Fz7 is present in the protrusions simply because the protein is 
localised on the plasma membrane. 
In summary, work discussed in this chapter included generation of expression 
vectors for tagged Fz7 and subsequent characterization of SKBr3-FLAG-Fz7 and SKBr3-
FLAG-Fz7 V574G stable cell lines, as well assessing activation of the canonical Wnt 
signalling in those cell lines. We have demonstrated that mutation introduced in the 
membrane distal PDZ-BM of Fz7 attenuates activation of the canonical Wnt signalling 
pathway in epithelial breast cancer cell line SKBr3. We have established, for the first time, 
that canonical Wnt signalling is regulated by Fz7 interactions with PDZ domain containing 
proteins through the C-terminal PDZ binding motif of the receptor. 
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3.2. Investigating the role of the Fz7 interaction with 
syntenin-1 
In the previous chapter it was shown that the mutation introduced in a membrane 
distal PDZ-BM of Fz7 attenuates activation of the canonical Wnt signalling pathway in the 
epithelial breast cancer cell line SKBR3. This finding implies that Fz7 interaction with a 
protein or proteins through its C-terminal PDZ binding motif is important for the regulation 
of the canonical Wnt pathway. To examine this further, we decided to focus initially on Fz7 
interaction with syntenin-1. Syntenin-1 is a protein containing two PDZ domains, which 
functions as a scaffolding partner for a number of transmembrane receptors (Beekman et al. 
2008), Importantly, it was reported to interact with Fz7 and regulate non-canonical Wnt 
signalling (Luyten et al. 2008). The aim of the work described in this chapter was to 
investigate whether expression, cell localization and signalling function of Fz7 are regulated 
by   syntenin-1.  
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3.2.1. Examination of Fz7 binding to syntenin-1 
3.2.1.1. Fz7 interaction with syntenin-1 involves PDZ domains 
To examine the Fz7–syntenin-1 interaction, a co-immunoprecipitation assay was 
performed. In these experiments we used wild type and Fz7 V574G expressing cells. We 
have also included a Fz7 V574E mutant in which the last C-terminal amino acid Val574 was 
replaced with glutamic acid (Glu, E). We predicted that the replacement of hydrophobic 
valine with glutamic acid, an amino acid containing negatively charged side chain would 
have a more dramatic affect on binding of Fz7 to PDZ proteins. HEK293T cells were co-
transfected with FLAG-syntenin-1 and Myc-Fz7 (WT, or with mutation V574G or V574E). 
Cells were lysed and incubated with anti-FLAG agarose beads to pull down syntenin-1 
together with associated proteins. Proteins retained by the beads were resolved by SDS-
PAGE and analysed by western blotting. Membranes were incubated with anti-FLAG pAb to 
detect syntenin-1 and anti-Myc pAb to detect Fz7. Immunoprecipitation samples were 
prepared under non-reduced conditions to facilitate Fz7 detection. WB analysis revealed that 
syntenin-1 interacts with the wild type Fz7 (lane 2, Figure 3.8.A). In these experiments we 
also observed the association with both mutants of Fz7 V574G and V574E (lanes 4 and 6, 
respectively). Densitometry analysis was performed on data obtained in three independent 
experiments and presented as a histogram, plotted as a percentage of syntenin-1 binding to 
Fz7 mutants relative to the interaction of syntenin-1 with the wild type Fz7 (taken as 100%) 
(Figure 3.8.B). Optical density (OD) was measured for both, Fz7 and syntenin-1, and the 
ratios between the two proteins were calculated for each sample. This allowed us to compare 
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samples with each other. Analysis revealed that syntenin-1 binding to Fz7 V574G was ~40% 
lower, and to Fz7 V574E was 60% lower, when compared to the interaction of syntenin-1 
with wild type Fz7. Thus, V574E mutation had more substantial impact on the syntenin-1 – 
Fz7 interaction. 
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Figure 3. 8. Fz7 interaction with syntenin-1 involves PDZ domains. 
(A) HEK293T cells were co-transfected with Myc-Fz7 (WT, V574G or V574E) and FLAG-
syntenin-1. 24h after transfection cells were lysed in 0.5% Brij98-0.5% Triton X-100 and 
lysates were incubated with Anti-FLAG®M2 Agarose Beads. After immunoprecipitation, 
the retained proteins were resolved by SDS-PAGE, followed by western blotting and 
protein detection using rabbit anti-Myc pAb and rabbit anti-FLAG pAb. Images depict a 
representative of three independent experiments. (B) Densitometry analysis performed on 
data obtained in three independent experiments and demonstrated on a histogram, 
plotted as percentage of Syntenin-1 binding to Fz7 mutants relative to the interaction of 
syntenin-1 with the wild type Fz7 (taken as 100%). The statistical significance was 
determined by a two-tailed, unpaired Student’s t-test (*p<0.05).  
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Reciprocal co-immunoprecipitation experiments were also performed. HEK293T cells 
were transiently transfected to express FLAG-Fz7, FLAG-Fz7 V574G or FLAG-Fz7 V574E 
and the interaction with the endogenous syntenin-1 was examined after 
immunoprecipitation with anti-Flag mAb (Figure.3.9.A). Syntenin-1 was found to interact 
with Fz7 WT (lane 2), and also with Fz7 V574G (lane 3) and Fz7 V574E (lane 4), albeit the 
interaction with the two mutants was dramatically diminished. Densitometry analysis  
(performed as above) showed that syntenin-1 binding to Fz7 V574G was five fold lower, and 
to Fz7 V574E was more than ten fold lower, when compared with binding to the wild type 
Fz7. These experiments clearly demonstrated that mutations in the PDZ-BM of Fz7 
significantly decreases interactions of the protein with syntenin-1. These results also 
suggested that the interaction with Fz7 involves at least one of the PDZ domains of syntenin-
1. 
  3.RESULTS AND DISCUSSION 
148 
 
 
Figure 3. 9. Fz7 interacts with endogenous syntenin-1. 
HEK293T cells were co-transfected with FLAG-Fz7 (WT, V574G or V574E). 24h after 
transfection cells were lysed in 1% Triton X-100 and lysates were incubated with Anti-
FLAG® M2 magnetic beads. Immunoprecipitated proteins were resolved by SDS-PAGE, 
followed by western blotting and protein detection using rabbit anti-FLAG pAb and 
rabbit anti-syntenin-1 mAb. Images depict representatives of at least three independent 
experiments. (A) Densitometry analysis performed on data obtained in three independent 
experiments and presented as a histogram, plotted as percentage of syntenin-1 binding to 
Fz7 mutants relative to the interaction of syntenin-1 with the wild type Fz7 (taken as 
100%). The statistical significance was determined by a two-tailed, unpaired Student’s t-
test (*p<0.05; ***p<0.001).  
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3.2.1.2. Mapping of syntenin-1 domain that interacts with Fz7 
The nature of the syntenin-1 - Fz7 interaction was analysed further using the 
following synteinin-1 – encoding constructs: HA-syntenin-1-PDZ1* (G126D), PDZ2* (G210E) 
or PDZ1*PDZ2* (G126D, G210E) with introduced mutations in the interacting loops that 
prevented binding through the PDZ1, PDZ2 or both, respectively (Latysheva et al. 2006). In 
the control experiments we used a construct encoding HA-tagged syntenin-1 (wild type).  
HEK293T were co-transfected with FLAG-Fz7 and one of the syntenin-1 – encoding plasmids 
and the interaction between the proteins was analysed by immunoprecipitation. These 
experiments revealed that both PDZ domains of syntenin-1 are required for its interaction 
with Fz7 (Fig.3.10.A). This was evident by a significant decrease in the amount of syntenin-1 
mutants detected in Fz7 immunoprecipitates: compare signals in lane 4 (PDZ1*), lane 6 
(PDZ2*) and lane 8 (PDZ1*2*) with lane 2 (syntenin-1 WT). Densitometry analysis showed 
that both PDZ domains of syntenin-1 contribute to the interaction with Fz7, as syntenin-1 
PDZ1* binding to Fz7 was ten fold lower, whereas syntenin-1 PDZ2* and syntenin-1 
PDZ1*PDZ2* binding was 20 times lower when compared with the interaction of wild type 
syntenin-1 to Fz7 (Figure 3.10.B)  
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Figure 3. 10. Interaction with Fz7 involves both PDZ domains of syntenin-1. 
(A)HEK293T cells were co-transfected with FLAG-Fz7 and HA-syntenin (WT or with 
introduced mutation in PDZ1*, PDZ2* or both PDZ1*PDZ2*). Immunoprecipitation assay 
was carried out in 0.8% Brij98-0.2% Triton X-100 buffer. Lysates were incubated with Anti-
FLAG®M2 Agarose Beads. After immunoprecipitation, beads were washed and 
resuspended in 2x SDS sample-loading buffer. Retained proteins were resolved by SDS-
PAGE, followed by western blotting and protein detection using rabbit anti-FLAG pAb 
and rabbit anti-HA pAb. Images depict a representative of two independent experiments. 
(B) Densitometry analysis was performed on data obtained in two independent 
experiments and demonstrated on a histogram, plotted as percentage of syntenin-1 
binding to Fz7 mutants relative to the interaction of syntenin-1 with the wild type Fz7, 
taken as 100%. The statistical significance was determined by a two-tailed, unpaired 
Student’s t-test (**p<0.01; ***p<0.001).  
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To investigate the interaction between Fz7 and syntenin-1 in more detail nuclear 
magnetic resonance (NMR) analysis was used in collaboration with Dr Sundaresan Rajesh. 
NMR titration analysis of 15N-labeled syntenin-1-PDZ1-2 domains with unlabeled Fz7 
peptide, corresponding to the last 8 amino acid of cytoplasmic tail of the receptor, was 
carried out. The method was previously described in (Latysheva et al. 2006;Rajesh et al. 2011) 
where detailed structural information on the role of syntenin-1’s individual amino acids is 
provided. The decrease in signal intensity (chemical shift) for each amino acid of syntenin-1 
upon interaction with Fz7 peptide at various concentrations (50 μM – 800 μM) was 
calculated and later mapped onto the crystal structure of the syntenin-1-PDZ1-2 monomer, 
PDB:1N99 (Kang et al. 2003). The colour code was used to highlight the calculated values: 
green represents a decrease in signal intensity of 25-40%; yellow represents a decrease of 40-
60%, orange represents a decrease of 60-80%; and red a decrease of more than 80% (Figure 
3.11). The decrease of NMR signal intensity correlates with the proximity of the relevant 
amino acid with the interacting peptide. Analysis revealed that syntenin-1-PDZ2 domain is 
predominantly involved in the Fz7 peptide binding, although the involvement of PDZ1 was 
also observed. When the Fz7 peptide was used at 50 μM (1:0.25 ration toward syntenin-1 
monomer concentration) a chemical shift was observed for Ile125 (PDZ1) and Thr219 (PDZ2), 
suggesting that the initial step of Fz7 binding involves both PDZ domains (Figure 3.11.A). 
However, when the concentration of Fz7 peptide was increased to 100 μM (1:0.5 ratio) a 
chemical shift of Gly210 was observed in the carboxylate binding loop of PDZ2, as well as of 
several residues in the vicinity of this site Phe211, Phe213, Gly216, and Thr219. In contrast, 
chemical shift perturbations in PDZ1 were limited to Ile125 and Gly126 in the carboxylate 
binding loop of PDZ1, and to Arg191 (Figure 3.11.B).  The chemical shift perturbations, 
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obtained when peptide was added in four fold excess (800 μM) (Figure 3.11.C), were used to 
map binding sites and revealed a contact surface present predominantly in the syntenin-
PDZ2 domain binding pocket, and to a lesser extent in the PDZ1 (Figure 3.11.D). Namely 
residues 199-201, 203-204, 207-211, 213-216, 220, 223-226, 229-235, 239, 242, 246, 255-256, 258-
259 and 265-270 in PDZ2, and 120, 125-127, 130, 141, 147, 179, 186 and 190-191 in PDZ1 were 
involved in Fz7 peptide binding. This structural data support our co-immunoprecipitation 
assay observations presented in the previous paragraph.  
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Figure 3.11. Interaction with Fz7 is predominantly mediated by PDZ2 domain of  
syntenin-1.  
Graphs present perturbation of syntenin-1 PDZ1-2 NMR signals upon interaction with 
Fz7 peptide: (A) equal concentration of the peptide and syntenin-1 monomer; (B) four fold 
excess of the peptide . The residues displaying combined chemical shift changes greater 
than the mean value plus one (25 Hz) are colour coded as indicated below and (C) mapped 
onto the surface of crystal structure of the syntenin-1 PDZ1-2 (PDB:1N99) monomer 
resolved by (Kang et al. 2003). The decrease in signal intensity (chemical shift changes) for 
every amino acid of syntenin-1 PDZ1-2 monomer upon interaction with the peptide was 
calculated and represented using the following colour code: green represents a decrease in 
signal intensity of 25-40%; yellow represents a decrease of 40-60%, orange represents a 
decrease of 60-80%; and red a decrease of more than 80%. The degree of decrease in signal 
indicates the proximity between the relevant amino acid of syntenin-1 with the target 
peptide.  
 
 
 
 
 
 
D.
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3.2.2. Syntenin-1 modulates canonical Wnt signalling 
pathway 
3.2.2.1. Syntenin-1 knockdown attenuates canonical Wnt pathway 
signalling in the SKBr3 cell line 
The role of syntenin-1 in canonical Wnt signalling was examined in the SKBr3 
epithelial breast cancer cell line stably expressing FLAG-Fz7 wild type or FLAG-Fz7 V574G 
mutant, after syntenin-1 depletion. For this purpose SKBr3 cells were transfected with the 
siRNA targeting syntenin-1, or with a control siRNA (siNeg) and with reporter plasmids. On 
the following day, cells were stimulated with Wnt3a. 24h after later β-catenin reporter 
activity was compared to cells with and without syntenin-1 knock-down (Figure 3.15.A). 
Cellular lysates obtained in the experiment were analysed by SDS-PAGE and WB to quantify 
the level of syntenin-1 knockdown (Figure 3.15.B). WB analysis confirmed the syntenin-1 
knockdown (lanes 3, 4, 7 and 8). The protein expression levels were reduced by 90%, 
compared with the control samples. These experiments showed that syntenin-1 depletion 
attenuates activation of Wnt signalling in cells expressing wild type Fz7. Reporter activity in 
SKBr3-FLAG-Fz7 cells with syntenin-1 knockdown was reduced by 40%, when compared 
with control cells. On the other hand, syntenin-1 depletion didn’t alter Wnt signalling in 
SKBr3 cells expressing the Fz7 V574G mutant. Taken together, syntenin-1 depletion 
attenuates canonical Wnt signalling in SKBr3 cells expressing wild type Fz7, but not the Fz7 
V574G mutant. 
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Figure 3. 12. Syntenin-1 depletion attenuates canonical Wnt signalling in SKBr3 cells 
expressing Fz7 WT. 
(A) Wnt3a-induced signalling was analysed using the TOP-Flash luciferase reporter assay. 
SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cells were transfected with siRNA against 
Syntenin-1 or control siNegative. Cells were stimulated for 24h with Wnt3a conditioned 
medium and TOP/FOP activity was analysed 48h after transfection with reporter 
plasmids. Assays were performed in triplicate and three independent experiments were 
performed. Statistical significance was determined by two-tailed, unpaired Student’s t-
test (* p<0.05). (B) Cellular lysates obtained in the assay were examined in SDS-PAGE and 
WB, with anti-syntenin-1 mAb and anti-FLAG pAb. Image presents a representative  of 
three independent experiments. Densitometry analysis was performed on syntenin-1 
immunoreactive bands. Optical densities (OD), standardized to β-actin, are shown for 
each lane.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  3.RESULTS AND DISCUSSION 
158 
 
3.2.2.2. Syntenin-1 regulates canonical Wnt signalling through its 
interaction with Fz7 
Our results indicate that syntenin-1 regulates canonical Wnt signalling due to its 
direct interaction with Fz7. However, one can’t exclude the possibility that syntenin-1 also 
interferes with canonical Wnt signalling downstream of the Fz7 receptor, or indirectly by 
affecting the activity of alternative pathways (see Introduction). To address this issue, we 
compared activation of the canonical Wnt pathway in syntenin-1-depleted cells either 
stimulated with Wnt3a, or treated with the GSK3 inhibitor (SB216763), which activates the 
catenin – dependent pathway downstream of the receptor. In control experiments, cells 
were treated with control siRNA. SKBr3-FLAG-Fz7 cells were transfected with siSyntenin-1 
or siNeg and incubated with Wnt3a conditioned medium or control medium. In parallel, 
cells transfected with siRNA were treated with 10 μM GSK3i or equivalent amounts of 
DMSO. Wnt activation was quantified by TOP-Flash reporter assay 24h later; data is 
presented in  Figure 3.16.A. Analysis of the reporter assay showed that syntenin-1 depletion 
only downregulates Wnt pathway when cells are stimulated with Wnt3a ligand and not with 
GSK3i. The level of syntenin-1 knock-down was assessed by analysing cell lysates obtained 
the assay by SDS-PAGE and WB with anti-syntenin-1 pAb (Figure 3.16.B), which confirmed 
that the protein expression level was more than 90% lower when compared with control 
samples. These results provide an additional evidence for syntenin-1 affecting  canonical 
Wnt signalling upstream of GSK3.  
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Figure 3. 13. Syntenin-1 regulates canonical Wnt signalling due to its interaction with Fz7. 
A) Wnt3a-induced signalling was analysed using TOP-Flash luciferase reporter assay. 
SKBr3-FLAG-Fz7 cells were transfected with siRNA against Syntenin-1 or control 
siNegative. Cells were stimulated for 24h with Wnt3a conditioned medium or with 10 μM 
GSK-3i (SB216763) and TOP/FOP activity was analysed 48h after transfection with 
reporter plasmids. Assays were performed in triplicate and three independent 
experiments were performed. Statistical significance was determined by two-tailed, 
unpaired Student’s t-test (*p<0.05). (B) Cellular lysates obtained in the assay were 
examined in SDS-PAGE and WB, with anti-syntenin-1 mAb and anti-β-actin mAb. Image 
presents a representative of three independent experiments. Densitometry analysis was 
performed on syntenin-1 immunoreactive bands. Optical densities (OD), standardized to 
β-actin, are shown for each lane.  
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3.2.3. Syntenin-1 regulates Fz7 distribution in SKBr3 cells   
SKBr3 cell lines stably expressing FLAG-Fz7 or FLAG-Fz7 V574G were used to 
determine whether syntenin-1 co-localizes with Fz7. Due to the lack of a suitable antibody to 
detect endogenous syntenin-1 by immunofluorescence staining, Myc-syntenin-1 was used 
for the co-localization studies. SKBr3, SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cells 
were transfected with Myc-syntenin-1 and, 48h later,  fixed and stained with rabbit anti-
FLAG and mouse anti-Myc antibodies. DAPI was used to visualize nuclei. Immunoreactivity 
for both proteins was analysed by confocal microscopy and presented in the Figure 3.12. 
Syntenin-1 has been found to be abundantly present in the cytoplasm of parental SKBr3 cells. 
Using a transient transfection approach in which only ~25% cells were transfected with a 
syntenin-1 – encoding plasmid allowed us to examine the effect of syntenin-1 overexpression 
on localization of Fz7. These experiments revealed that syntenin-1 overexpression changes 
Fz7 cell distribution. In both cell lines, SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G, 
immunoreactivity for Fz7 was not observed in plasma membrane, in cells overexpressing 
syntenin-1. On the other hand, Fz7 immunoreactivity was detected in small puncta 
(presumably intracellular vesicles) in the cytoplasm. As expected, no reactivity with anti-Flag 
Ab was detected in SKBr3 control cells. 
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Figure 3. 14. Overexpression of syntenin-1 alters Fz7 cell distribution. 
SKBr3, SKBr3-FLAG-Fz7 WT and SKBr3-FLAG-Fz7 V574G cells were transfected with 
Myc-Syntenin-1 and proteins distribution was analysed by confocal imaging. Cells were 
fixed 48h after transfection and stained with rabbit anti-FLAG pAb and with mouse anti-
Myc mAb. DAPI was used to visualize nuclei. Overexpression of syntenin-1 resulted in 
redistribution of both, Fz7 WT and Fz7 V574G from plasma membrane to cytoplasmic 
vesicles.  
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Considering the fact that mutations introduced in PDZ domains of syntenin-1 
attenuate its interaction with Fz7 (as shown the previous section), we wished to investigate 
whether the activity of syntenin-1 towards Fz7 is dependent on its PDZ domains. For this 
purpose SKBr3-FLAG-Fz7 cells were transfected with different HA-tagged syntenin-1 
constructs. 48h after the transfection, SKBR3-FLAG-Fz7 cells were fixed and stained with 
mouse anti-HA mAb to detect syntenin-1 and rabbit anti-FLAG pAb to detect Fz7. 
Immunoreactivities for both proteins were analysed by confocal microscopy and 
representative images are presented in Figure 3.13. When HA-syntenin-1 WT was 
overexpressed, Fz7 staining was not observed in the plasma membrane, but in vesicles in a 
cytoplasm, similarly as previously observed in cells transfected with Myc-Syntenin-1. 
However, when cells were transfected with HA-syntenin-1 PDZ1*, HA-syntenin-1 PDZ2* or 
HA-syntenin-1 PDZ1*PDZ2*, Fz7 receptor remained in the plasma membrane, where it co-
localized with the mutants of syntenin-1. 
Taken together, overexpression of wild type syntenin-1 leads to relocalisation of Fz7 
from plasma membrane in SKbr3 cells and this activity of syntenin is dependent on PDZ 
domains of the protein.  
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Figure 3.15. Fz7 co-localizes with syntenin-1 with mutations introduced in PDZ domains . 
SKBr3, SKBr3-FLAG-Fz7 WT and SKBr3-FLAG-Fz7 V574G cells were co-transfected with 
FLAG-Fz7 and HA-syntenin-1 (WT or with introduced mutation in PDZ1*, PDZ2* or both 
PDZ1*PDZ2*) and proteins distribution was analysed by confocal imaging. Cells were 
fixed 48h after transfection and stained with rabbit anti-FLAG pAb and with mouse anti-
HA mAb. DAPI was used to visualize nuclei. Overexpression of  wild type syntenin-1 led 
to removal of  Fz7 from plasma membrane.  All three syntenin-1 PDZ mutants co-localize 
with Fz7.  
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3.2.4. Syntenin-1 is not involved in the regulation of Fz7 
expression 
Syntenin-1 overexpression induces changes in Fz7 distribution in SKBr3 cells (Section 
3.2.2.). In the reverse experiments we analysed whether depletion of syntenin-1 would also 
influence the cellular distribution of Fz7. SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cells 
were transfected with siRNA targeting syntenin-1 (or with control siRNA) and 24h later cells 
were stimulated with Wnt3a conditioned medium or with control conditioned medium. 
Cells were collected after further 24h and expression levels and distribution were analysed 
by WB, flow cytometry and immunofluorescence. Densitometry analysis confirmed 
syntenin-1 expression level was 90% lower in cells transfected with siSyntenin-1, than in the 
control cells. The analysis of Fz7 expression in whole cell lysates (using anti-FLAG pAb), 
revealed no significant changes in total expression level of both, Fz7 WT and Fz7 V574G 
(Figure 3.14.A). In parallel, flow cytometry analysis was conducted to assess the surface 
expression of Fz7 in collected cells, using anti-FLAG mAb. Fz7 wild type or Fz7 V574G 
mutant cell surface expression was not altered in cells with syntenin-1 knock-down (Figure 
3.14.B). Finally, cell localization of Fz7 was examined by immunofluorescence. We noticed 
that syntenin-1 depletion changed morphology of SKBr3 cells, as they became more 
flattened. Nonetheless, no obvious alterations were observed in the receptor distribution in 
cells with syntenin-1 knock-down.   
Taken together, the analysis of total and membrane expression of Fz7 and cell 
distribution by western blot, flow cytometry and immunofluorescence didn’t provide 
evidence that syntenin-1 knock-down influences Fz7 expression in SKBr3 cells.  
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Figure 3. 16. Syntenin-1 depletion does not change Fz7 membrane expression or cell 
distribution. 
SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cells were transfected with siRNA against 
Syntenin-1 or with control siNeg. 24h later cells were stimulated with Wnt3a conditioned 
medium or with control conditioned medium. 48h after the transfection cell lysates were 
collected and analysed by SDS-PAGE and WB, flow cytometry and immunofluorescence. 
(A) Lysates of equal protein concentration were resolved by SDS-PAGE, followed by 
western blotting with Anti-FLAG pAb to examined Fz7 expression level, anti-Syntenin-1 
mAb to monitor LNX2 knock-down level. β-actin served as a loading control. (B) Flow 
cytometry with anti-FLAG mAb was used to examine membrane expression of Fz7. Cells 
were incubated on ice for 1h with  mouse anti-FLAG (M2) mAb. 4C5G monoclonal 
antibody against phosphatidylinositol 4-kinase was used as an isotype control. Cell 
surface staining of FLAG-Fz7 (WT or V574G) was detected by flow cytometry following 
incubation for 1h on ice with anti-mouse FITC-conjugated secondary antibodies. Data 
analysis was carried out using FlowJo analysis software. The values of calculated mean 
fluorescence are presented in top-right corner of the plots. (C-D) Fz7 WT (C) and V574G 
(D) cell distribution was analysed by confocal imaging. Cells were fixed and stained with 
mouse anti-FLAG (M2) mAb and Alexa Fluor 488-conjugated goat-anti mouse ab (green). 
DAPI was used to visualize nuclei. 
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3.2.5. Discussion 
We have found in the proceeding chapter that the canonical Wnt signalling is 
regulated by Fz7 interactions through its C-terminal PDZ-BM. Additionally, Fz7 expression 
and cell distribution also seem to be dependent on the receptor associations with PDZ 
proteins.  To examine this issue further, we have initially decided to focus on the interaction 
between Fz7 and syntenin-1. Syntenin-1 is a scaffold protein with a tandem of PDZ domains, 
previously shown to bind Fz7 (Luyten et al. 2008). The protein was reported to regulate 
trafficking of several membrane receptors, such as syndecans, syndecan associated receptors 
e.g. FGF, or tetraspanin CD63 (Beekman et al. 2008) (see Introduction). For these reasons, we 
have decided to determine whether syntenin-1 regulates Fz7 functions, as well as canonical 
Wnt signalling in breast cancer cells. 
Our experiments confirmed that syntenin-1 binds to Fz7 in our breast cancer model. 
Furthermore, as expected, mutations in both PDZ-BM of Fz7 and PDZ domains in     
syntenin-1, significantly decreased the interaction between the two proteins. These results 
clearly demonstrate the importance of PDZ domains in Fz7 – syntenin-1 interactions. 
However, the fact that none of the mutations analysed completely abolish the association 
might indicate a possible contribution of the other part(s) of Fz7 (and syntenin-1) in 
stabilization of the complex. If proved in future experiments this would be reminiscent of a 
model of Frizzled-Dishevelled interactions, which was recently presented by Tauriello and 
colleagues. Specifically, it was demonstrated that this interaction involves a three-segmented 
discontinuous binding surface, comprising of the internal PDZ-BM and two additional 
motifs in intracellular loops of the Frizzled receptor (Tauriello et al. 2012). Alternatively, one 
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can not exclude a possibility that a small proportion of syntenin-1 is recruited to the Fz7 
complex indirectly via a network of PDZ-independent interactions.   
Our results demonstrated that PDZ2 plays a predominant role in recruiting   
syntenin-1 to Fz7. Nevertheless, we have shown that the mutation in PDZ1 also decreased 
the interaction of syntenin-1 with Fz7. Luyten and colleagues (2008) reported that syntenin-1 
interaction with Fz7 relies on PDZ1. In their study recombinant GST-PDZ domains of 
syntenin-1 were used in different type of test (overlay assay), which might explain 
differences between our findings and (Luyten et al. 2008). The authors showed single GST-
PDZ1, but not GST-PDZ2, was sufficient to bind to Fz7 peptide. Interestingly, tandem GST-
PDZ2-PDZ2 displayed strong interaction with Fz7. Most protein ligands of syntenin-1 show 
preference for PDZ2 (for example syndecans and ephrinB), whereas PDZ1 binds with higher 
affinity to IL-5Rα (interleukin-5 receptor α), neurexin, merlin and CD63 (Beekman et al. 
2008). Previous reports have also shown that despite preference for one of the PDZ domain, 
both of them are required for the interaction of syntenin-1 with different transmembrane 
proteins (Sarkar et al. 2004).  
Syntenin-1 was reported to be involved in the regulation of non-canonical Wnt 
signalling by controlling activation of the PKC/CDC42 pathway (Luyten et al. 2008). This 
study also suggested that syntenin-1 does not contribute to the canonical Wnt pathway. By 
contrast, our results clearly indicate that depletion of syntenin-1 in breast cancer cells 
attenuated -catenin – dependent signalling as tested in the TOPFlash reporter assay.  We 
based our conclusion on two lines of evidence. Firstly, observed decrease of TOP-Flash 
signal following syntenin-1 depletion occurs only in SKBr3 cells expressing Fz7 WT, and not 
in cells expressing the Fz7 mutant with reduced capability to bind to syntenin-1 (Figure 3.12). 
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Secondly, analysis of the canonical Wnt pathway activation after treatment with an inhibitor 
of GSK3 (Figure 3.13) leads to a conclusion that syntenin-1 regulates Wnt signalling 
upstream of GSK3 kinase, presumably on Wnt receptor level. One possible explanation for 
the discrepancy between our results and conclusions from the previous study is that 
different cell models were used. Conclusions by Luyten and colleagues were based on the 
experiments performed using MCF7 cells, wherein overexpression of syntenin-1 didn’t have 
any significant effects on -catenin – dependent signalling (TOP-Flash experiments). 
However, we and others (Wheeler et al. 2011) have shown that canonical Wnt pathway is not 
functional in this cell line, due to inhibitory effect of NHERF overexpression.  
Further research is required to elucidated the exact mechanism in which syntenin-1 
regulates canonical Wnt signalling. However, syntenin-1 was shown to bind syndecans, 
ubiquitous transmembrane heparan sulphate proteoglycans. The heparan sulphate chains of 
their extracellular domain allow syndecans to act as co-receptors, as they bind and 
concentrate growth factors, including Wnts, at the cell surface and facilitate their interactions 
with receptors (Bishop et al. 2007;Couchman 2003). It was proposed previously in (Luyten et 
al. 2008) that syntenin-1 serves as a scaffold for Fz7-syndecan-4 complex and therefore 
regulate noncanonical Wnt signalling, due to the ability of syndecan-4 to bind and activate 
PKCα. In this regard, syndecan-1 was recently described as a regulator of β-catenin 
dependent Wnt signalling in triple negative subtype of breast cancer. The authors showed 
that syndecan-1 depletion correlates with downregulation of LRP6 and reduced 
responsiveness to Wnt signalling (Ibrahim et al. 2013). Another possible mechanism may 
involve syntenin-1 interaction with another binding partner, such as merlin 
(neurofibromatosis 2, NF2). Merlin acts a membrane stabilizing protein and was shown to 
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bind and colocalize with syntenin-1 at the plasma membrane (Jannatipour et al. 2001). Merlin 
was found to interact with proteins forming adherens junctions (AJs): cadherins and catenins 
(Lallemand et al. 2003), with which syntenin-1 was also reported to colocalize (Zimmermann 
et al. 2001). Recently, it was shown merlin knockout leads to increased canonical Wnt 
signalling in mouse embryonic fibroblasts (Zhou et al. 2011). Thus, interaction between these 
two proteins might also be important for regulation of Wnt signalling.  
Our results indicate that syntenin-1 may be involved in regulation of receptor 
trafficking. Specifically. syntenin-1 overexpression in both SKBr3-FLAG-Fz7 and SKBr3-
FLAG-Fz7 V574G resulted in redistribution of the receptor  from the plasma membrane to  
small puncta, supposedly cytoplasmic vesicles (Figure 3.14.). Importantly, all three PDZ 
mutants of syntenin-1 (PDZ1*, PDZ2* and PDZ1*PDZ2*) were deficient towards Fz7. These 
results seem to indicate that syntenin-1 interaction through PDZ domains regulates 
subcellular localization of Fz7. Surprisingly, we found that Fz7 V574G mutant was also 
redistributed from plasma membrane upon overexpression of the wild type syntenin-1. 
It seems that the effect of syntenin-1 on Fz7 distribution is likely to be indirect and involves 
another protein (or proteins) whose interaction with syntenin-1 requires PDZ domain. 
Syntenin-1 is known to regulate trafficking of  a number transmembrane receptors (Beekman 
et al. 2008). It has been also reported that complex syndecan-syntenin-1-ALIX is able to 
recruit syndecan associated proteins to the intraluminal vesicles of multivesicular endosomes 
and exosomes (Baietti et al. 2012). Since syndecan-1 was also implicated in Wnt signalling 
(Ibrahim et al. 2013), it is possible that syndecan-1-syntenin-1-ALIX complex recognize Fz7 as 
a cargo and traps it in the intraluminal vesicles. 
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Finally, we have examined whether syntenin-1 depletion alters Fz7 expression. 
SKBr3-FLAG-Fz7 WT and SKBr3-FLAG-Fz7 V574G cells were transfected with siRNA 
against syntenin-1 and stimulated with Wnt3a. Subsequently total and membrane 
expression, as well as cellular localization of Fz7 was assessed. Analysis by western blot, 
flow cytometry and immunofluorescence did not provide evidence that syntenin-1 knock-
down affects Fz7 WT or Fz7 V574G expression (Figure 3.16). 
Taken together, syntenin-1 is a scaffold protein binding Fz7 in PDZ dependent 
manner.  For the first time, we have determined that the interaction between the two proteins 
plays a role in regulation of the canonical Wnt signalling in breast cancer cells. We have also 
shown that syntenin-1 regulates trafficking and cell localization of Fz7 receptor. 
 
 
 
 
 
 
 
 
 
 
 
 
  3.RESULTS AND DISCUSSION 
176 
 
3.3. Fz7 interacts with PDZ domain containing proteins 
Cytoplasmic tails of all Frizzled receptors contain Postsynaptic density-95, Disc large, 
ZO-1 (PDZ) binding motifs (PDZ-BMs). The C-terminal PDZ-BM (x-S/T-x-φ, where φ 
represents a hydrophobic residue) was reported to bind different PDZ proteins including 
GOPC, MAGI-3, Syntenin-1, Kermit, PSD-95 (Wawrzak et al. 2009) (discussed in the 
Introduction). Whilst some of these proteins were implicated in noncanonical Wnt pathways, 
their roles in transduction of canonical Wnt signalling haven’t been widely addressed  in the 
past. The aim of work described in this chapter was to identify PDZ proteins that interact 
with Fz7 in breast cancer cells, and thus to help elucidate the mechanism by which the C-
terminal PDZ-BM of Fz7 works.  
 
3.3.1. Pull-down of Fz7 binding partners and their 
identification by Mass-Spectrometry 
In order to find binding partners of Fz7 that interact with WT but not with V574G, a 
pull-down assay was performed, described in details in section 2.4.6. of Materials and 
Methods. Schematic representation of designed experiments is presented in the Figure 
3.17.A. Cellular lysates of epithelial breast cancer cell line MCF7 were incubated either with 
biotin-conjugated Fz7 WT or with Fz7 V574G peptide immobilized on agarose resins (Figure 
3.17.B). For the control sample, NeutrAvidin agarose resins without peptide were used. 
Retained proteins were resolved on SDS-PAGE gel and stained with InstantBlue. Marked 
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differences were observed, when “WT” and “V574G” pull-down samples were compared 
(Figure 3.17.B), indicating that the C-terminal PDZ binding motif of Fz7 is essential for 
interactions with a number of cellular proteins. Proteins specifically pulled down by WT 
peptide (marked by red arrows in the Figure 3.17.B) were digested with trypsin and 
analyzed by mass spectrometry. Details of samples preparation are described in section 2.4.7. 
Protein sequencing was performed by Dr Douglas Ward using liquid chromatography and 
mass spectrometry (LS-MS) at the Proteomics Facility of University of Birmingham. Analysis 
revealed several PDZ domain-containing proteins that could be Fz7 binding partners. 
Identified proteins are listed in the Table 3.1. Among the identified candidates were proteins 
involved in receptor trafficking (DLG1, SNX27, LNX1, LNX2, MAGI3, Scribble) and 
establishment of cell polarity and tight junction formation (MPP5, MPP7, ZO-2, MAGI3, 
INADL, Scribble). 
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Figure 3. 17. Pull down of PDZ domain containing binding partners of Fz7. 
(A) MCF7 cells were lysed in 1% Triton X-100. The lysates were firstly precleared with 
NeutrAvidin agarose resins and then incubated with NeutrAvidin agarose resins with 
immobilized biotinylated peptides: Fz7 WT or V574G. For the control sample, 
NeutrAvidin agarose resin without peptide was used. After the pull-downs the beads 
were washed and resuspended in 2x SDS sample-loading buffer. (B) Samples were 
subjected to SDS-PAGE and stained with the Coomassie dye. The protein bands that were 
visible in Fz7 WT pull-down lanes, but not in Fz7 V574G  pull-down lane or beads alone 
pull-down control lane, (marked by red arrows) were excised, processed and analysed by 
mass spectrometry 
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Table 3. 1. Mass spectrometry results showing potential Fz7-binding proteins. 
The table indicates the gene symbol, name, molecular weight and number of detected 
peptides obtained from the digested gel fragments (samples) labelled in the Fig. 3.17.  
Accession Protein MW  
(kDa) 
Peptides Sample 
 PDZ PROTEINS:    
SCRIB Protein scribble homolog  174.8 62 1,2,3,4,5,6,7 
INADL InaD-like protein  196.2 37 1,2,3 
MPP5 MAGUK p55 subfamily member 5  77.2 36 5,6,7 
MAGI3 Membrane-associated guanylate kinase, WW 
and PDZ domain-containing protein 3  
165.5 35 2,3,4 
MPP7 MAGUK p55 subfamily member 7  65.5 27 5,6,7 
MAGI1 Membrane-associated guanylate kinase, WW 
and PDZ domain-containing protein 1  
164.5 27 2,3,4 
DLG1 Disks large homolog 1  100.4 11 5,6,7 
SNX27 Sorting nexin-27  61.2 11 5,6,7 
ZO-2 Tight junction protein ZO-2  133.9 7 4 
LNX2 Ligand of Numb protein X 2  76.0 6 5,6 
MPDZ Multiple PDZ domain protein  218.5 6 2 
LNX1 E3 ubiquitin-protein ligase LNX  80.6 5 5 
CSKP Peripheral plasma membrane protein CASK  105.1 4 5,6,7 
ZO-1 Tight junction protein ZO-1 193.3 1 1 
 OTHER MISCALLENOUS HITS:    
PLOD3 Procollagen-lysine,2-oxoglutarate  
5-dioxygenase 3  
84.7 22 5,6 
PLOD1 Procollagen-lysine,2-oxoglutarate  
5-dioxygenase 1  
83.5 18 5,6,7 
MYH9 Myosin-9  226.4 18 1,2,3,4,5,6,7 
MCCA Methylcrotonoyl-CoA carboxylase subunit 
alpha, mitochondrial  
80.4 11 6 
DDX5 Probable ATP-dependent RNA helicase DDX5  69.1 10 7 
TP4A3 Protein tyrosine phosphatase type IVA 3  19.5 9 1,2,3,4,5,6,7 
DTNB Dystrobrevin beta  71.3 6 7 
KU70 ATP-dependent DNA helicase 2 subunit 1  69.8 6 7 
DDX17 Probable ATP-dependent RNA helicase 
DDX17  
72.3 5 7 
HNRPQ Heterogeneous nuclear ribonucleoprotein Q  69.6 5 7 
DTNA Dystrobrevin alpha OS=Homo sapiens  83.8 4 6 
PYC Pyruvate carboxylase, mitochondrial  129.6 4 5,7 
KU86 ATP-dependent DNA helicase 2 subunit 2  82.7 4 5 
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3.3.2. Mutation in the C-terminal PDZ binding motif of 
Fz7 affects binding of PDZ domain containing 
proteins 
In order to verify data obtained in mass spectrometry and check whether replacement 
of C-terminal valine (Val574) with glycine can disrupt Fz7 binding to identified proteins, a 
series of pull-down experiments was conducted. MCF7 cells were transiently transfected 
with plasmids encoding PDZ domain containing proteins identified in the section 3.2.1. 
(Scribble, INADL, MAGI3, MAGI1, DLG1, LNX2, MPP7, SNX27 and MPP5). In additional 
experiments we also examined the interaction of Fz7 peptides with PDZ proteins that have 
been previously reported to bind Fz7 (syntenin-1, GIPC1, NHERF, GOBC, and PSD95) 
(Wawrzak et al. 2009). The interaction with syntenin-1 was examined using endogenous 
protein. Lysates of MCF7 cells expressing PDZ domain-containing proteins were incubated 
with NeutrAvidin beads conjugated with biotinylated Fz7 peptides (Fz7 WT or Fz7 V574G). 
As a control for unspecific binding of proteins to the beads lysates were incubated with 
NeutrAvidin beads without conjugated peptide.  
Pull-down assays showed that all of the tested proteins can be pulled down with Fz7 
WT peptide (lane 7) and that most of them did not bind to Fz7 V574G peptide (lane 8) 
(Figure 3.18.A). However five of the PDZ proteins (syntenin-1, SNX27, MPP5, GOPC and 
PSD95) partially retained the ability to bind Fz7 V574G peptide (lane 8), albeit their binding 
capacities were markedly diminished (lane 7, Figure 3.18.B).   
Taken together, these results revealed that the Val to Gly mutation at the C-terminus 
of Fz7 (V574G) affects the ability of the receptor for PDZ-mediated binding to all identified 
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PDZ domain-containing partners. Nonetheless, it should be noted that several proteins 
posses the ability to bind to Fz7 V574G, however with lower capacity than to Fz7 WT. In the 
next chapters, interactions between Fz7 and selected proteins of both types will be further 
investigated. 
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Figure 3. 18. Western blot confirming pull down of PDZ domain-containing proteins with 
Fz7 WT or V574G peptide.  
Interaction of Fz7 PDZ domain containing partners with Fz7 WT and Fz7 V574G peptides 
was assessed by pull down assay. The interaction with Scribble, INADL, MAGI3, MAGI1, 
DLG1, LNX2, MPP7, NHERF, GIBC1, SNX27, GOPC, MPP5 and PSD95 was analysed  
using cells transfected to express epitope-tagged proteins. The interaction with syntenin-1 
was examined using antibodies recognizing an endogenous protein. MCF7 cells were 
lysed with 1% Triton X-100 48h after transfection. Lysates were precleared and incubated 
with NeutrAvidin agarose resins with immobilized biotinylated peptides. For the control 
sample, NeutrAvidin agarose resin without peptide was used. After the pull-downs 
retained proteins were resolved by SDS-PAGE, followed by western blotting. Proteins 
were detected with epitope-specific antibodies (rabbit anti-HA pAb; rabbit anti-Myc pAb; 
rabbit anti-V5 pAb; rabbit anti-FLAG pAb; rabbit anti-GFP pAb) and with rabbit anti-
Syntenin-1 mAb. Densitometry analysis was performed on pull down blots and optical 
densities (OD) are shown for each lane. (A) Scribble, INADL, MAGI3, MAGI1, DLG1, 
LNX2, MPP7, NHERF and GIPC1 interact with the wild type, but not mutant Fz7 peptide. 
(B) Syntenin-1, SNX27, GOPC, MPP5 and PSD95 interact with Fz7 WT peptide and are 
able to retain partial binding to Fz7 V574G peptide.  
GOPC – Golgi-associated PDZ and coiled-coil motif-containing protein; GIPC1 - PDZ 
domain-containing protein GIPC1 ; NHERF – Na(+)/H(+) exchange regulatory cofactor; 
PSD95– Postsynaptic density protein 95;  
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3.3.3. Further investigation of Fz7 interaction with LNX1 
and LNX2 proteins 
3.3.3.1. Fz7 interaction with proteins from LNX family involves 
PDZ domains 
In the mass spectroscopy analysis two members of the LNX family were identified: 
LNX1 and LNX2, as potential binding partners of Fz7. These two proteins share an identical 
domain structure (RING domain and four PDZ domains), but LNX1 has two isoforms, full 
length p80 and p70, which lacks the RING domain (Wolting et al. 2011). To verify whether 
different isoforms of LNX can bind to Fz7, a pull-down assay with Fz7 WT and Fz7 V574G 
peptides was employed. HEK293T cells were transfected with GFP-LNX1 p80, GFP-LNX1 
p70 and GFP-LNX2. Non-transfected cells were used to examine binding of endogenous 
LNX2 to peptides. Due to lack of suitable antibody to detect endogenous LNX1 by western 
blot, the analysis of this protein was limited to GFP-tagged LNX1 isoforms. Collected cell 
lysates were incubated with NeutrAvidin beads with immobilized biotinylated peptides, Fz7 
WT and Fz7 V574G, but also with Fz3 and Fz8 peptides. Sequences of the two latter peptides 
represented the last 25 C-terminal amino acids of Frizzled-3 or Frizzled-8, respectively, two 
Frizzled receptors which may share some of the PDZ partners with Fz7 (Luyten et al. 2008). 
In theses experiments we compared the binding specificities of LNX proteins with that of 
syntenin-1. Proteins retained by beads were resolved in SDS-PAGE and detected using anti-
GFP, anti-LNX2 or anti-syntenin-1 antibodies. Results presented in the Figure 3.19. show that 
both isoforms of LNX1, p80 and p70, bind strongly to the Fz7 WT peptide, and weaker to the 
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Fz7 V574G peptide. Specifically, binding capacity of LNX1 p80 to Fz7 V574G peptide is more 
than three times lower than to Fz7 WT peptide, whereas of LNX1 p70 is 18 times lower. 
Neither isoform binds to Fz3 or Fz8 peptides. LNX2 binds to Fz7 WT peptide, but not to Fz7 
V574G peptide. LNX2 also binds to Fz8 with a similar capacity as to Fz7, but not to Fz3 
peptide. Finally, we observed that syntenin-1 binds to Fz7 WT, and, to certain extent, to Fz7 
V574G (with 10 times lower capacity), as already reported in previous section. Syntenin-1 
was also found to bind to Fz3, but not to Fz8 peptide. It’s binding to Fz3 peptide was, 
however, twofold lower when compared with Fz7 peptide. Taken together, LNX1, LNX2 and 
syntenin-1 have different binding capacities towards tested Frizzled peptides. 
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Figure 3. 19. Pull down assays demonstrating interactions of LNX1, LNX2 and syntenin-1 
proteins with Fz7, Fz3, and Fz8 peptides. 
The interaction of LNX1, LNX2, syntenin-1 and Fz7, Fz3 and Fz8 was assessed by pull-
down assay. HEK293T cells were lysed 24h after transfection with DNA plasmid encoding 
LNX proteins (GFP-LNX1 p80; GFP-LNX1 p70 and GFP-LNX2). Interaction with 
endogenous LNX2 and syntenin-1 was also examined. Lysates were precleared and 
incubated with NeutrAvidin agarose resins with immobilized biotinylated peptides (Fz7 
WT; Fz7 V574G; Fz3; Fz8). Peptide sequences correspond to the last 25 amino acids of the 
C-terminal cytoplasmic regions of Frizzled receptors. As a control sample, NeutrAvidin 
agarose resin without peptide was used. After the pull-downs retained proteins were 
resolved by SDS-PAGE, followed by western blotting and protein detection using rabbit 
anti-GFP pAb. rabbit anti-LNX2 pAb or rabbit anti-Syntenin-1 mAb. Densitometry 
analysis was performed on pull down blots and optical densities (OD) are shown for each 
lane. 
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The interaction between Fz7 and LNX proteins was also verified by co-
immunoprecipation using full length FLAG-Fz7 and FLAG-Fz7 V574G mutant. While very 
useful, pull-down assays, where only short peptides are used, do not always reflect the 
binding dynamics of proteins in cells. The reason for that might be the tertiary structure of 
the proteins, their complexes with other binding partners or different compartmentalization 
within the cell. In these experiments we also used the FLAG-Fz7 V574E mutant.      
HEK293T cells were co-transfected with GFP-LNX1 p80, GFP-LNX1 p70 or GFP-
LNX2 and FLAG-Fz7 WT, FLAG-Fz7 V574G or FLAG-Fz7 V574E. FLAG-Fz7 (WT, V574G 
and V574E) complexes were pulled down by the beads and proteins immunoprecipitated 
together with Fz7 were analysed by SDS-PAGE and WB. Lysates from cells transfected with 
GFP-LNX proteins, but not with Fz7, were used as control samples to visualise possible 
unspecific binding of LNX to the beads. To compare binding capacities of LNX proteins to 
Fz7 wild type and mutants, densitometry analysis was performed. Optical density (OD) was 
measured for both, LNX and Fz7, and the ratio between the two proteins was calculated for 
each sample. This allowed us to compare different samples with each other, as the amount of 
precipitated proteins may vary between them. 
GFP-LNX1 p80 isoform was not immunoprecipitated together with Fz7 (Figure 
3.20.A). It is contrary with findings from pull-down experiments. On the other hand, GFP-
LNX1 p70 isoform has been found to interact with Fz7 WT (Figure 3.20.B, lane 2). The signal 
was also detected in the immunoprecipitated prepared from cells expressing V574G (lane 3) 
and V574E mutants (lane 4), as presented in the Figure 3.20.B. Densitometry analysis 
revealed that LNX1 p70 binding to Fz7 V574G was threefold lower, and to Fz7 V574E was 
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five fold lower, when compared with binding to the wild type Fz7. Thus, as predicted, the 
V574E mutation inhibited the interaction more drastically than V574G.  
Similar analysis was performed for the LNX2 interaction with Fz7. As illustrated in 
Figure 3.20.D, LNX2 has been found to interact with Fz7 WT (lane 2), with Fz7 V574G (lane 
3) and V574E (lane 4). Densitometry analysis was performed on data obtained in three 
independent experiments and presented as a histogram: plotted are percentages of LNX2 
binding to Fz7 mutants relative to the interaction of LNX2 with the wild type Fz7 (taken as 
100%) (Figure 3.20.E). Analysis revealed that LNX2 binding to Fz7 V574G was four fold 
lower, and to Fz7 V574E was more than 16 fold lower, when compared with binding to the 
wild type Fz7. Thus, as in the case of LNX1 p70, the V574E mutation inhibited the interaction 
more drastically than V574G.   
Additionally, the interaction between Fz7 and LNX2 was verified using GFP-Trap 
system. HEK293T cells were transfected with Myc-LNX2 and GFP or GFP-Fz7 (WT, V574G 
or V574E). Lysates from these cells were incubated with GFP-Trap beads to pull down GFP-
tagged proteins. Retained proteins were resolved by the SDS-PAGE and detected by western 
blotting using anti-Myc and anti-GFP antibody (Supplementary Figure S.4.A). LNX2 has 
been found to interact with Fz7 WT (lane 2), but also with Fz7 V574G (lane 3) and V574E 
(lane 4). Densitometry analysis was performed on data obtained in three independent 
experiments and presented as a histogram: plotted are percentages of LNX2 binding to Fz7 
mutants relative to the interaction of LNX2 with the wild type Fz7 (taken as 100%) 
(Supplementary Figure S.4.B). Analysis of this experiment confirmed that LNX2 binding to 
Fz7 V574G was four fold lower, and to Fz7 V574E was more than ten fold lower, when 
compared with binding to the wild type Fz7. 
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 Taken together, pull down experiments and immunoprecipitation assays, 
demonstrated that Fz7 interacts with proteins from LNX family and that this interaction is 
mediated by PDZ domains of LNX and C-terminal PDZ binding motif of Fz7. To start 
investigating functional consequences of Fz7-LNX interactions, we decided to focus on 
LNX2. 
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Figure 3. 20. Fz7 interaction with LNX1 p70 and LNX2 involves PDZ domains. 
HEK293T cells were co-transfected with FLAG-Fz7 (WT, V574G or V574E) and GFP-LNX1 
p80 (A), GFP-LNX1 p70 (B) or GFP-LNX2 (D). 24h after transfection cells were lysed in 1% 
Triton X-100 and lysates were incubated with Anti-FLAG ® M2 Magnetic Beads. 
Immunoprecipitated  proteins were resolved by SDS-PAGE, followed by western blotting 
and protein detection using rabbit anti-GFP pAb. Shown images represent one of at least 
three independent experiments. (C and E) Densitometry analysis was performed on data 
obtained in three independent experiments and presented as a histogram: plotted are 
percentages of LNX2 binding to Fz7 mutants relative to the interaction of LNX2 with the 
wild type Fz7 (taken as 100%). The statistical significance was determined by a two-tailed, 
unpaired Student’s t test (*p<0.05; *** p<0.001).  
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3.3.3.2. Mapping of LNX2 domain that interacts with Fz7 
LNX2 contains four PDZ domains. Pull-down assays were performed to determine 
whether the interaction with Fz7 is mediated by one or more PDZ domains. HEK293T cells 
were transfected with constructs to express HA-tagged LNX2 wild type, and truncation 
mutants of LNX2, containing only the four PDZ domains (PDZ1-4), the first two domains 
(PDZ1-2) or the last two domains (PDZ3-4) of the protein. Lysates from the transfected cells 
were incubated with NeutrAvidin beads conjugated with biotinylated Fz7 peptide. Pulled 
down proteins were resolved using SDS-PAGE and detected by western blotting with anti-
HA antibody (Figure 3.21.A). Densitometry analysis was performed on the data obtained in 
two independent experiments and presented as a histogram, showing percentage of binding 
to Fz7 peptide relative to the total levels of the proteins in corresponding lysates (Figure 
3.21.B). These experiments showed that LNX2 PDZ1-4 binding to Fz7 peptide was 4 fold 
lower, LNX2 PDZ1-2 was 500 fold lower and LNX2 PDZ3-4 was 100 fold lower, when 
compared with wild type LNX2. Thus, more than one PDZ domains of LNX2 is involved in 
the interaction, as the binding affinity of the LNX2 truncation mutants to Fz7 peptide is 
significantly lower when compared to the full length protein. 
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Figure 3. 21. Interaction with Fz7 involves more than one PDZ domain of LNX2. 
(A) Schematic representation of HA-tagged LNX2 constructs. (B) HEK293T cells were 
transfected with plasmids encoding HA-tagged LNX2 WT, LNX2 PDZ1-4, LNX2 PDZ 1-2 
or LNX2 PDZ 3-4. Lysates were precleared and incubated with NeutrAvidin agarose resins 
with immobilized biotinylated Fz7 WT peptide. For the control samples, NeutrAvidin 
agarose resins without peptide were used. After the pull-downs the beads were washed 
and resuspended in 2x SDS sample-loading buffer. Retained proteins were resolved by 
SDS-PAGE, followed by western blotting and protein detection using rabbit anti-HA 
pAb. (C) Densitometry analysis of the blots, plotted as percentage of LNX2 WT binding to 
the Fz7 peptide. Data shown is an average of at least two independent experiments. The 
statistical significance was determined by a two-tailed, unpaired Student’s t-test (*p<0.05; 
**p<0.01; ***p<0.001). 
 
 
 
 
 
 
C.
100,00
25,34
0,19 0,86
0
20
40
60
80
100
120
LNX2 WT LNX2 PDZ1-4 LNX2 PDZ1-2 LNX2 PDZ3-4
%
 o
f 
b
in
d
in
g
binding to Fz7 peptide
**
***
***
*
*
  3.RESULTS AND DISCUSSION 
197 
 
3.3.3.3. Testing co-localization of Fz7 and LNX2 in SKBr3 cells   
If LNX2 interacts with Fz7, these two proteins should be present in the same cellular 
compartments. To verify whether they co-localize we performed immunofluorescence 
experiments on SKBr3 cell lines stably expressing FLAG-Fz7 WT and FLAG-Fz7 V574G. Due 
to lack of a suitable antibody to detect endogenous LNX2 by immunofluorescence, Myc-
LNX2 was used for the co-localization study. SKBr3, SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 
V574G cells were transfected with Myc-LNX2 and co-distribution of the proteins was 
analysed 48h later using rabbit anti-FLAG and mouse anti-Myc antibodies. DAPI was used 
to visualize nuclei.  
LNX2 was predominantly found in the cytoplasm but was also detected close to the 
plasma membrane in parental SKBr3 cells. In both cell lines, SKBr3-FLAG-Fz7 and FLAG-Fz7 
V574G, clear co-localization with LNX2 was observed in plasma membrane proximity 
(Figure 3.22.). These results provided a supporting evidence for the interaction between 
LNX2 and Fz7 in vivo.  
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Figure 3. 22. LNX2 co-localizes with Fz7 in SKBr3 cells. 
SKBr3, SKBr3-FLAG-Fz7 WT and SKBr3-FLAG-Fz7 V574G cells were transfected with 
Myc-LNX2 and co-distribution was analysed by confocal imaging. Cells were fixed 48h 
after transfection and stained with rabbit anti-FLAG pAb and with mouse anti-Myc mAb. 
DAPI was used to visualize nuclei. Both, Fz7 WT and Fz7 V574G co-localize with LNX2.  
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3.3.4. Discussion 
We have found in the proceeding chapters that introduction of a mutation in the C-
terminal PDZ binding motif of Frizzled-7 receptor affects canonical Wnt signalling in breast 
cancer cell lines. Subsequently, we have provided evidence that Fz7 interaction with PDZ 
protein syntenin-1 regulates functions of the receptor. Nonetheless, one could not exclude 
the possibility that other PDZ domain containing proteins are also involved in modulating 
Fz7 signalling. To identify cellular proteins that might be responsible for PDZ-BM – 
dependent regulation of the canonical Wnt pathway we were searching for novel Fz7 
binding partners. We have employed a standard pull-down assay using biotinylated 
peptides and found striking differences in an amount of proteins pulled down by Fz7 WT 
peptide and Fz7 V574G peptide (Figure 3.17). Proteins pulled down by Fz7 WT peptide, but 
not Fz7 V574G peptide, are known to be involved in receptor trafficking, as well as in 
establishment of cell polarity and tight junction formation (INADL/PATJ, MPDZ, Scribble, 
DLG1, ZO-1, ZO-2, PALS1/MPP5, MPP7, MAGI1, MAGI3, SNX27, LNX1, LNX2; Table 3.1). 
Among the identified proteins only MAGI3 and INADL/PATJ were previously reported to 
interact with Frizzled receptors. MAGI3 was shown to bind Fz4 and support non-canonical 
Wnt/JNK signalling (Yao et al. 2004), whereas INADL/PATJ interacts with dFz1 and inhibits 
Wnt/PCP signalling (Djiane et al. 2005).  
The remaining proteins are potentially novel binding partners of Fz7. The interactions 
with a number of “polarity proteins” suggest a link between Fz7 and basoapical tissue 
polarity. Basoapical polarity in the normal epithelium relies on polarity protein complexes 
and cell junction components asymmetrically localized between the apex and the base of the 
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cell (Bazzoun et al. 2013). Three conserved complexes of protein have been determined: 
Crumbs (Crumbs/PALS/PATJ) and Par (Par3/Par6/aPKC/Cdc42) which are apical, and 
Scribble (Scribble/Dlg/Lgl) which is basolateral. Polarity proteins control the establishment of 
cell junction complexes that consist of transmembrane proteins (occludin, claudin and JAM 
for tight junctions; cadherins for adherens junctions; connexins for gap junctions) associated 
with cytoplasmic proteins (ZO proteins, catenins and others). Par complex ensures the 
localization of tight junctions at the apical domain of cells. The Crumbs complex also 
regulates tight junction maintenance through its reciprocal interactions with Par proteins. 
The basolateral side of cells is characterized by the presence of both adherence and gap 
junctions. Scribble complex associates with adherence junctions to assure their segregation 
from tight junctions and to stabilize the coupling of E-cadherins with catenins, but it’s not 
certain how Scribble regulates gap junctions (Bazzoun et al. 2013).   
One needs to remember that all of the pulled-down proteins contain PDZ domains 
and some of them form complexes with each other (see below). Hence at this stage we cannot 
be certain which of the proteins is a primary binding partner of Fz7. Among the identified 
potential binding partners of Fz7 are PALS1/MPP5 and PATJ/INADL (present in the Crumbs 
complex), Scribble and DLG1 (Scribble complex), ZO-1 and ZO-2 (tight and gap junctions), 
as well as MPP7 (interacting with DLG1) and MAGI1, protein regulating cell junctions. 
PALS1 was reported as an adaptor protein facilitating interaction between Crumbs and 
PATJ, which is a scaffolding protein that regulates protein targeting and integrity of tight 
junctions (Roh et al. 2002). MPDZ (MUPP1), also identified in our proteomic screen, is a 
protein homological to PATJ, and it was shown to bind identical proteins (Assemat et al. 
2008). Scribble is a large (175 kDa) cytoplasmic multi-domain scaffold, playing various roles 
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in cells. It physically interacts with DLG proteins (Mathew et al. 2002) and with ZO-2 (Metais 
et al. 2005). As already mentioned, Scribble co-localizes with adherens junctions, thus 
interaction with ZO-2 probably takes place before ZO-2 is segregated to the tight junctions. 
Additionally, ZO-2 has been shown to bind to ZO-1, among other components of tight 
junction (Itoh et al. 1999). Scribble has been shown to regulate Ras/MAPK and JNK signalling 
pathways (Subbaiah et al. 2011), and reported to play an important role in the recycling and 
signalling of transmembrane receptor TSHR (thyroid stimulating hormone receptor) (Lahuna 
et al. 2005). Similarly to Frizzled receptors, TSHR belongs to GPCR superfamily of proteins. 
Thus it is possible that Scribble may be also be involved in Fz7 recycling.  The function of 
DLG1 protein is not clear, but it associates with APC protein (Matsumine et al. 1996) and it 
has been shown to regulate its correct subcellular localization, in a PDZ domain dependent 
fashion; however, the functional significance of this interaction remained unknown (Etienne-
Manneville et al. 2005). It also interacts with MPP2, MPP3, MPP7 and Lin7 (Assemat et al. 
2008). The interaction between DLG1 and MPP7 regulates formation of tight junction, 
whereas Lin7 stabilizes DLG1 and its distribution (Bohl et al. 2007;Stucke et al. 2007). MAGI1 
was also implicated in regulation of tight and adherens junction (Subbaiah et al. 2011). 
Furthermore it was shown to bind β-catenin (Dobrosotskaya et al. 2000) and to regulate the 
tumour suppressor, PTEN (Glaunsinger et al. 2000). Potentially it forms a trimeric β-catenin-
MAGI-PTEN complex (Kotelevets et al. 2005). Further research would be required to explore 
which of the identified proteins directly interacts with Fz7 receptor, whether they affect 
distribution of Fz7 and whether interaction with any of these proteins affect the canonical 
Wnt pathway.    
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Fz7 has been reported to be involved in regulation of planar tissue polarity, as it acts 
as a receptor in planar cell polarity (PCP) pathway, one of the non-canonical Wnt signalling 
pathways (Dijksterhuis et al. 2014). The link between basoapical and planar cell polarity 
remains poorly understood. Djiane and colleagues reported apical localization of dFz1 (a 
PCP receptor) in Drosophila epithelial cells and its direct interaction with dPatj, a component 
of the Crumbs complex. The authors proposed that dFz1-dPatj interaction leads to aPKC 
recruitment and subsequent phosphorylation and inhibition of Fz1/PCP signalling (Djiane et 
al. 2005). Since Fz7 is also involved in PCP signal transduction, there is possibility that one 
the polarity proteins regulates its basoapical localization in cells. Additionally, Scribble has 
been implicated in PCP establishment in the Drosophila eye and wing, by interaction with 
Stbm/Vang complex (Courbard et al. 2009). Interestingly, Frizzled receptors have also been 
implicated to interact with Stbm/Vang during PCP signalling (Wu et al. 2008).  
Loss of basoapical cell polarity is a hallmark of the epithelial-to-mesenchymal 
transition (EMT), a process in which cells become more spindle-shaped, mobile and acquire 
stemlike characteristics. Interestingly, the role of Wnt signalling in promotion of EMT has 
been established in various human cancers, e.g. HCC, prostate and breast cancer (Talbot et 
al. 2012). Indeed, Scribble was reported to regulate EMT through modulation of the MAPK-
ERK signalling (Elsum et al. 2013). Thus a potential Scribble-Fz7 interaction might play role 
in the process. 
Another protein identified in the proteomics screen was SNX27 (sorting nexin-27). 
It functions as an endosome-associated cargo adaptor. It interacts with transmembrane 
proteins containing NPxY motif through its C-terminal FERM-like domain, or PDZ-BM (S/T-
x-φ) through the PDZ domain (Lauffer et al. 2010). SNX27 forms a complex with retromer, a 
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heterotrimer composed of VPS26, VPS29 and VPS35, and regulates recycling of cargo-
proteins from endosomes to plasma membrane (Temkin et al. 2011). Interestingly, VPS26A 
binding to SNX27 increases the affinity of the PDZ domain of the protein to the ligands, 
implying cooperativity in cargo selection (Gallon et al. 2014). SNX27-retromer complex in 
involved in regulation of trafficking of β2-adrenergic receptor, ionotrophic glutamate 
receptors (NMDA and AMPA receptors) (Loo et al. 2014), potassium channels (Balana et al. 
2011), somatostatin receptor (Bauch et al. 2014) and the glucose transporter (Steinberg et al. 
2013). Recent proteomics analysis also identified Fz1 and Fz2 among more than 80 
transmembrane proteins that can bind to SNX27 (Steinberg et al. 2013). Taking it all into 
account, it is possible that SNX27-retromer regulates Fz7 recycling from endosomes to 
plasma membrane. Further research is necessary to explore the nature of Fz7-SNX27 
interaction. 
Finally, we have also identified two proteins from the LNX family. Ligand of Numb 
Protein X (LNX) family contains proteins described as E3 ubiquitin ligases, characterized by 
the presence a RING domain (see Introduction for more details). Our proteomics analysis 
revealed that two members of the LNX family: LNX1 and LNX2, are potential binding 
partners of Fz7. These two proteins share an identical domain structure (RING domain and 
four PDZ domains), with LNX1 having two isoforms, a full length p80 and p70 which lacks 
the RING domain (Wolting et al. 2011). Interestingly, phylogenetic analysis revealed that 
LNX1/2 share a common ancestor with two other proteins, also identified in the proteomic 
screen: MPDZ/MUPP1 and INADL/PATJ. LNX1/2 have been also shown to associate with 
tight junction proteins JAM4, claudin-1 and CAR, and the later two also interact with 
MUPP1 (Flynn et al. 2011). Recently, several reports have suggested the role of LNX proteins 
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in regulation of Wnt signalling. LNX1 was shown to bind to Wnt signalling regulators 
Naked2 (Nkd2) and Dishevelled-3 (Dvl3) (Wolting et al. 2011). LNX2b (an LNX zebrafish 
ortholog) has been shown to bind and ubiquitylate the Wnt inhibitor Bozozok and in 
consequence upregulate the β-catenin Wnt signalling (Ro et al. 2009). Finally, siRNA-
mediated silencing of LNX2 reduces Wnt signalling in colorectal cancer cells through 
downregulation of TCF7L2 (Camps et al. 2013). For that reason we have decided to further 
explore the nature of the interaction between Fz7 and LNX.  
To verify whether different isoforms of LNX can bind to Fz7, a pull-down assay with 
Fz7 peptides was employed (Figure 3.19). Both isoforms of LNX1, p80 and p70, bind strongly 
to the Fz7 WT peptide but not to the peptides corresponding to the C-terminal cytoplasmic  
tails of Fz3 or Fz8. On the other hand LNX2 binds to both Fz7 WT and Fz8 peptides (but not 
to Fz3 peptide). The observed binding specificity of LNX1 and LNX2 supports distinct 
binding properties of LNX PDZ domains (Guo et al. 2012) and suggests non-redundant 
functions of these enzymes in Frizzled-dependent pathways. In other experiments we found 
that syntenin-1 binds to Fz7 and Fz3, but not to Fz8 peptide. While our observation on 
syntenin-1 binding to Fz7 and Fz3 is in agreement with the report by Luyten and colleagues 
(2008), were unable to confirm their finding on the syntenin-1 – Fz8 interaction. Although the 
reasons behind these differences remain unknown, one the possible explanation may be 
difference in the experimental protocols used by us (peptide-based pull down from cellular 
lysates) and these authors (interaction between recombinant syntenin-1 and the peptide) 
(Luyten et al. 2008). 
Pull-down assays with peptides do not always reflect the binding dynamics of 
proteins in living cells. Accordingly, we have used co-immunoprecipitation assay to further 
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verify the interactions. We have established that LNX1 p70 and LNX2 bind to the full length 
Fz7, however p80 isoform of LNX1 does not. It might be due to the tertiary structure of the 
proteins, their complexes with another binding partners or different compartmentalization 
within the cell. Importantly, in the immunoprecipitation experiments we confirmed that 
LNX-Fz7 interactions are mediated through PDZ domain interactions. Furthermore, our 
results indicate that more than one PDZ domains of LNX2 is involved in these interactions 
(Figure 3.21). In this regard, several other proteins has also been shown to bind two PDZ 
domain of LNX ligases, e.g. PLEKH5 (PDZ1 and PDZ3), or PAK6 and PKC-α1 (PDZ2 and 
PDZ4) (Wolting et al. 2011).  
Taken together, work presented in this chapter included identification of novel 
binding partners of Fz7 by mass spectrometry. To our knowledge, it’s the first systematic 
proteomic screen in search of cytoplasmic proteins interacting with Fz7. Among identified 
interactors we have found a number of PDZ proteins forming polarity complexes, thus 
suggesting the involvement of Fz7 in establishment or disruption of basoapical cell polarity. 
We have also identified several proteins, previously reported to be involved in trafficking of 
membrane receptors, to associate with Fz7, such as SNX27, Scribble, DLG1, MAGI3. They 
might be novel regulators of Fz7 recycling. Finally, two proteins from LNX family, LNX1 and 
LNX2, were also recognized to associate with Fz7 in PDZ domain dependent fashion. 
Further analysis confirmed interaction between full length Fz7 and LNX2 in epithelial cells, 
as well their colocalization in plasma membrane proximity. The functional significance of 
this interaction will be explored in the next section. 
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3.4. Investigating the role of the Fz7 interaction with 
proteins from LNX family 
We have established that Fz7 interacts with LNX1 and LNX2. Whilst previous studies 
have reported a functional connection between Wnt signalling and LNX proteins (Camps et 
al. 2013;Ro et al. 2009), to date, no investigation has identified a link between LNX and a 
specific Frizzled receptor or determined a mechanism explaining how LNX is involved in 
regulating Wnt signalling. The aim of the work described in this chapter was to assess 
whether Fz7 functions are regulated by LNX proteins.  
 
3.4.1. LNX1 and LNX2 modulate Fz7 ubiquitylation. 
3.4.1.1. LNX1 p80, LNX1 p70 and LNX2 overexpression decreases 
Fz7 ubiquitylation level 
In order to verify whether Fz7 is an ubiquitylation substrate of LNX1 or LNX2, an in 
vivo ubiquitylation assay was performed, as described in Materials and Methods (section 
2.5.2.). HEK293T cells were transfected with plasmids encoding GFP-LNX1 p80, GFP-LNX1 
p70, GFP-LNX2 or GFP, together with FLAG-Fz7 and HA-ubiquitin. 24h post transfection, 
cells were lysed and Fz7 was immunoprecipitated using anti-FLAG magnetic beads. Protein 
ubiquitylation was analysed by SDS-PAGE and WB using anti-HA pAb (Figure 3.23). Fz7 
ubiquitylation was detected as a smear in the anti-FLAG immunoprecipitate by anti-HA 
antibodies, indicating protein polyubiquitylation. Interestingly, the amounts of ubiquitylated 
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protein species in Fz-immunoprecipitates were consistently lower than in the control 
samples. Specifically, densitometry analysis revealed that the levels of ubiquitylated Fz7 
were decreased by 50% when both isoforms of LNX1 or LNX2 proteins were overexpressed. 
Whilst these experiments involved incubation of samples at 60°C to ease Fz7 detection by 
western blotting, additional test with samples incubated at 100°C before SDS-PAGE analysis 
confirmed the decreased ubiquitylation level of Fz7 after LNX overexpression (data not 
shown). 
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Figure 3. 23. LNX1 and LNX2 decrease the levels of Fz7 ubiquitylation. 
(A) HEK293T cells were co-transfected with GFP-LNX1 p80, GFP-LNX1 p70, GFP-LNX2 or 
GFP, FLAG-Fz7 WT and HA-Ubiquitin. Subsequently cells were lysed in the lysis buffer 
containing 0.5% SDS, incubated at 60°C, diluted with 1% Triton X-100 and sonicated.  
Subsequently lysates were incubated with Anti-FLAG®M2 Magnetic Beads and to pull-
down FLAG-Fz7. Ubiquitylated proteins were detected by immunoblotting with anti-HA 
antibody. Images depict representatives of at least three independent experiments. (B) 
Densitometry analysis of the blots. Data shown is an average of at least three independent 
experiments. Ratios between densitometry values (optical density, OD) of 
immunoprecipitated HA-ubiquitin and Fz7 were calculated for each sample and presented 
in the histogram. This allowed to compare different samples with each other, as the 
amount of precipitated proteins may vary between them. Ubiquitylation values of Fz7 
were standardized to the value of the control sample (Fz7 co-transfected with GFP, lane 4). 
The statistical significance was determined by a two-tailed, unpaired Student’s t-test 
(*p<0.05). 
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3.4.1.2. LNX2 modulation of Fz7 ubiquitination does not involve 
proteasomal degradation of the receptor 
In the previous section, decreased levels of Fz7 ubiquitylation were observed in 
response to LNX1 and LNX2 overexpression. LNX proteins may regulate Fz7 ubiquitylation 
and expression levels through a mechanism involving proteasome dependent protein 
degradation. To address this question, we carried out in vivo ubiquitylation experiments in 
the presence of MG132, a widely used proteasome inhibitor. HEK293T were co-transfected 
with FLAG-Fz7, HA-ubiquitin and GFP-LNX2 or GFP. Cells were then treated with 10 μM 
MG132 or the vehicle (DMSO) for 24h. Subsequently, they were lysed, and Fz7 complexes 
were immunoprecipitated using anti-FLAG beads (as described in the section 2.5.2. of 
Materials and Methods). Protein ubiquitylation was analysed by WB using anti-HA pAb for 
detecting HA-ubiquitin (Figure 3.24).  
As expected, MG132 treatment increased the overall levels of protein ubiquitylation 
in cells. Furthermore, the treatment with MG132 increased the levels of Fz7 ubiquitylation by 
70% in control cells. LNX2 expression led to a reduction inFz7 ubiquitylation in the absence 
(lane 1) and in the presence (lane 3) of the proteasome inhibitor MG132. Densitometry 
analysis revealed that ubiquitylation of Fz7 cells expressing LNX2 was two fold lower 
(treated with the vehicle) or three fold lower (treated with MG132), when compared to the 
control samples. These findings suggest that the level of Fz7 ubiquitylation is decreased in 
cells overexpressing LNX2. However, a decrease in the overall levels of ubiquitylation of 
cellular proteins was also observed in cells overexpressing LNX2. The mechanism of 
observed alterations do not seem to involve proteasome-dependent degradation. Finally, we 
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have also noticed that the total level of LNX2 is increased in MG132-treated cells, suggesting 
that LNX2 expression level is controlled by proteasomal degradation.  
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Figure 3.24. LNX2 decrease the level of Fz7 ubiquitylation in the presence of the 
proteasome inhibitor MG132. 
HEK293T cells were co-transfected with GFP-LNX2 (or GFP), FLAG-Fz7 WT and HA-
Ubiquitin. Cells were subsequently treated with the proteasome inhibitor MG132 (10 μM) 
or DMSO for 24h. Subsequently cells were lysed in 0.5% SDS lysis buffer, incubated at 
60°C, diluted in 1% Triton X-100 and sonicated. Lysates were subsequently incubated with 
Anti-FLAG®M2 Magnetic Beads to pull-down FLAG-Fz7, followed by detection of 
ubiquitylation of Fz7 by immunoblotting with anti-HA antibody. Images depict a 
representative of three independent experiments. (B) Densitometry analysis of the blots. 
Optical density (OD) was measured for both, HA-ubiquitin and Fz7. Ratios between 
densitometry values of immunoprecipitated HA-Ubiquitin and Fz7 were calculated for 
each sample and presented in the histogram. Ubiquitylation values of Fz7 were 
standardized to the value of the control sample (Fz7 co-transfected with GFP and not 
treated with MG132, lane 2). Data shown is an average of at least three independent 
experiments. The statistical significance was determined by a two-tailed, unpaired 
Student’s t-test (**p<0.01).  
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3.4.1.3. Mutations in PDZ-BM of Fz7 lead to increased 
ubiquitylation of the receptor 
Given that the interaction of Fz7 with LNX2 involves PDZ domains of the latter and 
mutations in the C-terminal binding motif of Fz7 inhibit this interaction (section 3.2.3.1.), 
ubiquitylation of the Fz7 V574G mutant was also examined. The influence of LNX2 on the 
Fz7 mutant was tested by in vivo ubiquitylation assay as described above. These analyses 
revealed that the Fz7 V574G mutant is ubiquitylated to higher levels than Fz7 WT,  
compared to samples transfected with GFP only (Figure 3.25.). Ubiquitylation of Fz7 V574G 
(lane 4) mutant was more than two fold higher, than that of the Fz7 WT (lane 2). Introduction 
of LNX2 into the cells decreased ubiquitylation of both Fz7 WT and Fz7 V574G mutant. 
However, the LNX2-induced changes in ubiquitylation levels of Fz7 V574G were not as 
pronounced as they were in the case of Fz7 WT. The levels of ubiquitylation  of Fz7 WT was 
reduced by 50%, and Fz7 V574G by 40% when transfected with LNX2, though there was 
higher experimental variation in case of the latter. The analysis of several experiments 
showed a trend, although the data did not reach statistical significance. These experiments 
suggest that modulation of Fz7 ubiquitylation by LNX2, might be partially dependent on a 
direct interaction between these two proteins.  
 
  3.RESULTS AND DISCUSSION 
216 
 
 
1   2     3    4    
LysatesIP:FLAG
WB: HA-Ubiquitin
WB: FLAG-Fz7
WB: GFP-LNX2
WB: GFP
WB: β-Actin
+    - +    - +    - +     -
5      6    7   8     
72
55
35
40
100
130
170
72
55
100
130
35
kDa
Fz
7
Fz
7 
V
57
4G
Fz
7
Fz
7 
V
57
4G
LNX2
A.
40
  3.RESULTS AND DISCUSSION 
217 
 
 
Figure 3.25. LNX2 decreases the levels of Fz7 ubiquitylation with mutation introduced in 
the PDZ binding motif. 
(A) HEK293T cells were co-transfected with GFP-LNX2 or GFP, FLAG-Fz7 (WT or V574G)  
and HA-Ubiquitin. Subsequently cells were lysed in 0.5% SDS lysis buffer, incubated at 
60°C, diluted with 1% Triton X-100 and sonicated. Lysates were incubated with Anti-
FLAG®M2 Magnetic Beads, to pull-down FLAG-Fz7, followed by detection of 
ubiquitylation of Fz7 by immunoblotting with anti-HA antibody. Images depict a 
representative of three independent experiments. (B) Densitometry analysis of the blots. 
Optical density (OD) was measured for both, HA-ubiquitin and Fz7. Ratios between 
densitometry values of immunoprecipitated HA-ubiquitin and Fz7 were calculated for 
each sample and presented in the histogram. Ubiquitylation values of Fz7 were 
standardized to the value of the control sample (Fz7 WT co-transfected with GFP, lane 2). 
Data shown is an average of three independent experiments. The statistical significance 
was determined by a two-tailed, unpaired Student’s t-test (**p<0.01).  
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3.4.2. LNX2 depletion does not alter Fz7 expression   
Given the involvement of LNX2 in Fz7 ubiquitylation, it was important to assess 
whether knock-down of the enzyme would also influence the levels of expression and the 
intracellular distribution of the receptor. SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cells 
were transfected with siRNA against LNX2 or with control siNeg. 24h later cells were 
stimulated with Wnt3a conditioned medium or with control conditioned medium. 
Subsequent analyses were carried out 48h post  transfection. The efficiency of LNX2 knock-
down was shown to be  ~90% in cells transfected with siLNX2compared to control cells. The 
analysis of Fz7 expression in whole cell lysates (using anti-FLAG pAb), showed an increase 
in the total expression level of Fz7 WT in non-stimulated LNX2-depleted cells; the expression 
level was decreased in these cells after stimulation with Wnt3a. By contrast, no changes were 
observed in Fz7 V574G expression (Figure 3.26.A). In parallel flow cytometry experiments, 
we found that depletion of LNX2 did not affect surface expression of surface expression of 
either Fz7 WT or Fz7 V574G proteins as assessed by staining with anti-FLAG mAb (Figure 
3.26.B). Finally, no apparent alterations in the receptor localization were observed in cells 
with transfected with siRNA that target LNX2.   
Taken together, apart from the observation that under basal conditions Fz7 WT 
expression is increased in LNX2-depleted cells, the analysis of total and membrane of Fz7, 
WT and V574G, as well as examination of receptor cell localization by immunofluorescence 
didn’t indicate that LNX2 knock-down influence major changes in Fz7 expression in SKBr3 
cells.  
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Figure 3.26. LNX2 depletion does not change Fz7 membrane expression or cell 
distribution.  
SKBr3-FLAG-Fz7 and SKBr3-FLAG-Fz7 V574G cells were transfected with siRNA against 
LNX2 or with control siNeg. 24h later cells were stimulated with Wnt3a conditioned 
medium or with control conditioned medium. 48h after the transfection cell lysates were 
collected and analysed by SDS-PAGE and WB, flow cytometry and immunofluorescence. 
(A) Lysates of equal protein concentrations (2 μg/μl) were resolved on SDS-PAGE, 
followed by western blotting with Anti-FLAG pAb to examined Fz7 expression level, anti-
LNX2 pAb to monitor LNX2 knock-down level. β-actin served as a loading control. (B) 
Flow cytometry with anti-FLAG mAb was used to examine membrane expression of Fz7. 
Cells were incubated on ice for 1h with mouse anti-FLAG (M2) mAb. 4C5G monoclonal 
antibody against phosphatidylinositol 4-kinase was used as an isotype control. Cell 
surface staining of FLAG-Fz7 (WT or V574G) was revealed by flow cytometry following 
incubation for 1h on ice with anti-mouse FITC-conjugated secondary antibodies. Data 
analysis was carried out using FlowJo analysis software. The values of calculated mean 
fluorescence are presented in top-right corner of the plots. (C-D) Fz7 WT (C) and V574G 
(D) cell distribution was analysed by confocal imaging. Cells were fixed and stained with 
mouse anti-FLAG (M2) mAb and Alexa Fluor 488-conjugated goat-anti mouse Ab (green). 
DAPI was used to visualize nuclei. 
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3.4.3. LNX2 is involved in regulation of canonical Wnt 
signalling pathway in epithelial breast cancer cells 
3.4.3.1. LNX2 depletion attenuates canonical Wnt pathway in 
SKBr3 cell line 
Fz7 is a membrane receptor involved in Wnt signalling. LNX2 has been shown to 
interact with Fz7 in a PDZ dependent manner (section 3.2.3). Given that Fz7 signalling is 
regulated by interactions via its C-terminal PDZ-BM (section 3.1.5.2.), the role of LNX2 in 
canonical Wnt pathway signalling was examined. Activation of the pathway was assessed in 
SKBr3 epithelial breast cancer cell line stably expressing FLAG-Fz7 wild type or FLAG-Fz7 
V574G mutant, after LNX2 depletion, using the TOP-Flash reporter assay. SKBr3 cells were 
transfected with the siRNA targeting LNX2, or with a control siNegative. On the following 
day, cells were stimulated with Fz7 ligand, Wnt3a, and 24h later, TOPFlash activity was 
assessed, as described in section 2.5.1 of Materials and Methods. The β-catenin reporter 
activity was compared in cells with and without LNX2 knock-down (Figure 3.27.). Western 
blot analysis confirmed the efficiency of LNX2 knockdown (lanes 3, 4, 7 and 8), as the protein 
expression level was more than 90% lower, when compared with the control samples (lanes 
1, 2, 5 and 6). These experiments showed that LNX2 depletion attenuates activation of Wnt 
signalling in cells expressing wild type Fz7. Cells with LNX2 knockdown were characterized 
by 50% lower reporter activity, when compared with control cells. On the other hand, LNX2 
depletion did not alter Wnt signalling in SKBr3 cells expressing the Fz7 V574G mutant. 
  3.RESULTS AND DISCUSSION 
224 
 
Examination of the levels of total β-catenin by western blotting showed that the degree of the 
protein stabilization in cells corresponds to the TOP-Flash results.  
Taken together, LNX2 depletion attenuates canonical Wnt signalling in SKBr3 cells 
expressing wild type Fz7, but not Fz7 V574G mutant. 
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Figure 3.27. LNX2 depletion attenuates canonical Wnt signalling in SKBr3 cells expressing 
Fz7 WT. 
(A) Wnt-induced signalling was analysed using TOP-Flash luciferase assay. SKBr3-FLAG-
Fz7 and SKBr3-FLAG-Fz7 V574G cells were transfected with siRNA against LNX2 or 
control siNeg. Cells were stimulated for 24h with Wnt3a conditioned medium and 
TOP/FOP activity was analysed 48h after transfection with reporter plasmids. Tests were 
done in triplicates and three independent experiments were performed. Statistical 
significance was determined by two-tailed, unpaired Student’s t-test (*p<0.05). (B) Cellular 
lysates obtained in the assay were examined in SDS-PAGE and WB, with anti-LNX2 pAb, 
anti-β-catenin mAb, anti-FLAG pAb and anti-β-actin mAb. Image present a representative  
of three independent experiments. Densitometry analysis was performed on LNX2 and β-
catenin immunoreactive bands. Optical densities (OD), standardized to β-actin, are shown 
for each lane. 
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3.4.3.2. LNX2 regulates canonical Wnt signalling through its 
interaction with Fz7 
Our results suggest that the direct interaction of LNX2 with Fz7 may regulate 
canonical Wnt signalling. However, one can’t exclude a possibility that LNX2 also interferes 
with Wnt pathway downstream of Fz7 receptor, or affects alternative pathways which 
impinge on the canonical Wnt pathway (see Introduction). To address this issue, we 
compared activation of the canonical Wnt pathway in LNX2-depleted cells either stimulated 
with Wnt3a, or treated with the GSK3 inhibitor (SB216763), which induced Wnt signalling 
downstream of the receptor. SKBr3-FLAG-Fz7 cells were transfected with siLNX2 or siNeg 
and incubated with Wnt3a conditioned medium or control medium. In parallel, cells 
transfected with siRNA were treated with 10 μM GSK3i or DMSO. Wnt activation was 
quantified by the TOP-Flash reporter assay 24h later and presented in the Figure 3.28.A. 
Analysis of the reporter assay showed that LNX2 depletion only downregulates Wnt 
pathway when cells are stimulated with Wnt3a ligand and not with GSK3i. That result 
provides an additional evidence for LNX2-mediated regulation of canonical Wnt signalling 
pathway occurs upstream of GSK3. 
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Figure 3. 28. LNX2 regulates canonical Wnt signalling upstream of GSK3. 
(A) Wnt-induced signalling was analysed using TOP-Flash luciferase assay. SKBr3-FLAG-
Fz7 cells were transfected with siRNA against LNX2 or control siNegative. Cell were 
stimulated for 24h with Wnt3a conditioned medium or with 10 μM GSK3i (SB216763) and 
TOP/FOP activity was analysed 48h after transfection with reporter plasmids. Test was 
done in triplicates and three independent experiments were performed. Statistical 
significance was determined by two-tailed, unpaired Student’s t-test (*p<0.05). (B) Cellular 
lysates obtained in the assay were examined in SDS-PAGE and WB, with anti-LNX2 pAb 
and anti--actin mAb. Image presents a representative of three independent experiments. 
Densitometry analysis was performed on LNX2 and immunoreactive bands. Optical 
densities (OD), standardized to -actin, are shown for each lane.  
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3.4.4. Discussion 
 The work described in the proceeding chapter demonstrate that the E3 ubiquitin 
ligases: LNX1 and LNX2 are novel binding partners of Fz7. Surprisingly, in vivo 
ubiquitylation experiments demonstrated that overexpression of LNX proteins (LNX1p80, 
LNX1p70 and LNX2), led to an overall decrease  in the levels of ubiquitylatied cellular 
proteins (i.e. in total protein lysates), as well asa decrease in the levels of Fz7 ubiquitylation 
compared to control samples. It is important to consider that due to the conditions used in 
the protocol (incubation of samples for 10 minutes at 60°C before loading on SDS-PAGE gel), 
it is possible that  the anti-HA signals (HA-ubiquitin) observed in the anti-FLAG 
immunoprecipitate may constitute HA-ubiquitin tagged proteins found in a complex with 
Fz7. Given that the interaction of Fz7 with LNX2 involves the PDZ domains of the latter, the 
ubiquitylation of the Fz7 V574G mutant was also investigated (Figure 3.25). Basal 
ubiquitylation of Fz7 V574G was found to be higher than that of  Fz7 WT, which identifies a 
contribution of the Fz7 PDZ-BM in receptor ubiquitylation. Thus, our data seem to indicate 
that Fz7 is not directly ubiquitylated by LNX proteins, which, in fact, function as negative 
regulators of ubiquitylation. Although the molecular mechanism(s) underlying this 
phenomenon remains to be explored, there are several possibilities which may be 
considered. Firstly, LNX proteins might sterically impede interactions of Fz7 with other 
ubiquitin ligases. So far, the only identified E3 ubiquitin ligases of Frizzled receptors are two 
transmembrane proteins ZNRF3 (zinc and ring finger 3) and RNF43 (ring finger 43), detected 
in LGR5 crypt stem cells and colon cancer (Hao et al. 2012;Koo et al. 2012). Both have been 
reported to regulate the stability and cell-surface expression of Frizzled receptors (Fz5 and 
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Fz8) via multiubiquitylation and subsequent targeting for lysosomal degradation. Whether 
Fz7 is also targeted by ZNRF3 and RNF43 and the structural requirements for specific 
targeting of Fz receptors by these E3 ligases remain unknown. Another possibility is that 
different, as yet unidentified, E3 ubiquitin ligase(s) of Fz7 bind to the receptor indirectly via 
another PDZ partner. In this scenario, overexpressed LNX would out compete the alternative 
PDZ partners in cells, leading to decreased ubiquitylation of Fz7. Thirdly, one might 
hypothesise that LNX itself interacts and regulates the activity of an E3 ubiquitin ligase 
targeting Fz7. To elucidate the mechanism of LNX2 dependent regulation of protein 
ubiquitylation further experiments are required. Since it is possible that LNX proteins may 
target other regulators of the ubiquitylation process in cells, it should be assessed whether 
the E3 ligase activity of LNX2 contributes to the observed decrease of protein ubiquitylation. 
Introduction of LNX2 with an inactivating mutation in the RING domain in cells expressing 
Fz7 might be used for this purpose. Employing the novel CRISPR/Cas9 technology would 
allow to replace endogenous LNX2 with the mutant and should be followed by testing the 
ubiquitylation of proteins in vivo.  Fz7 ubiquitylation should also be assessed in cells with 
LNX1 and LNX2 depletion. Additionally mutations can be introduced in PDZ domains of 
LNX2 to verify whether such disruption of binding to Fz7 would affect ubiquitylation of the 
receptor. 
 Our data appear to indicate that LNX2 modulates Fz7 expression. We have 
consistently observed that in LNX2-overexpressing cells, the total levels of Fz7 is lower than 
in  control cells. Furthermore, expression of Fz7 V574G mutant, which displays a reduced 
capacity to bind to PDZ proteins, seems to be less susceptible to the effects of LNX2. In 
agreement with this observation, LNX2 depletion increases the total expression of Fz7 WT, 
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but not Fz7 V574G, under basal conditions. At the same time, Fz7 cell surface expression and 
subcellular localization remains unchanged. It might be possible that LNX2 regulates 
stability of the receptor by affecting its endocytic trafficking.  Recently, Sewduth and 
colleagues have shown that LNX3/PDZRN3 in endothelial cells ubiquitylates Dvl3 to 
promote endocytosis of the Fz4/Dvl3 complex, for activation of PCP signalling pathway 
(Sewduth et al. 2014). However, the proposed mechanisms are unlikely to be similar to the 
LNX2-dependent regulation of Fz7. The study reports that it is the interaction between LNX3 
and PDZ domain of Dvl that is required for recruitment of LNX3 to the Fz4 complex. 
Interestingly, Dvl3 has been also identified as a binding partner of LNX1 in a proteomic 
screen presented in (Wolting et al. 2011). Performing biotinalytion assay on Fz7 expressing 
cells, when LNX2 is overexpressed or depleted, would provide further evidence whether this 
protein is (or is not) involved in regulation of Fz7 cell surface expression. Futhermore, 
assessing Fz7 expression and trafficking using bafilomycin A1, would allow LNX2 plays role 
in lysosome-dependent degradation of the receptor. 
Finally, LNX2 role in regulation of the canonical Wnt signalling was examined. We 
have established that LNX2 is a novel regulator of Fz7 signalling in breast cancer cells. 
Importantly, the contribution of LNX2 to catenin signalling was not observed in cells 
expressing Fz7 V574G thus further emphasising the importance of the C-terminal PDZ-BM 
in the canonical Wnt pathway. It was previously reported that siRNA-mediated silencing of 
LNX2 downregulates Wnt signalling in colorectal cancer cells (Camps et al. 2013). Our data 
obtained in breast cancer are in agreement with this report. Whilst, Camps and colleagues 
have not determined what is the mechanism of Wnt signalling regulation by LNX2, our 
results strongly indicate that the direct interaction of LNX2 with Fz7 receptor is an important 
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factor. It is also possible that LNX2 interacts with other proteins that form complex with Fz7, 
for example Dishevelled. As already mention, one of the Dishevelled isoforms, Dvl3, has 
been found to interact with LNX1 and LNX3 (Sewduth et al. 2014;Wolting et al. 2011). 
Although the authors haven’t reported a role of those proteins in canonical Wnt signalling.  
In summary, in this chapter we have reported LNX2 as a novel regulator of Fz7-
dependent canonical Wnt signalling in breast cancer cells. We have found out that LNX2  
plays role in regulation of Fz7 ubiquitylation and expression level, which might be 
responsible for the modulation of the receptor signalling. It was proposed previously that the 
expression level of Frizzled receptor correlates with Wnt responsiveness, is controlled by the 
interplay between E3 ubiquitin ligase and an deubiquitylating enzyme (Mukai et al. 2010). 
However further study is required to elucidated the exact mechanisms underlying the role of 
LNX2 in Fz7 functions. 
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4. GENERAL DISCUSSION AND 
FUTURE WORK 
 
Activation of Wnt signalling, as evidenced by nuclear localisation of β-catenin, has 
been previously observed in human breast cancer (Lin at al. 2000; Lopez-Knowles et al. 
2010). However, unlike colorectal cancer, this is not a consequence of mutations in APC or 
catenin (Candidus et al. 1996;Sorlie et al. 1998), but instead deregulation frequently occurs 
through epigenetic modulation of key target genes (Klarmann et al. 2008;Suzuki et al. 2008). 
Frizzled-7 seems to be one of the most important Wnt receptors involved in breast cancer. Its 
expression is characteristic for triple-negative breast cancer (TNBC) and TNBC-derived cell 
lines, where it activates the β-catenin/Wnt pathway and plays a crucial role in regulation of 
cell proliferation (Yang et al. 2011). PDZ domain-containing proteins are often involved in 
regulation of cell signalling. Indeed, several of them have been implicated in Wnt signalling. 
The aim of our study was to determine the role of PDZ domain-containing proteins in 
modulating Frizzled-7 signalling and its trafficking pathways, in the context of epithelial 
breast cancer cells. Obtained data demonstrate the importance of the C-terminal PDZ-BM of 
Frizzled receptors in canonical Wnt signalling. Focusing on syntenin-1 and LNX2, we 
reported them as novel regulators of Frizzled-7 and Wnt signalling. Finally, we have also 
laid out a strong platform for future investigations by identifying novel binding partners of 
Frizzled-7. 
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Firstly, we have demonstrated, for the first time, the importance of the C-terminal 
PDZ-BM of Frizzled-7 for the correct functioning of the receptor. Our findings illustrate that 
Frizzled-7 interactions mediated by the C-terminal PDZ binding motif are crucial for 
regulation of trafficking and signalling of the receptor. Investigation of these processes in 
more detail and, particularly, the contribution of the newly identified Fz7 partners will 
certainly be merited in the future. Our data seem to suggest that mutation introduced in C-
terminal PDZ binding site alters Fz7 maturation process, demonstrated by changes in ratio 
between expression levels of two monomers with different degree of glycosylation. The 
detailed mechanism of the receptor maturation and the role of Fz7 glycosylation in signalling 
have not been addressed widely in the past. Thus it would be important to further explore 
the involvement of PDZ proteins in the process. So far, the only known regulator of Fz7 
glycosylation is Shisa, protein localized in the ER (Yamamoto et al. 2005). However, since it 
does not contain a PDZ domain, its interaction with Frizzled-7 does not explain observed 
changes occurring after introduction of mutations into PDZ-BM of the receptor. Thus, it is 
likely that other mechanisms are involved. 
Secondly, our findings clearly indicate the involvement of syntenin-1 in the 
modulation of Fz7 signalling in the canonical Wnt pathway and in the trafficking of the 
receptor. Syntenin-1 was reported as an adaptor for a number of transmembrane proteins 
(Beekman et al. 2008), thus it may act as a platform for bringing other proteins into the 
complex with Fz7. Among those proteins syndecans and tetraspanins are of a particular 
interest, given their well-established role as modulators of signalling and trafficking. 
Furthermore, syntenin-1, in complex with syndecans and ALIX, was shown to recruit 
syndecan-associated proteins to multivesicular endosomes and exosomes (Baietti et al. 2012). 
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This might explain Fz7 redistribution from plasma membrane in cells overexpressing 
syntenin-1. However syndecans, similarly like Fz7, were shown to bind preferentially to 
PDZ2 of syntenin-1, even though both PDZ domains seem to be essential for the association 
(Grootjans et al. 2000). Therefore, they might compete with Fz7 for binding to syntenin-1. On 
the other hand, tetraspanin CD63 binds syntenin-1 via PDZ1 (Latysheva et al. 2006). CD63 is 
a transmembrane protein present in plasma membrane, but also in lysosomes and late 
endosomes. It is enriched on the intraluminal vesicles, which are secreted as exosomes. 
Additionally CD63 is implicated to function as a regulator of a transport of its interacting 
partners (Pols et al. 2009). Thus it may contribute to the receptor trafficking by forming a 
tripartite complex with Fz7 and syntenin-1. Another possibility may involve syntenin-1 
ability to link transmembrane proteins to ubiquitylated proteins. Ubiquitin binding seems to 
be an important factor controlling syntenin-1 relocalization to late endocytic compartments 
(Rajesh et al. 2011). To verify whether Fz7 redistribution depends on syntenin-1 interaction 
with ubiquitin, one may analyze receptor localization in syntenin-depleted cells and 
reconstituted with various syntenin-1 mutants, unable to bind ubiquitin. Interestingly, 
ubiquitin binding involves a specific motif in the N-terminal domain of syntenin-1 and is 
controlled by Ulk-1 dependent phosphorylation (Rajesh et al. 2011). Ulk-1 is a Ser/Thr kinase 
involved in regulation of different trafficking pathways, but also plays a crucial role in 
autophagy. Since autophagy was recently reported to attenuate canonical Wnt signalling in 
colon cancer, there is possibility for syntenin-1-Ulk-1 involvement in the process (Gao et al. 
2010a;Zhang et al. 2011). Considering all possible scenarios, it is important to determine the 
fate of Fz7 in cells expressing syntenin-1.  
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Thirdly, our data demonstrate, for the first time, that direct interaction of Frizzled-7 
with LNX proteins modulates canonical Wnt signalling mediated by the receptor in 
epithelial breast cancer cells. Our findings have identified several avenues in need of further 
investigation in order to fully understand the contribution of these proteins in regulation of 
Frizzled functionality. Proteins from LNX family of molecular scaffolds were reported to act 
as E3 ubiquitin ligases (D'Agostino et al. 2011;Nie et al. 2002). However, our data clearly 
demonstrate that Fz7 is not a substrate for ubiquitylation by LNX1 or LNX2, two proteins 
identified in proteomics analysis. Interestingly, overexpression of these proteins leads to a 
significant decrease of Fz7 ubiquitylation level. These findings indicate that after all LNX 
proteins are involved in regulation of Fz7 ubiquitylation, nonetheless via an unknown 
mechanism. Our results point towards previously unsuspected function of LNX as an 
adaptor protein or a competitive inhibitor of ubiquitylation. Therefore, it would be essential 
to do more research into a structural aspect of the Fz7-LNX interaction. In this regard our 
observation concerning the differential association of Fz7 with LNX1 isoforms is particularly 
intriguing. Overexpression of both LNX1 isoforms decreases Fz7 ubiquitylation, even though 
LNX1p80 did not bind to Fz7, as shown in the immunoprecipation assay. On the other hand, 
LNX1p70, lacking the RING domain, forms a complex with Fz7 and affects the receptor in 
a similar way as LNX2. One also needs to identify a relevant Fz7 ubiquitin ligase and 
understand the relationship between LNX and this enzyme. A starting point here might 
involve establishing a possible link between LNX proteins and ZNRF3 or RNF43, ubiquitin 
ligases that were shown to target other Fz receptors (Hao et al. 2012;Koo et al. 2012).  
Finally, we have identified a number of novel putative binding partners of Fz7; 
namely INADL/PATJ, MPDZ, Scribble, DLG1, ZO-1, ZO-2, PALS1/MPP5, MPP7, MAGI1, 
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MAGI3, SNX27, LNX1, LNX2. These PDZ proteins have been previously shown to be 
involved in regulation of trafficking of other membrane receptors, as well as in establishment 
of cell polarity. One of them is SNX27, sorting nexin-27, an endosome-associated adaptor 
controlling recycling of proteins to plasma membrane (Temkin et al. 2011). It is highly 
probable that SNX27 regulates Fz7 trafficking between endosomes and plasma membrane. 
Thus it would be very interesting to investigate the interaction between these two proteins 
and its functional implications. Interestingly, recycling activity of SNX27 requires both, PDZ 
domain–dependent binding of the cytoplasmic tail of the ligand and Phox homology (PX) 
domain–dependent interaction with the phosphoinositides in endosome membrane (Lauffer 
et al. 2010). Hence, one speculate about possible link between SNX27 and syntenin-1 through 
phosphoinositides, as the latter also interacts with PtdIns, but via PDZ1 domain 
(Zimmermann 2006). Furthermore, SNX27 was shown recently to cooperate with two other 
PDZ proteins (GOPC/PIST and NHERF1/3) in regulation of the subcellular localization and 
plasma membrane availability of a GPCR protein, somatostatin receptor subtype 5 (SSTR5) 
(Bauch et al. 2014). It was reported that those PDZ proteins act sequentially on the 
transmembrane ligand during the subcellular trafficking. Accordingly, it is possible that a 
similar mechanism regulates Frizzled receptor trafficking. Last but not least, a very 
interesting link emerges between Fz7 and basoapical cell polarity, as several of the identified 
proteins are components of polarity complexes. Fz7 has been implicated in regulation of 
planar cell polarity (Dijksterhuis et al. 2014), yet it wasn’t associated with basoapical polarity. 
Basoapical polarity in epithelial cells relies on three conserved complexes, two apical: 
Crumbs (Crumbs/PALS/PATJ) and Par (Par3/Par6/aPKC/Cdc42) and one basolateral: 
Scribble (Scribble/Dlg/Lgl) (Bazzoun et al. 2013). In the proteomic screen we have identified 
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PALS and PATJ (Crumbs complex), as well as Scribble and DLG1 (Scribble complex). The 
Crumbs complex regulates tight junction maintenance, whereas the Scribble complex 
associates with adherence junctions and controls their segregation from tight junctions.  We 
have also identified ZO-1 and ZO-2 (elements of tight junctions) and MPP7, protein 
interacting with DLG1, as potential interactors of Fz7. Due to the fact that many of the 
proteins mentioned above associate with each other, it is crucial to find among them 
a primary binding partner (or partners) of Fz7. Subsequently the function and relevance of 
this interaction should be assessed. Importantly, the involvement of the polarity proteins in 
the distribution of Fz7 needs to be examined. Furthermore, the possible involvement of these 
interactions in the EMT (epithelial-to-mesenchymal transition) should be also considered. 
Basoapical polarity is tightly regulated in epithelial cells and its loss correlates with gaining 
migratory and invasive properties by cells (Talbot et al. 2012). Since activation of Wnt 
signalling promotes EMT in cancer cells, it would be beneficial to establish whether 
interaction between Fz7 and polarity proteins plays role in the process.  
In summary, the data presented in this study demonstrate the importance of Frizzled-
7 interactions through its C-terminal PDZ binding motif. Our findings provide an insight 
into the role of PDZ domain containing proteins, focusing on LNX2 and syntenin-1, in 
regulation of Fz7 functions in breast cancer cells. The mechanisms in which the two proteins 
regulate Fz7 functions seem to be distinct, as evidenced by different effects on the receptor 
function when introduced into the model system. Nonetheless, both of them modulate 
canonical Wnt signalling in epithelial breast cancer cells due to their binding to Fz7 
. 
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Figure S. 1. Characterization of Myc-Fz7 and GFP-Fz7 expression constructs. 
(A) Western blot analysis of whole cell lysates of HEK293T cells transiently transfected 
with GFP-Fz7 (lane 1) or Myc-Fz7 (lane 3) expression vectors. Cells were lysed in 1% 
Triton X-100 and lysates of equal protein concentration were resolved by SDS-PAGE 
under non-reduced conditions, followed by detection with rabbit anti-GFP or rabbit anti-
Myc antibodies. β-actin served as a loading control. (B) MCF7 cells transiently transfected 
with Myc-Fz7 or GFP-Fz7 expression vector display membrane immunoreactivity. 48h 
after transfection cells were fixed and stained with mouse anti-Myc mAb and Alexa Fluor 
488-conjugated goat-anti mouse ab (green). Autofluorescence of GFP was examined. DAPI 
was used to visualize nuclei.  
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Figure S. 2. Verification of Myc-Fz7 and GFP-Fz7 constructs functionality. 
Wnt3a-induced signalling was analysed using TOP-Flash luciferase assay. HEK293T cells 
were transfected with reporter plasmids and with plasmid encoding Myc-Fz7 (A), GFP-Fz7 
(B) or mock transfected. Cells were stimulated for 24h with Wnt3a conditioned medium 
and TOP/FOP activity was analysed 48h after the transfection. Test was done in triplicates 
and three independent experiments were performed. Statistical significance was 
determined by two-tailed, unpaired Student’s t-test (* p<0.05; ** p<0.01) 
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Figure S. 3. Mutation in C-terminal PDZ-binding motif of Fz7 attenuates canonical Wnt 
signalling pathway in SKBr3 cells.  
Wnt-induced signalling was analysed using TOP-FLASH luciferase assay. SKBr3 breast 
cancer cells were stably transfected with Fz7 (WT or V574G). Cells were stimulated for 24h 
with Wnt3a conditioned medium and TOP/FOP activity was analysed 48 hours after the 
transfection with reporter plasmids. Test was done in triplicates and three independent 
experiments were performed. Statistical significance was determined by two-tailed, 
unpaired Student’s t-test (*p<0.05).  
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Figure S. 4. Fz7 interaction with LNX2 involves PDZ domains (GFP-trap). 
(A) HEK293T cells were co-transfected with GFP, GFP-Fz7 (WT, V574G or V574E) and 
Myc-LNX2. 24h after transfection cells were lysed in 1% Triton X-100 and lysates were 
incubated with GFP-Trap beads. After immunoprecipitation, retained proteins were 
resolved by SDS-PAGE, followed by western blotting and protein detection using mouse 
anti-Myc mAb and rabbit anti-GFP pAb. Images depict representatives of two 
independent experiments. (B) Densitometry analysis performed on data obtained in two 
independent experiments and demonstrated on a histogram, plotted as percentage of 
LNX2 binding to Fz7 mutants relative to the interaction of LNX2 with the wild type Fz7 
(taken as 100%). The statistical significance was determined by a two-tailed, unpaired 
Student’s t-test (*p<0.05; *** p<0.001).  
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